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In the past decade, synthesis of superparamagnetic nanoparticles has been intensively 
developed not only for its fundamental scientific interest but also for many 
technological applications. A wide range of metal, magnetic, semiconductor and 
polymer nanoparticles with tunable sizes and properties can be synthesized by wet-
chemical techniques. Magnetic nanoparticles (MNPs) have the advantages of good 
dispersibility in various solvents, high surface area and strong magnetic responsivity. 
These magnetic nanoparticles have emerged as excellent materials in many fields, such 
as immobilized catalysis, labelling and sorting of biological species, targeted drug or 
gene delivery, magnetic resonance imaging, and hyperthermia treatment. An important 
application of these nanoparticles is magnetic separation. Because of strong magnetism, 
these MNPs can be used as separable supports for adsorbent, which makes profound 
contribution to green chemistry. The surfaces of these particles are often modified by 
capping agents such as polymers, inorganic metals or oxides, and surfactants to make 
them stable, biocompatible, and suitable for further functionalization and applications. 
Cyclodextrins (CDs) are natural products which are produced from starch by means of 
enzymatic conversion. Typical cyclodextrins contain a number of glucose monomers 
ranging from six to eight units in a ring, creating a cone shape. CDs are promising tools 
for applications in drug carrier systems, nano reactors, bioactive supramolecular 
assemblies, molecular recognition and catalysis. The combination of CDs and inorganic 
nanoparticles has attracted increasing attention. These particles can be utilized for 
sensing, chiroselective analysis, controlled hydrophobic drug delivery and so on. In this 
work, magnetite silica particles coated with carboxymethyl-β-cyclodextrin (CMCD) are 
                                                                                                             Summary 
ix 
 
synthesized via layer-by-layer method. Cyclodextrin derivatives are synthesized and 
applied as chiral selectors because of their favorable properties (stability, low cost, UV 





salts in the ratio of 1:2 under alkaline and inert condition. Afterwards, 
surface of these particles are modified by silica to achieve stability against 
agglomeration and further modification of the particles‟ surface is done by coating with 
CMCD. The functionalized magnetic nanoparticles (core-shell) are characterized using 
several analytical methods namely Fourier Transform Infra-Red (FTIR) spectroscopy, 
Transmission Electron Microscopy (TEM), X-ray Photoelectron Spectroscopy (XPS), 
X-ray Diffraction (XRD) and Vibrating Sample Magnetometer (VSM). The thickness 
of silica shell is about 9 nm and average size of Fe3O4/SiO2/CMCD MNP (silica and 
CMCD coated magnetic nanoparticle) is around 29 nm. 
 The as-synthesized particles are used to adsorb single amino acid enantiomers namely 
D- and L- tryptophan (Trp), D- and L-phenylalanine (Phe) and D- and L-tyrosine (Tyr). 
Adsorption of these amino acid enantiomers on Fe3O4/SiO2/CMCD MNPs are also 
studied in detail as function of initial solution pH and temperature. High adsorption 
capacities of these MNPs are observed at pH around isoelectric points (pI) of the amino 
acids and at temperature 25°C. Noteworthy, remarkable differences are observed 
between adsorption capacities of the particles toward the above mentioned D- and L-
enantiomers of amino acids. At low concentration of amino acids, adsorption capacities 
are compared and in same conditions, adsorption capacities of the particles toward 
amino acids are in the order of tryptophan> phenylalanine>tyrosine. It seems that 
structure and hydrophobicity of amino acid molecules are responsible for difference in 
adsorption, by influencing the strength of interactions between amino acid molecules 
and the particles. It has been shown that adsorption of amino acids are consistent with 
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Freundlich isotherm equation. Finally, desorption of amino acids is carried out using 
methanol as eluent and it is found that around 90% desorption of L-amino acids and 
(75-80) % desorption of D-amino acids are achieved under described condition.  
Moreover, chiral resolution of racemic aromatic amino acids, DL-tryptophan (Trp), DL- 
phenylalanine (Phe), DL- tyrosine (Tyr) from phosphate buffer solution is achieved in 
present study employing the concept of selective adsorption by surface functionalized 
magnetic nanoparticles. Resolution of enantiomers from racemic mixture is quantified 
in terms of enantiomeric excess using chromatographic methods. The nanoparticles 
selectively adsorb L-enantiomer of Trp, Tyr, and Phe from racemic mixture and the 
enantiomeric excesses (e.e) are determined as 94%, 73% and 58% for Trp, Phe and Tyr 
enantiomers, respectively. Furthermore, XPS studies explore that interaction of the 
enantiomers is mainly attributed to the formation of hydrogen bond between amino 
group of the amino acid molecule and secondary hydroxyl group of CMCD on the 
particle surface. Noteworthy, FTIR studies prove that the enantiomers interact with 
hydrophobic cavity of cyclodextrin molecule to from inclusion complex. Furthermore, 
higher binding constants are obtained for inclusion complexation of CMCD with L-
enantiomers compared to D-enantiomers using flurometric titrations which might have 
yielded enantioselective properties of the CMCD functionalized magnetite silica 
nanoparticles.  
Afterwards, synthetic strategies are developed for grafting of amino-β-cyclodextrin (β-
CDen) onto superparamagnetic Fe3O4 nanoparticles by layer-by-layer methods. β-CDen 
(en:-NHCH2CH2NH2) functionalized magnetic nanoparticles  are fabricated by grafting 
mono-6-ethylenediamino-6-deoxy-β-CD (β-CDen) onto thiodiglycolic acid (TDGA) 
modified magnetic nanoparticles. For confirmation of grafting of β-CDen onto nano-
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sized magnetic particles, characterizations are carried out using FTIR spectroscopy, 
TEM, XPS, XRD analysis, VSM and Thermogravimetric Analysis (TGA). 
Characterizations by these methods reveal that CDen-MNPs are superparamagnetic 
nanoparticles with mean diameter of around 11.5 nm. Thermogravimetric analysis 
indicates that the amount of β-CDen grafted onto the CDen-MNPs is 0.050 mmolg−1. 
These as-synthesized β-CDen bonded magnetic nanoparticles with combined effect of 
inclusion properties of CD and magnetic properties of iron oxide are used as potential 
adsorbent for removal of two pharmaceuticals, carbamazepine (CBZ) and naproxen 
(NAP) and an endocrine disrupting agent, bisphenol A (BPA) from aqueous solution. 
Adsorption of the pharmaceuticals and endocrine disrupting compound is found to be 
pH dependent. β-CDen being grafted on TDGA-coated Fe3O4 nanoparticle contributes 
to an enhancement of adsorption capacities because of the inclusion abilities of its 
hydrophobic cavity with organic contaminants through host-guest interactions. 
Experimental data for adsorption of these three chemicals are fitted well to Freundlich 
isotherm model. Under same experimental conditions (pH 7 and 25°C), adsorption 
capacities of β-CDen-MNPs toward the three above mentioned targets are found to be 
in the order of carbamazepine> naproxen> bisphenol A. For better understanding of the 
interaction between target molecules and CDen MNPs, their inclusion complexes are 
studied by FTIR spectroscopy which confirms formation of inclusion complexes 
through van der Waals interaction. Desorption study of pharmaceuticals and EDC 
shows that ethanol could be used as desorbing agent but for complete desorption 
multiple steps may be required. 
Adsorption of beta-blocker, propranolol utilizing silica and CMCD modified magnetic 
nanoparticles (Fe3O4/SiO2/CMCD MNPs) from phosphate buffer solution is also 
studied as function of initial solution pH and initial concentration of sorbate. 
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Adsorption capacity of the adsorbent increases as pH is increased from 3 to 9 and then 
reaches the plateau at pH 11. It appears that hydrophobicity of beta-blocker, propranolol 
affects the interaction with cyclodextrin functionalized magnetic nanoparticles as well 
as adsorption capacity of the MNPs. Sorption capacity of the nanoadsorbents bearing 
cyclodextrin is compared and is found to be higher than that of bare magnetic 
nanoparticles, which is due to presence of cyclodextrin on nanoparticles‟ surface. 
Kinetic studies reveal that adsorption of propranolol on the nanoadsorbents is very fast 
and is completed within 1 hr. The kinetic data of propranolol adsorption is found to 
follow pseudo-second-order kinetic model. Equilibrium data in aqueous solution is well 
represented by Freundlich isotherm model. XPS analysis reveals that propranolol 
adsorption onto the magnetic nanoparticle mainly involve nitrogen atoms to form 
surface complexes. In addition, FTIR spectroscopy is applied to investigate adsorption 
mechanism. Finally, desorption studies are carried out and 50% methanol solution is 
found to be effective for almost complete desorption. All these experimental results 
show that β-cyclodextrin derivative conjugated MNPs could be promising tools for 
separation of chiral molecules as well as separation/ removal of pharmaceuticals, 
endocrine disrupting compounds and beta-blockers from waste-water.  
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Chapter 1: Introduction 
 
1.1 Background on magnetic separation 
Separation is an important process in chemical engineering which is used to enrich one 
of the components from the feed solution. Magnetic separation is a process in which 
magnetically susceptible material is extracted from a mixture using magnetic force. 
Magnetic separation techniques are used in several different areas ranging from steel 
production to biotechnology, since they are rapid, cost effective and highly efficient. 
The process, magnetic separation involves magnetic particles, carrier liquids, 
complexes and target molecules. In a standard process, magnetic particles are 
compounded with some intermediate to form a complex. These complex particles can 
interact with the target molecules and can be separated using magnetic field gradient. The 
basic concept is to utilize physical interactions between magnetic complex particles and 
target molecules as well as the specific chemical interactions between the particles and 
target molecules. The interaction forces involved in magnetic separation process could 
be electrostatic, hydrophobic and specific ligand interactions. 
In 1987, Wikström reported the use of magnetically susceptible additives (ferrofluids or 
iron oxide particles) and an external magnetic field induced faster phase separations in 
liquid–liquid extraction procedures than the more conventional methods like 
chromatography, filtration and distillation processes [1].  Since the introduction of 
magnetic separation techniques employing small magnetic particles in the 1970s, 
increased attention has been paid to their development and applications in different 
areas such as medical imaging, magnetic field assisted transport, separations analysis, 
biomedical and biotechnological applications including drug delivery, biosensors, 
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chemical and biochemical separation and concentration of trace amounts of specific 
targets, such as bacteria, enzyme encapsulation and contrast enhancement in magnetic 
resonance imaging (MRI) [2-11].  
1.2 Surface functionalization of magnetic particles 
Over the last few years, synthesis of superparamagnetic nanoparticles (NPs) was 
intensively developed for various applications because of the advantages of good 
dispersibility in various solvents, high surface area, and strong magnetic responsivity 
[12, 13]. However, several unavoidable problems are associated with magnetic NPs, 
such as their intrinsic instability over long periods due to their tendency to aggregate in 
order to reduce their surface energy, as well as the ease with which they are oxidised in 
air. The aggregation of magnetic nanoparticles can significantly decrease their 
interfacial area, thus resulting in the loss of magnetism and dispersibility. It is therefore 
crucial to develop new strategies to chemically stabilize the bare magnetic nanoparticles 
against degradation during or after the synthesis processes [14]. Surface 
functionalization allows immobilized affinity ligands to capture target biomaterials. 
Research has shown that coatings of polymer, silica, or other materials over magnetic 
nanoparticles can prevent aggregation and functionalize the magnetic nanoparticles to 
extend their applications in catalysis and biomedicine. Various materials such as 
surfactant, dextran, polyethylene glycol (PEG), organic acids, polyoxoamines, metal 
oxide and silica have been used for coating and stabilizing magnetic nanoparticles. 
Among the materials studied for coating, silica is particularly attractive as it exhibits 
high biocompatibility and stability, low toxicity, and simple functionality [14-16]. 
Unlike polymers, it is not subjected to microbial attack and it neither swells nor changes 
porosity in response to the environmental pH values [17]. 
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Now-a-days, cyclodextrins (CDs) play major roles in many disciplines such as 
supramolecular chemistry, analytical chemistry, catalysis and biomedicine [18-24]. 
Since their discovery, parent CDs and their derivatives have served as multi-purpose 
prototypes for novel host compounds. The CD molecules assume shape of a truncated 
cone in aqueous environment, exposing their hydroxyl groups to the solvent while the 
relatively more hydrophobic remainder of the molecule constitutes internal cavity. 
Properly sized and shaped guests can enter the cavity to form inclusion complexes that 
can be stabilized by hydrophobic interactions, van der Waals forces and hydrogen 
bonds [18-25]. All these properties account for their aqueous solubility and ability to 
encapsulate hydrophobic moieties into their cavities. The incorporation of guest 
molecules in CD inclusion complexes in aqueous media has been the basis for their 
most biomedical applications [20, 21, 26]. Recently, some researchers have started 
using cyclodextrin coated particles using their inclusion complex formation property for 
various applications [27-30].  
Initially in this work, we have coated bare magnetic nanoparticles with silica and 
carboxymethyl-β-cyclodextrin (CMCD) and have utilized the as-synthesized particles to 
separate single chiral amino acid enantiomers from aqueous solutions. Benefit of using 
cyclodextrin bonded magnetic silica particles is tributed by the combined properties of 
the particles such as magnetic properties of Fe3O4, biocompatibility of silica shell and 
chiral recognition and inclusion complex formation properties of cyclodextrin.  
Afterwards, silica and CMCD coated magnetic nanoparticles have been applied to 
separate chiral amino acid enantiomers from their racemic mixture in aqueous solution. 
Moreover, superparamagnetic nanoparticles have been coated with amino-CD (β-CDen) 
and these nanoparticles have been utilized as potential adsorbent for separation of 
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pharmaceuticals and endocrine disrupting compound. Recently, magnetic nanoparticles 
coated with silica and CMCD have been used for adsorption separation of beta-blocker, 
propranolol from aqueous solution. These as-prepared β-CD derivative coated magnetic 
nanoparticles with inclusion complex formation capabilities and magnetic properties, 
would be of great use for chiral separation and separation of emerging contaminants 
(pharmaceuticals, EDCs and beta-blockers) from waste-water. 
1.3 Research objectives 
Currently established chiral chromatographic separation methods are able to resolve 
most of the protein amino acids, but there is still need for a rapid, highly efficient and 
cost effective method for enantioseparation of amino acids. To the best of our 
knowledge, no such work has been published for enantioseparation of amino acids 
using coated/ uncoated magnetic nanoparticle which will be a promising way to 
separate the enantiomers and also inexpensive. Although the magnetic separation 
processes are increasingly appealing due to their simplicity, efficiency and versatility, 
there is still a need to study these separation processes in a systemically and detailed 
way. Firstly, previous published work focused on application of chromatographic 
methods for chiral separation. So, separation of chiral enantiomers can be studied 
utilizing surface functionalized magnetic particles. Secondly, for batch adsorption 
mode, adsorption equilibrium, adsorption kinetics and effects of various parameters 
(such as pH, temperature, etc.) on adsorption need to be studied in details. Furthermore, 
enantioselective separation/ chiral resolution of racemic amino acids should be 
investigated. Lastly, exploration of interaction forces involved and enantioseparation 
mechanism of the racemic amino acids onto Fe3O4/SiO2/CMCD MNPs is very 
important. 
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Research on the effects of chemical pollution in the environment related to urban waste-
waters‟ discharge and reuse until recently was focused almost exclusively on 
conventional pollutants. Thousands of tons of pharmacologically active substances 
being used annually are ending up in waste-waters. In addition, during last several years 
there has been a growing level of concern related to the hypothesis that various 
chemicals may exhibit endocrine disrupting effects. In many countries facing prolonged 
droughts and implementing waste-water reuse schemes for irrigation and groundwater 
discharge, existence of xenobiotic compounds in the tertiary treated waste-waters 
constitutes a new concern. To the best of our knowledge, no such research work has 
been found which utilizes cyclodextrin functionalized magnetic nanoparticles for 
removal of pharmaceutically active compound, endocrine disruptors and beta-blockers. 
Thus the application of cyclodextrin derivative functionalized magnetic nanoparticles 
for removal of pharmaceuticals, endocrine disrupting compound and beta-blocker 
should be investigated. Furthermore, adsorption equilibrium, detailed adsorption 
kinetics and effect of operating condition on adsorption should be studied in batch 
adsorption mode. Desorption of the adsorbed molecules and regeneration of the nano 
adsorbents should be studied as well. 
The overall objectives of this research program are to study the application of nanosized 
magnetic particles for separation of chiral amino acids, pharmaceuticals, endocrine 
disrupting compound and beta-blocker and the evaluation of effectiveness of the 
separation method. The desired goals of different procedures could be divided into the 
following: 
1) Preparation of nano-sized magnetic particles, and modify the surface with silica 
and carboxymethyl-β-cyclodextrin. 
   Chapter 1 
6 
 
2) Characterization of as-synthesized magnetic particle coated with silica and 
carboxymethyl-β-cyclodextrin (Fe3O4/SiO2/CMCD MNPs). 
3) Study on adsorption equilibrium, adsorption kinetics and effects of various 
parameters on adsorption of single amino acid enantiomers. 
4) Study on selective adsorption of the enantiomers of chiral amino acids and 
analysis of chiral separation of enantiomers. 
5) Exploration of chiral separation mechanism of the amino acids onto 
Fe3O4/SiO2/CMCD MNPs using several analytical techniques. 
6) Synthesis of thiodiglycolic acid (TDGA) and amino-cyclodextrin (β-CDen) 
functionalized magnetic nanoparticle and characterization of the synthesized 
particle. 
7) Detailed study of adsorptive removal of pharmaceuticals (carbamazepine, 
naproxen) and endocrine disrupting compound (bisphenol-A) using β-CDen 
coated particle. 
8) Study of adsorption behaviour of beta-blocker, propranolol onto 
Fe3O4/SiO2/CMCD MNPs in details. 
9) Study on desorption of adsorbed targets using different chemicals. 
1.4 Organization of the Thesis 
The thesis is organized into nine chapters. Chapter 1 gives an introduction to the 
magnetic separation method. The objectives of the present work are introduced and 
structural organization of the whole thesis is also presented in this chapter. Chapter 2 
describes the background of magnetic separation, reviews previous work on magnetic 
separation and introduces the recent progress in separation of chiral biomolecules, 
pharmaceuticals, endocrine disrupting compounds and beta-blockers. Based on the 
detailed review on past work, scope of this study is presented. In Chapter 3, description 
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on experimental materials and methods are presented. Chapter 4 describes the detailed 
characterization of silica and carboxymethyl-β-cyclodextrin coated magnetic 
nanoparticles. In Chapter 5, adsorption results of single amino acid enantiomers of Trp, 
Phe and Tyr on silica and CMCD coated MNPs under different operating conditions are 
presented and kinetics of the batch adsorption studies are investigated.  In Chapter 6, 
chiral separation of racemic amino acids utilizing silica and CMCD coated MNPs is 
explored. Selective adsorption capacities of the magnetic particles towards the 
enantiomers are studied, enantiomeric excesses of the amino acids are determined and 
some insights are presented regarding chiral separation mechanism. In Chapter 7, 
adsorption results of pharmaceuticals and endocrine disrupting compounds are 
presented. Effect of operating conditions, kinetics of sorption separation and desorption 
conditions of pharmaceuticals and endocrine disruptor onto β-CDen modified MNPs 
are explored in this chapter. Chapter 8 covers detailed adsorption studies of beta-
blocker, propranolol which include effect of operating parameters, kinetic studies of 
adsorption onto CMCD functionalized magnetite silica nanoparticles and desorption 
studies. Adsorption mechanism is also described using different analytical methods in 
Chapter 8. Finally, in Chapter 9 conclusions obtained from the research work are 
presented and trends for future works are presented.




Chapter 2: Literature review 
 
In this chapter, literature review on magnetic separation, magnetic nanoparticles, their 
properties and surface modification, cyclodextrin and its structural properties and 
applications, chiral amino acid separation, separation of pharmaceuticals, endocrine 
disrupting compounds and beta-blockers are presented. 
2.1 Magnetic separation 
Economical separation from bioprocesses is important for purification of bioproducts. 
However, mechanical separation techniques such as centrifugation or filtration have 
some disadvantages; i.e. centrifugation requires a lot of energy and filtration sometimes 
becomes very troublesome by clogging of filters. Among the other separation 
techniques, chromatography is a powerful technology for purification of biological 
substances in both analytical and preparative scales. But, packed bed chromatographic 
column is prone to clogging. To overcome this drawback, various alternative separation 
techniques have been developed, including fluidizing bed adsorption [31], expanded 
bed adsorption [32] and magnetic separations [33, 34]. Compared with mechanical 
separation, magnetic separation is particularly attractive since less energy is needed and 
strong magnetic force can be generated easily. 
There have been several separation approaches performed under magnetic field. The 
most well-known technique is the magnetically stabilized fluidized bed [34]. The others 
involve high gradient magnetic filtration [35], magnetophoresis [36] and magnetic split-
flow thin fractionation [37]. 
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2.1.1 Classifications of magnetic separation  
The technique magnetic separation can be classified as follows- 
1. Magnetic separation: In a narrow sense, magnetic separation is a technique whose 
goal is to concentrate a magnetic material, to remove magnetic impurity or to extract 
valuable magnetic materials by discharging the particles captured by a magnet at a 
position depending on their magnetic properties. 
2. Magnetic filtration: Magnetic filtration is the method to separate magnetic particles 
by capturing them in a filter. 
3. Magnetic flotation: Magnetic interactions are used to separate materials of different 
density by magnetic flotation. 
4. Magnetohydrostatic separation: When the separation target is non-magnetic or an 
ion, the magnetic reagent method, in which separation target is sprinkled with a 
magnetic reagent, is employed. Magnetohydrostatic separation is used to separate non-
magnetic materials suspended in a magnetic fluid by adjusting the magnetic buoyant 
force on materials with a magnetic gradient field. 
These techniques are all based on the magnetic feature of the solid-phase employed to 
achieve a desired separation. Thus, the availability of inexpensive magnetic supports 
with high selectivity and magnetic responsiveness is crucial to the large-scale 
application of the above-mentioned techniques. 
2.1.2 Principle of magnetic separation 
Magnetic separations fall into two general types: (1) those in which the material to be 
separated is intrinsically magnetic, (2) those in which one or more components of a 
mixture have been rendered magnetic by the attachment of a magnetically responsive 
entity.  
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Large-scale industrial magnetic separations are based on the intrinsic magnetic 
properties of materials. For example, low grade iron ores can be separated magnetically 
into hematite and waste; iron sulfide is paramagnetic and can be extracted from 
pulverized coal [38, 39]. Furthermore, red blood cells [40, 41] (which contain high 
concentrations of paramagnetic haemoglobin) and magnetic bacteria [42] (which 
contain small magnetite particles) provide examples of intrinsically magnetic 
responsive biological particles. So, in this method, magnetic separation of the target 
molecule can be achieved without further modification of magnetic materials.  
In biological systems, magnetic separations generally involve conferring magnetism 
upon a non-magnetic (diamagnetic) molecule by attaching or adsorbing it to a 
magnetically responsive particle. Magnetic support materials have been widely used in 
the field of biotechnology in bioseparations and immunoassays and as immobilizers of 
enzymes and drug carriers [43-49], separation and purification of protein [50, 51]. The 
principle of this method is to utilize magnetic particles, which bind the target molecules 
via intermediates to form complexes that subsequently can be separated from the bulk 
solution in a gradient magnetic field. Thus, the non-magnetic targets firstly interact with 
the surfactants; polymer or ligand coated on magnetic particles, and then form a 
magnetic complex, which can magnetically respond to an external magnetic field. 
Separation process of non-magnetic target molecules is presented in Figure 2-1. 
 




Figure 2-1 Schematic diagram of separation of non-magnetic targets. 
 
2.1.3 Interaction forces involved in magnetic separation 
Amino acid is a molecule containing an amine group, a carboxylic acid group and a 
side-chain that varies between different amino acids. Amino acids are usually classified 
by the properties of their side-chain into four groups. The side-chain can make an 
amino acid a weak acid or a weak base, and a hydrophile if the side-chain is polar or a 
hydrophobe if it is nonpolar. The amine and carboxylic acid functional groups found in 
amino acids allow them to have amphiprotic properties. An amphoteric species is a 
molecule or ion that can react as an acid as well as a base. Amino acids are found in all 
living organisms. Proteins are made in association of 20 primary amino acids [52]. It 
was found that molecular recognition plays important role in adsorption of amino acids 
[53].  
Carbamazepine (CBZ) is a drug generally used for treatment of epilepsy and referred as 
neutral drug. Naproxen (NAP) is used for relief from fever, pain and exists as free acid 
which is practically insoluble in water. On the other hand, bisphenol A (BPA) is an 
endocrine disruptor and has two phenol functional groups in its structure. CBZ and 
BPA have pKa >10 and they exist in neutral form below their pKa. On the other hand, 
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NAP has pKa of 4.15 and exists in neutral form below pH 4.15 and exists as negatively 
charged molecule above pH 4.15.  
Propranolol is a sympatholytic non-selective beta-blocker. Sympatholytic is used to 
treat hypertension, anxiety and panic. Propranolol is available in generic form as 
propranolol hydrochloride. Propranolol (pKa = 9.42), exists as a positively charged 
molecule in the tested pH below its pKa and it exists as negatively charged molecule 
above its pKa. Because of differences in surface charge, structure and physicochemical 
properties of the adsorbate and adsorbent, their uptake may differ significantly [54]. 
The adsorption behavior of the adsorbates at solid surfaces of magnetic nanoparticles is 
the net result of hydrogen bonding, ionic interaction, van der Waals interaction or 
hydrophobic effect which is described below. 
1. Electrostatic interaction: If biomolecules have positive or negative surface charges, 
electrostatic interaction may guide the molecule to orient in the unique direction to 
bond with the oppositely charged surface of magnetic particles. Electrostatic interaction 
between amino acid and magnetic particle also exists at the isoelectric point of the 
amino acid. Some researchers studied the electrostatic aspects of the interaction of the 
amino acids utilizing different adsorbents [55, 56]. It was observed that, adsorption of 
acidic and basic pharmaceuticals on acrylic aster resin were attributed by electrostatic 
interaction [57]. Some researchers found that adsorption was dominated by electrostatic 
interaction using modified attapulgites for sorptive removal of beta-blocker propranolol 
[58]. 
2. Hydrophobic interaction: Hydrophobic interactions between biomolecules and 
magnetic particles also contribute to the adsorption process. Basically, non-polar side 
chain of biomolecules influence hydrophobic interaction with the magnetic particles‟ 
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surface. Some researchers found that the structure and hydrophobicity of amino acid 
molecules were responsible for the difference in adsorption, by influencing the strength 
of interactions between amino acid molecule and non-ionic polymeric adsorbent [53]. 
Furthermore, some work demonstrated the rational use of hydrophobic and electrostatic 
ligand-polymer interactions for recognition of D-Phe in a novel molecular imprinting 
system [55, 56]. Also, uptake of some pharmaceuticals and EDCs on some adsorbents 
was observed to be governed by the hydrophobicity of the compounds [54].  
3. Hydrogen bonding and van der Waals interaction: Hydrogen bonds are formed 
between amino-carbonyl, hydroxyl-amino or hydroxyl-carbonyl groups of the amino 
acid and the adsorbent [52]. van der Waals force is the sum of attractive or repulsive 
forces between molecules other than those due to covalent bonds or the electrostatic 
interaction of ions with one another or with neutral molecules. van der Waals forces are 
relatively weak compared to normal chemical bonds. It was observed that very little van 
der Waals interaction was involved in chemical shifting of some amino acids, L-alanine 
(Ala) and L-leucine (Leu) [59]. Some studies showed that, adsorption of neutral 
pharmaceutical on acrylic ester resin was solely attributable to nonelectrostatic 
interaction involving hydrogen bonding (probably through the oxygen groups of the 
adsorbents) and van der Waals interactions [57]. While studying adsorption of  beta-
blockers pinodolol and propranolol using β-cyclodextrin polymer, some researchers 
estimated that once the aromatic rings of pinodolol and propranolol were included 
within the CD cavities, their bulky chains might have interacted with the polymer 
network through hydrogen bonding [60]. 
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2.1.4 Advantages and disadvantages of magnetic separation 
Magnetic separation is a technology involving the transport of magnetic or magnetically 
susceptible particles in a gradient magnetic field. Compared to the conventional 
separation methods, such as centrifugation and filtration, magnetic separation has the 
following advantages: 
1. Magnetic separation process is simple and relatively easy to carry out in batch 
adsorption on magnetic particles. Separation of solid and liquid phases can be easily 
achieved only by manipulating an external magnetic field. 
2. Since nano-sized magnetic particles have larger specific surface area, adsorption of 
target molecules at the surface of magnetic particles occurs at high rate. Meanwhile,  
transfer of magnetic particles in magnetic field is also fast by applying strong magnetic 
field. 
3. The magnetic nanoparticles provide lower mass transfer resistance and less fouling 
[61]. 
4. Surface of magnetic nanoparticles‟ can be easily modified to contain different surface 
functional groups which are highly useful for separating wide range of sample 
molecules. For example, magnetic particles can be used to sort cells, recover antibodies/ 
enzymes, purify proteins etc. 
5. Size of nanoparticles can be controlled manipulating various reaction parameters 
from nanometer to micrometer range. 
6. Conventional separation methods need the use of expensive centrifuges or vacuum 
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However, disadvantages of magnetic separation technique are- 
1. The components of the system to be separated must have different magnetic 
susceptibilities [39]. 
2. Most of the present magnetic separation processes, especially in biotechnology, are 
studied only on lab-scale. 
2.2 Magnetic particle 
Most of the adsorption separation processes, including ion exchange, affinity, 
hydrophobic and reverse phase chromatography are performed in packed bed of 
particles typically having diameters on the order of tens of microns [62]. But because of 
the problems of „high-pressure‟ and fouling in the packed bed systems, there was ample 
necessity to use alternative adsorbent. Magnetic particles are such an adsorptive 
separation media which can provide large interfacial areas, small diffusional 
resistances, high selectivity, capacity for large products and can be easily recovered and 
regenerated, even in the presence of colloidal contaminants. The most commonly used 
magnetic particles are magnetite (Fe3O4) and maghemite (γ- Fe2O3). Other types of 
magnetic particles are MeO•Fe2O3, where Me= Ni, Co, Mg, Zn, Mn, Fe.  
The attractive or repulsive forces between magnetic materials can be described in terms 
of magnetic dipoles- tiny bar magnets with opposite poles. Materials can be classified 
into diamagnetic, paramagnetic, ferromagnetic, ferrimagnetic, and antiferromagnetic 
according to the arrangement of their magnetic dipoles in the absence and presence of 
an external magnetic field [63, 64]. Figure 2-2 shows schematic diagrams of these five 
different situations. 
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Figure 2-2 Schematic illustrating the arrangements of magnetic dipoles for five 
different types of materials in the absence or presence of an external magnetic field (H) 
[4]. 
 
If a material does not have magnetic dipoles in the absence of an external field and has 
weak induced dipoles in the presence of a field, the material is referred as diamagnetic. 
The magnetization of a diamagnet responds in the opposite direction to the external 
field. If a material has randomly oriented dipoles that can be aligned in an external 
field, it is paramagnetic. The magnetization of a paramagnet responds in the same 
direction as the external field. The magnetic interactions derived from the above two 
types of materials are very weak. For a ferromagnetic material, the magnetic dipoles 
always exist in the absence and presence of an external field and exhibit long-range 
order. Macroscopically, such a material displays a permanent magnetic moment. In a 
ferrimagnetic material there are always weaker magnetic dipoles aligned antiparallel to 
the adjacent, stronger dipoles in the absence of an external magnetic field. For an 
antiferromagnetic material, the adjacent dipoles are antiparallel in the absence of an 
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external field and cancel each other. In general, magnetic materials are referred to those 
characterized by either ferro- or ferrimagnetic features.    
2.2.1 Magnetic forces 
When a magnetic material is placed in a magnetic field of strength H, the magnetic 
induction/magnetic flux density can be expressed as: 
                            [2-1] 
where, µ0 is the permeability of free space, and magnetization M = m/V is the magnetic 
moment per unit volume, where, m is the magnetic moment on a volume V of the 
material. Relationship between magnetization and magnetic field strength is: 
                       [2-2] 
A magnetic field gradient is required to exert a force at a distance in the separation 
process. From the definition, magnetic force acting on a point like magnetic dipole m 
will be 
                                  [2-3] 
In case of dilute suspension of nanoparticles in pure water, it can be approximated that 
the overall response of the particles plus water system      , so that equation 2-2 
becomes:    
                                                                                                       [2-4] 
where, Fm is the magnetic force, χ is the magnetic susceptibility of magnetic particles, 
Vm  is the volume of the magnetic particles, µ0 is the permeability of free space, and B 
is magnetic flux density. In general, magnetic force exerted on magnetic particles by 
magnetic field can be used to capture particles. 
Both ferro- or ferrimagnetic materials can be described using a number of basic 
parameters derived from the magnetization curve where magnetization M or flux 
χ 
VmΔχ 
   µ0 
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density B is plotted against the magnetic field strength H [63, 64]. Figure 2-3 shows a 
typical curve, where magnetization always falls behind the applied magnetic field and 
produces a hysteresis loop because of magnetic domains inside the material [4]. From 
the magnetization curve, one can easily find the saturation magnetization Ms or the 
maximum value of M; residual magnetization Mr at zero applied field strength; and the 
coercivity Hc or the external field required to reduce the magnetization back to zero. A 
material is called a soft magnet if it can be magnetized readily in a weak field of around 
10 Oe (1 Oe=1000/4π Am–1) [63]. On the other hand, some magnetic materials can 
have very strong coercive fields and require large external fields applied to the opposite 
direction in order to be demagnetized. Such materials are known as hard magnets.  
 
Figure 2-3 The typical magnetization curve of a ferro- or ferromagnetic material [4]. 
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2.3 Superparamagnetic nanoparticles 
Magnetism is highly volume and temperature dependent because this property arises 
from the collective interaction of atomic magnetic dipoles [63, 64, 4]. When the size of 
a ferro- or ferrimagnet decreases to a certain critical value rc, the particles change from 
a state with multiple magnetic domains to one with a single domain. As shown in 
Figure 2-4 (a), if the size continues to decrease to a value r0, the thermal energy 
becomes comparable with that required for spin to flip directions, leading to the 
randomization of the magnetic dipoles in a short period of time. Such small particles do 
not have permanent magnetic moments in the absence of an external field but can 
respond to an external magnetic field. They are referred to as superparamagnetic 
particles. In superparamagnetic particles, thermal fluctuations are strong enough to 
spontaneously demagnetize a previously saturated assembly; therefore these particles 
have zero coercivity and have no hysteresis (Figure 2-4-(b)). 
The critical radius rc for a spherical particle with the stability defined by the flipping 
probability of the magnetic moment of < 10% over one second can be estimated using 
the following equation [63]: 
            
                                  [2-5] 
where kB is Boltzmann constant, T is temperature, and Ku is the crystalline 
magnetoanisotropy. Depending on Ku, the critical radii of nanoparticles can be 3–4 nm 












Figure 2-4 (a) Schematic illustrating the dependence of magnetic coercivity on particle 
size, (b) Magnetization characteristics of superparamagnetic (solid line), paramagnetic 
(dotted line) and ferromagnetic (dashed line) particles [4]. 
 
Superparamagnetic nanoparticles have found widespread use in many traditional areas 
including magnetic data storage, ferrofluids technology, magnetorheological polishing, 
and energy storage; they also hold great potential for many other applications related to 
biomedical research [4]. To this end, superparamagnetic colloids have been exploited 
for labelling and separation of DNAs, proteins, bacteria, and various biological species, 
(a) 
(b) 
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as well as applied to magnetic resonance imaging (MRI), guided drug delivery, and 
hyperthermia treatment of cancer [64, 65]. Table 2-1 includes some properties of 
superparamagnetic particles. 















Fe 3.0–9.3 1.7 × 106 (0 K) 1043 (TC) [63, 66] 
Co 2.0–12 1.4 × 106 (0 K) 1394 (TC) [63, 66] 
Ni 5.0–13 5.1 × 105 (0 K) 631 (TC) [66, 67] 
FePt 3.0–17 1.1 × 106 (0 K) 750 (TC) [63, 68, 69] 
CoPt 7.0 0.8 × 10
6 
(0 K) 840 (TC) [63, 69] 
γ-Fe2O3 3.0–25 4.5–4.9 × 10
5  
(300 K) 
848 (TC) [63, 65] 




858 (TC) [63, 65, 66] 
[70] 
CoO ~8 1.4 × 10
6
 (0 K) 291 (TN) [63, 69] 
CoFe2O4 2.0–12 4.8 × 10
5
 (0 K) 793 (TC) [63, 66, 71, 
72] 
 
2.3.1 Properties of superparamagnetic nanoparticles 
Superparamagnetism is characterized by zero intrinsic coercivity and no residual 
magnetism. Superparamagnetism is the phenomenon by which magnetic materials 
exhibit behavior similar to paramagnetism at temperatures below Curie temperature. 
Generally, coupling forces in magnetic materials cause the magnetic moments of 
neighboring atoms to align, resulting in very large internal magnetic field. At 
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temperatures above Curie temperature, the thermal energy is sufficient to overcome  
coupling forces, causing the atomic magnetic moments to fluctuate randomly. Because 
there is no longer any magnetic order, the internal magnetic field no longer exists and 
the material exhibits paramagnetic behavior. Superparamagnetism occurs when the 
material is composed of very small crystallites (1-10 nm). In this case, even though the 
temperature is below Curie temperature and the thermal energy is not sufficient to 
overcome coupling forces between neighboring atoms, thermal energy is sufficient to 
change the direction of magnetization of the entire crystallite. The resulting fluctuations 
in the direction of magnetization cause the magnetic field to average to zero. The 
susceptibility of magnetic fluid changes with temperature according to Curie-Weiss 
Law: 
                         χ                                 [2-6] 
where, χ is the magnetic susceptibility, C is a material-specific Curie constant, T is 
absolute temperature (°K), Tc is the Curie temperature (°K).  
2.3.2 Synthesis of superparamagnetic nanoparticles 
Numerous chemical methods can be used to synthesize magnetic nanoparticles for 
various applications: microemulsions [73], sol-gel syntheses [74], sonochemical 
reactions [75], hydrothermal reactions [76], hydrolysis and thermolysis of precursors 
[77], flow injection syntheses [78], and electrospray syntheses [79]. The synthesis of 
superparamagnetic nanoparticles is a complex process because of their colloidal nature. 
The synthesis approach is based on homogenous neucleation and subsequent particle 
growth as depicted in Figure 2-5. The first main chemical challenge consists of defining 
experimental conditions, leading to a monodisperse population of magnetic grains of 
suitable size. The second critical point is to select a reproducible process that can be 
 C 
T-TC 
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scaled up without any complex purification procedure, such as ultracentrifugation [80], 
size-exclusion chromatography [81], magnetic filtration [82] or flow field gradient [83]. 
The above mentioned methods have been used to prepare particles with homogeneous 
composition and narrow size distribution. However, the most common method for  
production of magnetite nanoparticles is the chemical co-precipitation technique of iron 
salts [84-86].  
          
 
Figure 2-5 Mechanism of nanoparticle production using liquid phase/colloidal methods 
[87]. 
The co-precipitation technique is probably the simplest and most efficient chemical 
pathway to obtain magnetic particles by which large amount of magnetic particles can 
be synthesized. Iron oxides (either Fe3O4 or γ-Fe2O3) are usually prepared by adding 
stoichiometric mixture of ferrous and ferric salts in aqueous medium. The chemical 
reaction of Fe3O4 formation may be written as equation 2-7. 
                                                                   [2-7] 
According to the thermodynamics of this reaction, complete precipitation of Fe3O4 
should be expected at a pH between 8 and 14, with a stoichiometric ratio of 2:1 







) in a non-oxidizing environment. However, magnetite (Fe3O4) is not very 
stable and is sensitive to oxidation. Magnetite is transformed into maghemite (γ-Fe2O3) 
in the presence of oxygen. 
                    
            
                      [2-8] 
2.3.3 Surface modification of magnetic nanoparticles 
Once the nanoparticles are produced and purified to a satisfactory level it is often 
necessary to introduce surface modifications. Surface modifications can be for the 
purposes of (a) passivating very reactive nanoparticle, (b) stabilizing very aggregative 
nanoparticle in a medium (which may be a solvent or a polymer melt) where the 
nanoparticles are to be dispersed, (c) functionalizing the nanoparticle for further 
applications or (d) promoting the assembly of nanoparticles (Figure 2-6). Most 
commonly used surface modification methods include grafting thiolated surfactants or 
polymers, adsorption of charged surfactants, charged ligands or polymer brushes, 
attachment of biological molecules such as DNA, peptides, proteins, antigens, 
streptavidin or coating a continuous polymer film on nanoparticles [87].  
 
Figure 2-6 Different approaches to surface modifications, (a) surface treatment to attain 
thermodynamic stability in dispersion, (b) surface adsorption of a surfactant or a block 
copolymer, (c) surface modification to make the nanoparticle functional [87]. 
 
(a) (c) (b) 
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2.3.3.1 Surface functionalization with monomeric stabilizer 
2.3.3.1.1 Coated with carboxylates 
Functional groups, including carboxylates, phosphates, and sulfates, are known to bind 
to the surface of magnetites [65]. Furthermore, this stabilization can be tailored for 
dispersibility into oil/hydrocarbon carrier fluids or aqueous media. The surface of 
magnetite nanoparticles can be stabilized in aqueous dispersion by the adsorption of 
citric acid [88]. Bee et al. have investigated the effect of concentration of citrate ions on 
the size of magnetic particles [89]. Krishnamurti and Huang have studied the influence 
of citrate on kinetics of Fe
2+
 oxidation and the resulting hydrolytic products of Fe
3+ 
[90]. Liu and Huang have observed that increasing concentrations of citric acid causes 
significant decrease in the crystallinity of the iron oxides formed during the synthesis 
[91]. Other coating molecules, such as gluconic acid, dimercaptosuccinic acid [92] and 
phosphorylcholine [93] can be used for stabilization of iron oxide in aqueous medium. 
2.3.3.1.2 Coated with phosphates 
Several researchers have studied the possibility of using alkanesulphonic and 
alkanephosphonic acid surfactants as efficient binding ligands on the surface of Fe2O3 
nanoparticles and as stabilizers for particle dispersion in organic solvents [94, 95]. Yee 
et al. proposed two possible bonding schemes for the phosphonate ions on Fe
3+
, i.e., one 
oxygen or two oxygen atoms of the phosphonate group binding onto the surface [96]. 
Sahoo et al. have reported the surface derivatization of magnetite by oleic acid, lauric 
acid, dodecylphosphonic acid, hexadecylphosphonic acid, and dihexadecyl phosphate 





 in the presence of highly hydrophilic poly(vinylalcohol 
phosphate) (PVAP). The impacts of the polymer concentration on the particle size, size 
distribution, colloidal stability, and magnetic property have been studied. The aqueous 
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suspension of magnetite, prepared using 1% PVAP solution, has been found to be stable 
for 4 weeks at pH 5-8 [98]. The acceptable biocompatibility of phosphonate and 
phosphate ligands may advance toward the use of encapsulated magnetic nanoparticles 
in medical applications, such as magnetic resonance imaging, and other biophysical 
purposes [99]. 
2.3.3.2 Surface functionalization with inorganic materials 
Iron oxide nanoparticles can be coated with silica, gold or gadolinium (III). These 
coatings not only provide stability to the nanoparticles in solution but also help in 
binding various biological ligands to the nanoparticle surface. These nanoparticles have 
an inner iron oxide core with an outer metallic shell of inorganic materials.  
2.3.3.2.1 Coated with silica 
Silica has been exploited as a coating material for magnetic nanoparticles [100-102]. 
Usually, an inert silica coating on the surface of magnetite nanoparticles prevents their 
aggregation in liquid, improves their chemical stability, and provides better protection 
against toxicity. This coating stabilizes the magnetite nanoparticles in two different 
ways [103]. One is by shielding the magnetic dipole interaction with the silica shell. On 
the other hand, the silica nanoparticles are negatively charged. Therefore, silica coating 
enhances the coulomb repulsion of the magnetic nanoparticles. The first method relies 
on the well-known Stöber process, in which silica was formed insitu through the 
hydrolysis and condensation of a sol-gel precursor, such as tetraethyl orthosilicate 
(TEOS) [103-105]. The second method is based on the deposition of silica from silicic 
acid solution [106, 107]. The third method is an emulsion method, in which micelles or 
inverse micelles are used to confine and control the silica coating. This method might 
require greater effort to separate the core-shell nanoparticles from large amount of 
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surfactants associated with the emulsion system [108, 109]. Yang et al. have used the 
emulsion method for the preparation of monodisperse silica-coated iron oxide 
superparamagnetic nanoparticles and further entrapment of biological macromolecules 
in the pore of the nanoparticles [110]. Recently, Tartaj et al. have prepared submicronic 
silicacoated magnetic sphere aerosol by the pyrolysis method [111]. 
2.3.3.2.2 Coated with gold 
Gold is another inorganic coating material which is highly adequate to implement 
functionality to magnetic nanoparticles as well as to improve their stability in aqueous 
dispersions. Some protocols exist in the literature to obtain magnetic nanoparticles 
coated with gold [112]. Lin et al. have synthesized core-shell-structured Fe/Au 
nanoparticles by a reverse-micelle approach [113]. Water soluble gold-coated magnetite 
nanoparticles with diameters of about 60 nm were synthesized by the reduction of Au 
(III) onto the surface via iterative hydroxylamine seeding [114]. 
2.3.3.3 Surface functionalization with polymer stabilizers 
Several approaches have been developed to coat iron oxide nanoparticles, including in 
situ coatings and post-synthesis coatings. In the first approach, nanoparticles are coated 
during the synthesis. In literature, the most common coatings are dextran, 
carboxymethylated dextran, starch, arabinogalactan, glycosaminoglycan, sulfonated 
styrene-divinylbenzene, polyethylene glycol (PEG), polyvinyl alcohol (PVA), 
poloxamers, and polyoxamines, poly (N-isopropylacrylamide) or PNIPAM. 
2.3.3.3.1 Coated with dextran and polyethylene glycol (PEG) 
Dextran is a polysaccharide composed exclusively of α-D-glucopyranosyl units with 
various degrees of chain length and branching. Dextran has been used often as a 
polymer coating mostly because of its biocompatibility [115-118]. Molday and 
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Mackenzie were the first who reported the formation of magnetite in the presence of 
dextran 40000 [118]. In that study, dextran was functionalized after iron oxide 
stabilization by oxidation to create more hydroxyl groups to allow for the binding of the 
amino groups of proteins. Pardoe et al. have reported detailed magnetic and structural 
properties on iron oxide formed in the presence of dextran (40000 g/mol) [119]. The 
results of the analysis suggested that the presence of polymer limits the particle size 
compared to particles prepared without the polymer. Recently, Bautista et al. described 
surface modification of pure superparamagnetic iron oxide nanoparticles with dextran 
prepared by laser pyrolysis and the co-precipitation method [120]. 
PEG is a hydrophilic, water-soluble, biocompatible polymer. Several investigations 
have reported the use of PEG to increase biocompatibility of the iron oxide dispersions 
and blood circulation times [121-124]. Various methods of coating were developed to 
prepare small (60-100 nm) and ultrasmall (20-35 nm) particles without size-separation 
processes. 
2.3.3.3.2 Coated with polyvenylalchohol (PVA) 
PVA is a hydrophilic, biocompatible polymer. PVA coating onto the particle surface 
prevents their agglomeration, giving rise to monodisperse particles [125, 126]. Lee et al. 
have modified the surface of nanoparticles with PVA by precipitation of iron salts in 
PVA aqueous solution to form stable dispersion [127]. These investigators suggest that 
PVA irreversibly binds to the surface of magnetite which was characterized using FTIR 
absorbance shifts. Recently, Chastellain et al. have synthesized PVA coated iron oxide 
nanoparticles according to a well-known method [128]. The colloidal stability of the 
final polymer-coated product as well as the resulting particle size distribution were 
determined for different iron/polymer ratios. As it is known, PVA is a unique synthetic 
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polymer that can transform into a polymer gel that is a class of macromolecular network 
with unique properties. Albornoz et al. have reported the synthesis of aqueous ferrofluid 
and the preparation of a magnetic gel with PVA and glutaraldehyde (GTA) [129]. The 
magnetic gel was dried to generate a biocompatible film. 
2.3.3.3.3 Coated with alginate 
Alginate is an electrolytic polysaccharide with many carboxyl groups. Researchers have 
thus speculated that the COO
-
 of alginate and iron ion would interact and the 
electrostatic repulsion may make the superparamagnetic iron oxide nanoparticles 
(SPIONs)
- 
alginate stable. Recently, several investigations dealing with the preparation 
of iron oxide nanoparticles with alginate have been developed [130-132]. The standard 
chemical synthesis consists of three steps: (a) gelation of alginate and ferrous ions, (b) 
in situ precipitation of ferrous hydroxide by the alkaline treatment of alginate and (c) 
oxidation of ferrous hydroxide with an oxidizing agent, such as O2 or H2O2. Some 
researchers have developed a new modified two-step co-precipitation method [131]. 
The results revealed that typical iron oxide nanoparticles had a core diameter of 5-10 
nm and that SPIONs-alginate had a hydrodynamic diameter of 193.8-483.2 nm.  
2.3.3.3.4 Coated with chitosan 
Chitosan is an alkaline, nontoxic, hydrophilic, biocompatible, and biodegradable 
polymer. Nowadays, the preparations of magnetic nanoparticles encapsulated in 
chitosan are of great interest [133, 134]. Kim et al. have synthesized SPIONs by a 
sonochemical method [135]. From these particles, they synthesized ferrofluids for use 
as MRI contrast agents by coating them with oleic acid as a surfactant and then 
dispersing them in chitosan, which is a suitable carrier for bioapplications. 
Microspheres composed of superparamagnetic iron oxide nanoparticles and chitosan 
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were developed as a novel MRI detectable embolic material. Lee et al. have prepared 
spherical superparamagnetic nanoparticles by sonochemistry and embedded them in 
chitosan to synthesize ferrofluids [136]. The synthesized microspheres showed strong 
enhancement of MR image contrast similar to the ferrofluid in Vitro. 
2.3.3.3.5 Coated with thermosensitive polymer 
N-isopropylacrylamide (NIPAM) is a commonly used monomer in the preparation of 
thermosensitive polymer coated magnetic particles. Magnetic particles coated with 
thermosensitive polymer shows reversible adsorption and desorption cycle sensitive to 
temperature. The thermosensitive magnetic particles can adsorb proteins when the 
temperature is higher than the lower critical solution temperature (LCST), and reversely 
release protein when the temperature is lower than LCST. Some research works showed 
magnetic particles coated with thermosensitive polymer have the potential in the 
separation and purification of enzyme and proteins [137, 138]. Some recent works 
include synthesis of magnetic nanoparticles immobilized inside PNIPAM microgels 
[139, 140]. These microgels based on poly-(N-isopropyl acrylamide), (PNIPAM), are 
very promising materials for biomedical applications such as drug delivery applications, 
because they could respond to thermal stimulus, e.g., local hyperthermia produced by a 
tumor tissue, delivering drugs locally and only when needed [140, 141]. 
Different polymers that have also been used are polymethacrylic acid [142], 
poly(ethyleneoxide)-b-poly(methacrylic acid) [143], poly(acrylic acid) (PAA) [144], 
poly(lactic acid) [145], poly(ɛ-caprolactone) [146], sulfonatedstyrene-divinylbenzene or 
arabinogalactan [147]. PAA coatings increase the stability and biocompatibility of the 
particles and also help in bio adhesion. 
                                                                                              Chapter 2 
31 
 
2.3.3.3.6 Coated with cyclodextrin 
 
CDs are cyclic oligosaccharides consisting of 6, 7, and 8 D-glucopyranose units joined 
by α-1, 4-glycosidic linkages, respectively designated as α, β, and γ-CDs (Figure 2-7). 
With the unique structures, CDs have a hydrophobic cavity and a hydrophilic surface, 
which endows CDs the ability to connect polymer chains to form inclusion complexes 
via the host-guest interaction [148]. Since all of the primary and secondary hydroxyl 
groups of CDs are on the outside of this toroidal shaped molecule, the cavity is 
relatively non-polar, thus allowing CDs to form inclusion complexes with a variety of 
polar and non-polar guest molecules. It is apparent that size and geometry of a guest 
molecule in relation to that of the cyclodextrin cavity are important factors in inclusion 
complex formation.  
 
Figure 2-7 Molecular structures of CDs [149]. 
 
Various applications and preparation methods of cyclodextrin modified magnetic 
nanoparticles are summarized in the following Table 2-2. 




Table 2-2 List of some applications and preparation methods of cyclodextrin modified magnetic nanoparticles. 
 
Particles Method of synthesis Application Reference 
γ-CD stabilized FePt particle Co-precipitation of iron salt and platinum 
acethylacetonate, Pt(acac)2 in the presence of 
oleic acid and oleylamine followed by stirring 
with γ-CD solution 
Catalytic activity [27] 
Fe3O4 nanoparticles coated 
with CD and fluronic 
polymer  
(F-127) 
Co-precipitation of iron salts in presence of β-
CD and F-127 solution 
Hyperthermia, magnetic resonance 
imaging (MRI) and drug delivery 
applications 
[28] 
β-CD fabricated Fe3O4 
magnetic nanoparticles 
Co-precipitation method followed by 
carbodiimide activation method 
Removal of copper ions from waste 
water 
[150] 
Folic acid and β-CD coated 
Fe3O4 magnetic nanoparticles 
Hydrolysis and condensation of Iron(III) 
allylacetylacetonate followed by reaction with 
3-chloropropyldimethylethoxysilane 
(CPDMES) and β-CD solution 







Co-precipitation of iron salts followed by 
stirring with APTES and solution of β-CD 
derivative later on 
Drug carrier and bio-separation [151] 
α-CD stabilized oleic acid 
capped iron oxide 
nanoparticles 
Thermal decomposition of iron pentacarbonyl 
in presence of oleic acid followed by stirring 
with α-CD solution 
Biological and environmental 
applications 
[152] 
β-CD based inclusion 
complex CoFe2O4 magnetic 
nanoparticle 
Stirring of CoFe2O4 magnetic nanoparticles 
with β-CD solution 
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Table 2-2 (continued) 
2-hydroxypropyl-β-




Co-precipitation of ferrous and ferric salts 
followed by carbodiimide activation 
Targeted delivery of all-trans-retinoic 
acid-(ATRA) 
[30] 
FePt core-shell magnetic 
nanoparticles stabilized by γ–
CD 
Stirring of Fe(CO)5  and Pt(acac)2 solution in 
presence of oleic acid and oleylamine 
followed by mixing with γ–CD solution 




Glycol (n) nonylphenyl 
ether)-α-CD 
Co-precipitation of ferrous and ferric salts in 
presence of NH3•H2O and α-CD solution 
followed by stirring with NPEn solution 
Magnetic separation, drug delivery [155] 
HP-β-CD coated magnetic 
nanoparticle 
Co-precipitation followed by stirring of 
magnetic particles with HP-β-CD solution 
and NH3•H2O solution 
Drug delivery [156] 
Fe3O4/β-CD magnetic 
nanoparticle 
Stirring of magnetite monodomain particles 
with tetramethylammonium hydroxide 






Stirring of Fe(acetylacetonate) in presence of 
OA, OAm β-CD solution 
 
Drug delivery [158] 
γ-Fe2O3/γ -CD magnetic 
nanoparticle 
Stirring of ferrous chloride solution with γ-
CD and NaOH 






Stirring of ferrous and ferric salts with 
surfactant and CD solution 







Co-precipitation of iron ferrous and ferric 
salts in presence of MWCTs followed by 
plasma induction and stirring with β-CD 
solution 
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Table 2-2 (continued) 
Fe3O4-β-CD complex Stirring of ferric chloride solution and ferrous 




gum arabic modified 
magnetic nanoparticles 
(GAMNPs) 
Co-precipitation of ferrous chloride and ferric 
chloride salts followed by sonication with 
GA solution and carbodiimide activation 
reaction with β-CD solution 





Solvothermal reduction method followed by 
stirring with tetraethyl orthosilicate (TEOS), 
ammonia and water, finally stirring with β-
CD solution, NaOH and 3-
glycidyloxypropyltrimethoxysilane (GTMS), 
ammonia solution 
Extraction of biphenolic pollutants 
(bisphenol A (BPA) and 
diethylstilbestrol (DES)) 
[164] 
Fe3O4/ β-CD magnetic 
nanoparticle 
Stirring of ferric chloride solution with β-CD 




Co-precipitation followed by stirring with 
carboxymethyl-β-CD in presence of 
epichlorohydrin 
Drug carrier and magnetic separator [166] 
Fe3O4/β-CD magnetic 
nanorods 





Co-precipitation of ferrous chloride and ferric 
chloride solution followed by stirring with β-
CD solution 
Biomedical applications [168] 
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2.4 Separation of chiral amino acids 
Compounds where chirality is caused by the presence of asymmetric carbon atoms are 
the dominating type of pharmaceutical, biochemical and biological interest. 
Consequently, they are the subject of principal analytical interest also. Determination of 
the enantiomeric composition of chiral substances has become important in recent years 
because chirality is a central factor in biological phenomena. Chiral amino acids have 
two enantiomers (non-superimposable mirror images), which can be defined as D-/L- 
(by configuration), R-/S- (by configuration) and +/- (by optical activity). Sighting with 
the hydrogen atom away from the viewer, if the groups (COOH, R, NH2 and H) are 
arranged clockwise around the carbon atom, then it is the D-form. Otherwise 
arrangement is the L-form. Because of the different behavior of the enantiomers of 
amino acids under chiral environment, several analytical methods and techniques have 
been developed for separation of chiral amino acid enantiomers. 
The earliest experiment on acid hydrolysis of proteins was performed by Braconnot in 
1820 in which concentrated acid was used to hydrolyze gelatine, wool and muscle fiber. 
In 1972, Moore and Stein were awarded the Nobel Prize for developing an automated 
instrument for separation of amino acids on an ion-exchange resin and quantification of 
them using ninhydrin [169]. In the past, the “gold standard” for studying chiral 
separations fell within the realm of chromatography (e.g., high performance liquid 
chromatography (HPLC), capillary electrophoresis and to some extent gas 
chromatography) and numerous publications have demonstrated the chiral separation of 
countless drug molecules using the above methods. However, several broad-ranging 
analytical techniques such as circular dichroism, crystallography, NMR, and 
fluorescence spectroscopy have demonstrated their distinctive ability for studying chiral 
interactions as well [170-172].   
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More recently, HPLC has been configured for amino acid analysis. Some methods use 
post column derivatization in which the amino acids are separated on an ion-exchange 
column followed by derivatization with ninhydrin, fluroscamine, or O-phthaldehyde 
[173]. Another approach has been to derivatize amino acid prior to separation on a 
reversed phase HPLC column. Examples of these techniques are dansyl [174], 
phenylthiocarbamyl (PTC) [175], 9-fluorenylmethyl chloroformate (Fmoc) [176, 177] 
derivatives of amino acids. The basis of enantioselective chromatography is the 
transient formation of noncovalent diastereomeric complexes between chiral solute and 
chiral stationary phase (CSP). In HPLC, chiral stationary phase based on α-cyclodextrin 
was also used for enantioseparation of amino acids and Armstong et al. achieved very 
good resolution of 22 chiral compounds [178]. Tao et al. achieved chiral recognition of 
D- and L-amino acids and mixtures of enantiomers were quantified in the gas phase, 
using the kinetics of competitive unimolecular fragmentations of trimeric Cu (II)-bound 
complexes [179]. Hofstetter et al. reported the production of highly stereoselective 
antibodies to D- and L-α-amino acids, respectively [180]. Use of chiral additives and 
metal chelate additives are also very attractive to separate enantiomers.  
In capillary electrophoresis (CE), achievement of chiral separation of compounds was 
very good too. So far, more than 200 papers dealing with chiral separation of amino 
acids and peptides by CE have been published and a variety of chiral CE modes and 
approaches have been developed, such as capillary zone electrophoresis (CZE) with 
cyclodextrin (CD-CZE), cyclodextrin modified micellar electrokinetic chromatography 
(CD-MEKC), gel filled chiral CE, chiral capillary electro chromatography (CEC), 
diastereomeric separation and so on. In addition, numerous reviews on CE have been 
presented highlighting continuous new developments of chiral separations of various 
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compounds [181, 182]. Chankvetadze has published an interesting book on capillary 
electrophoresis in chiral analysis [183].  
Enantiomers behave differently only in a chiral environment. Therefore, to differentiate 
a pair of enantiomers with mass spectrometry, the target enantiomers are ionized in the 
presence of a chiral selector (also called reference chiral compound, chiral reagent, 
resolving agent, etc.) to form diastereomeric complex ions. Yao et al. described how 
chiral recognition of 19 common amino acids was achieved by investigating the 
collision-induced dissociation spectra of protonated trimers that were formed from the 
electrospray ionization of amino acids in the presence of different chiral selectors [184]. 
Some other methods have recently been developed for enantiomeric separation of 
amino acids like electrokinetic chromatography [185], high-field asymmetric waveform 
ion mobility spectrometry (FAIMS) coupled to mass spectrometric detection [186] etc. 
Following tables (Tables 2-3, 2-4, 2-5, 2-6 and 2-7) broadly summarize 
enantioseparation and chiral recognition of amino acids by conventional methods. 
 
                                                                                              Chapter 2 
38 
 
Table 2-3 Separation of chiral amino acids using Chromatography. 
 
System used Chiral amino acid separated Packing material and stationary phase Mobile phase Reference 
Liquid 
chromatography (LC) 








Tyr, Glu, Asp, Ser, Thr, Gly, Val, Pro, 
Met, Ile, Leu, His, Phe, Arg 
Dowex 1-X8 (a strongly basic resin) and  
Dowex 50-X4 
columns 







N-acetyl esters of α-Ala, Val, Thr, 
Ser, Ile, Cys, Nva, Leu, Nle, Met, Gly,  
β-Ala, Pro, Asp, Glu, Tyr, hydroxyPro 
Chromosorb 
W coated  with polyethylene 




GLC N-trifluoroacetyl (TFA)- isopropyl esters 
of D-/L-Ala, D-/L-Ile, D-/L-Leu,  
D-/L-Val, D-/L-Nva, D-/L-Nle 
N-TFA-L-α-amino-n-butyryl- 
L-α-amino- n-butyric acid cyclohexyl 
ester 
Carrier gas-helium  [190] 
Gas chromatography 
(GC) with glass 
capillary 
D-/L –Lys, D-/L-Tyr, D-/L-Phe,  
D-/L-Glu, D-/L-Asp, D-/L-Met 
 Glass capillary coated with N-TFA-L- 
phenylalanyl-L aspartic acid 
bis(cyclohexy1) ester (phe-asp) 
 





Dansyl derivatives of  Lys, Met, Phe,  
Pro, Tyr,Val, Leu, Ile, Glu ,Gly, Trp, 
Cys,  Ala, Asp, Ser, Arg,  His, Thr 
Li Chrosorb SI 60 
( diameter 5 µm) 
Benzene-pyridine-





tert-butyl esters of  D-/L-Leu, D-/L-Val, 
D-/L-Nle, D-/L-Nva, D-/L-Ala, D-/L-Ile, 
D-/L-Phe, D-/L-Gly, D-/L-Pro and D-/L-
O-tert butyl-Ser, D-/L-O-acetyl-Tyr 
(N-formyl -L-valylamino) propyl 
(FVA) silica gel 
Diethyl ether, 






D-/L- Ala, D-/L-Val, D-/L-Nva,  
D-/L- Tyr,  D-/L-Phe, D-/L-Trp,  
D-/L-Nle, D-/L-Asn, D-/L-Glu,  
D-/L-Asp, D-/L-Ile, D/L-Leu 
Trimethylsilyl-treated Develosil C8 
column 
Acetonitrile/ solution 
of  N- 
(p-toluenesulfonyl)- 
L-phenylalanine- 
Cu (II)(TosPhe-Cu(II))  
  [194] 
LC Dansyl  derivatives of D-/L-Arg,  
D-/L-Met, D-/L-Nle, D-/L-Nva,  
D-/L-Phe, D-/L-Ser, D-/L-Thr 
Cyclobond I column (chiral 
β-cyclodextrin molecules chemically 
bonded to silica gel) 
Methanol-water   [195] 
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Table 2-3 (continued) 
HPLC D-/L-Glu, D-/L-Asp, D-/L-Ser, D-/L-Thr,  
D-/L-Nva, D-/L-Val,D-/L-Nle, D-/L-Leu, 
D-/L-Phe, D-/L-Trp 
β-CD, 6-O-phenylcarbamoylated β-




  [196] 
LC D-/L-Trp Silica immobilized bovine serum 
albumin (BSA) 
Phosphate buffer (pH 
7.4) 
  [197] 
HPLC Dansyl, N-(3,5-dinitrobenzoyl) (DNB), N-(2,4-
dinitrophenyl) (DNP), N-benzoyl and β-
naphthoyl derivatives of D-/L-Val, D-/L-Ser,  
D-/L-Trp, D-/L-Ala, D-/L-Glu 
Ergot alkaloid-based chiral 
stationary 
phase -(1-allyl-(5R,8S,10R)-
terguride bonded on silica gel 
 Phosphate buffer (pH 
3.0) 
/acetonitrile 
  [198] 
Reversed phase-HPLC Phenylthiocarbamoylated (PTC) derivatives of 
D-/L-Asp, D-/L-Glu, D-/L-Ser,  D-/L-Gly,  
D-/L-Asn, D-/L-Gln, D-/L-Thr, D-/L-Arg,  
D-/L-Tyr, D-/L-Val, D-/L-Met, D-/L-Leu,  
D-/L-Ile, D-/L-Trp, D-/L-Ala, D-/L-His,  
D-/L -Ser, D-/L -Phe 
Phenylcarbamoylated β- 
cyclodextrin bonded on steel column 




   [199] 
LC Ala, Asn, Asp, Glu, Leu, Met, Phe, Trp,  
m-Tyr, Val, Cys 
Teicoplanin chiral stationary phase Methanol-water    [200] 
HPLC D-/L-phosphoTyr, D-/L-Trp, D-/L-Phe,  
D-/L-Tyr, D-/L-p-aminoPhe 
Monoclonal antibody based CSP Phosphate-buffered 
saline (pH 7.4) 
   [180] 
Superficial fluid 
chromatography (SFC) 
N(O)-pentafluoropropionyl 1-propyl esters of 
D-/L-Ala, D-/L-Nva, D-/L-Ile, D-/L-Leu,  
D-/L-Nle, D-/L-Met, D-/L-Phe, D-/L-Glu,  
D-/L-Tyr  
Fused-silica column of permabond 
L-Chirasil-Val 
Carrier gas- helium [201] 
HPLC Fmoc-D-/L-Leu, Fmoc-D-/L-Phe,  
DNB-D-/L-Phe, DNB- D-/L-Glu, D-/L-β-Phe 
Ion-exchanger-type CSPs based on 
zwitterionic selectors 
Formic acid and 
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Table 2-4 Separation of chiral amino acids using Capillary Electrophoresis. 
 
System used Chiral amino acid separated Buffer solution/ electrolyte used(BGE)/ mobile 
phase and additive 





Dansyl derivatives of D-/L-Arg,  
D-/L-Trp, D-/L-Val, D-/L-Glu,  
D-/L-Asp, D-/L-Met  
2.5 mM Copper (II) sulphate/5.0 mM 
aspartame/10 mM ammonium acetate 
 





D-/L-Trp, D-/L-Thr, D-/L-Phe,  
D-/L-Tyr 
Tris or citrate (10 mM, pH 2.2) as carrier 




 CZE DNB derivatives of  
 D-/L-Phe  













Dansyl (DNS) derivatives of  D-/L-
Phe, D-/L-Val, D-/L-Thr, D-/L-Ile, 
D-/L-Leu, D-/L-Met 
150mM sodium dodecyl sulphate (SDS)/60mM γ-
cyclodextrin (γ-CD)/ 
10% acetonitrile/ 250mM borate buffer solution 
γ-CD  [206] 
CE Carboxybenzyl derivatives of  D-/L-
Trp, D-/L-Phe, D-/L-Tyr, D-/L-Leu, 
D-/L-Asp, D-/L-Asn 
4 mM heptakis(6-amino-6- 
deoxy )-β-cyclodextrin/50 mM 




CE Cyanobenz[f] isoindole(CBI)  
derivatized D-/L-Tyr, D-/L-Thr,  
D-/L-Asn, D-/L-Phe, D-/L-His, 
D-/L-Glu, D-/L-Met, D-/L-Ala,  
D-/L-Arg, D-/L-Asp, D-/L-Ile 
2 wt % sulfated-β-CD (S-β-CD)/ 25 mM 
phosphate buffer (pH 2) 




Fluorescein isothiocyanate (FITC) 
labeled D-/L-Leu, D-/L-Asp and 
mixed FITC labeled  Arg, Phe, Gly, 
Glu, Asp 
5 mM borate buffer (pH 9.2)/ 
8 mM β-CD/12 mM Sodium tauracholate 
(STC)  







fluorescence (LIF)  
Fluorescein isothiocyanate  
labeled(FITC)  D-/L-Asp, D-/L-Glu, 
D-/L-Asn, D-/L-Gln, D-/L-Leu,  
D-/L-His, D-/L-Ser, D-/L-Phe,  
D-/L-Trp 
10mM Tris-HCl buffer (pH 8.3)/1mM β-CD β-CD  [210] 
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 -boxaldehyde  labeled D-/L-Thr, 
D-/L-Asp, D-/L-Tyr, D-/L-Phe,  
D-/L-Ser, D-/L-Leu, D-/L-Ile,  
D-/L-Val, D-/L-Met  
10 mM β-CD or  
γ-CD/ 50 mM SDS/ 
100 mM borate buffer (pH 9) 
 






3, 5-dinitrobenzoylated  isopropyl 
esters of D-/L-Ala, D-/L-Leu,  
D-/L-Val, D-/L-Phe 
N-dodecanoy L-valinate, L-alaninate, and L-







FITC labeled Gly, Phe, Ser, Asn, 
Asp 
75 mM SDS/ 10mM disodium hydrogen 
phosphate / 6mM Na2B4O7 (pH 9.2) 
SDS  [213] 
Micellar electrokinetic 
chromatography (MEKC) 
Dansyl derivatives of D-/L-Leu,  
D-/L-Phe, D-/L-Val, D-/L-Glu,  
D-/L-Asp 
200 mM SDS/ 75 mM β-CD/ 250 mM 
borate buffer  
(pH 9.5) 
 β-CD  [185] 







Mobile phase-  
acetonitrile/50 mM acetic acid and 
methanol/50 mM acetic acid 





Leu, D-/L-Met, D-/L-Nle, D-/L-
Nva, D-/L-Phe, D-/L-Ser,  
 
pH 5.5, acetonitrile/ 
0.50 mM copper (II)acetate-50 mM 
ammonium acetate 
L-phenylalaninamide  [215] 
MEKC Phenylthiohydantoin (PTH) 
derivatives of  D-/L-Val, D-/L-
Nva, D-/L-Tyr 
50 mM poly-LV (poly-L-leucylvalinate)/ 
275mM boric acid/ 30mM sodium-
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Table 2-4 (continued) 
MEKC  Dns D-/L-Leu 50 mM phosphate/ 
25 mM borate buffer (pH 9)/24 mM poly 
sodium N-undecanoyl leucylvalinate (p-
SULV)  
Diastereomers of poly sodium 
N-undecanoyl leucylvalinate 
(p-SULV) 
       [217] 
MEKC in 3D microfluidic/ 
nanofluidic device 
Fluorescein isothiocyanate 
( FITC) labeled D-/L-Asp and  
D-/L-Ser 
Sodium borate buffer/ sodium taurocholate 
hydrate (STC)/β-CD/ methanol 
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Table 2-5 Separation of chiral amino acids using Membrane Separation. 
 




Chiral /non-chiral selector References 
Membrane separation D-/L-Tyr, D-/L-Trp Poly(L-glutamate) with amphiphilic 
side chains of (n-
nonylphenoxy)oligo (oxyethylene) 
(NONx-PLG) 
NONx-PLG  [219] 
Membrane separation D-/L-Trp, D-/L-Phe,  
D-/L-Ala, D-/L-Arg,   
D-/L-Glu 
Molecularly imprinted polymeric 
membranes, 
bearing  tetrapeptide derivative (H-
Asp-(OcHex)-Ile-Asp(OcHex)-Glu 
(OBzl)-CH2-) 
Tetrapeptide derivative (H-Asp- 
(OcHex)-Ile-Asp(OcHex)-Glu(OBzl)-CH2-) 
 [220] 
Membrane separation D-/L-Ascorbic acid Optically active polyelectrolyte 
multilayers (PEMU) 
 D-poly(lysine), poly(glutamic acid), poly(N-








D-/L-Lys, D-/L-Met,  
D-/L-Gln, D-/L-Glu, 
D-/L-Ala, D-/L-Nva,  
D-/L-Nle, D-/L-Arg, 
D-/L-Ile, D-/L-Eth 
Celgard 2500 film with 
surfactant(dioleyl- 
L-glutamate ribitol)-protease 
(protease from  Aspergillus oryzae , 
Aspergillus melleus and Bacillus 
subtillis) complex 
Protesase- α-cymotripsin   [222] 
Membrane separation D-/L-Phe Acetylated β-CD-immobilized 
cellulose dialysis membrane 
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Table 2-6 Chiral recognition and analysis of chiral amino acids using Mass Spectrometry. 
 
System used Chiral amino acid Chiral/non-chiral modifier or 
selector 
Carrier gas References 




Leu, D-/L-Ile, D-/L-Pro,  
D-/L-Phe, D-/L-Tyr, D-/L-
Trp, D-/L-His, D-/L-Met, 
D-/L-Cys, D-/L-Ser, D-/L-




and L/D-N-tert -butoxycarbonyl -O-
benzylSer (BSer) 
Helium  [184] 
ESI-MS/MS D-/L-Arg, D-/L-Asn, D-/L-
Gly, D-/L-Asp, D-/L-Glu, 
D-/L-Phe, D-/L-Trp, D-/L-
Tyr, D-/L-His, D-/L-Lys,  
D-/L-Met 
Chiral melamine derivatives Nitrogen  [224] 
Chiral ion mobility 
spectrometry (CIMS) 
D-/L-Trp, D-/L-Met, D-/L-
Thr, D-/LPhe, D-/L-Ser 
(S)-(+)-2- butanol Nitrogen (drift gas)  [225] 
High-field asymmetric 
waveform ion mobility 
spectrometry mass 
spectrometry (FAIMS-MS) 
D-/L-Trp, D-/L-Arg,  
D-/L-Phe, D-/L-Val,  










) and reference amino acid (L-Gly, 
L-Arg, L-Lys, L-Val, L-Pro, L-Gln,  
L-Ile) complex 










                                                                                              Chapter 2 
45 
 
Table 2-7 Separation of chiral amino acids using other methods. 
 
System used Chiral amino acid separated Chiral /non-chiral selector or 
additive 
References 
Liquid-liquid extraction D-/L-Leu, D-/L-Phe, D-/L-Trp Lanthanide tris (β-diketonate) [226] 
Micelle-enhanced 
ultrafiltration (MEUF) 





Enantioseparation using over 
oxidation 
pseudo-template technique 




\Chiral separation by asymmetric 
crystallization 
D-/L-Glu L-Arg (additive) 
 
[229] 
Enantioselective separation using 
chiral mesoporous silica 
D-/L-Val Chiral block copolymers of 






extraction using centrifugal 
contact separator (CCS) 





Chiral separation using CdSe 
/ZnS quantum dots 
D-/L-Phe, D-/L-Tyr β-CD [232] 
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2.5 Removal of pharmaceuticals and endocrine disrupting compounds 
(EDCs) 
Pharmaceuticals represent an important class of emerging organic micropollutants. 
Although pharmaceuticals are used in large quantities in modern society, their potential 
to reach surface waters and their impact on the environment have received great 
attention during the last few decades. Since the 1980s, investigations have been carried 
out on the occurrence and fate of different therapeutic classes of pharmaceuticals such 
as antidepressants, beta-blockers and lipid regulators in the environment [233-236]. The 
majority of these field investigations focused on the determination of concentration 
levels of specific compounds in various compartments of the aquatic environment. It is 
found that human pharmaceuticals enter the environment through incomplete 
wastewater treatment of drugs either not absorbed by the body or intentionally 
discarded down the drain. Unused human pharmaceuticals may also enter the 
environment through landfill leachates. Veterinary pharmaceuticals in animal wastes 
enter the environment directly through infiltration into groundwater or runoff into 
surface waters. As a result, presence of detectable concentrations of drugs or of their 
metabolites have then been reported in wastewater treatment plant (WWTP) effluents 
and natural waters [234, 235]. These pharmaceutically active compounds, including 
drugs and their active metabolites, have devastating impact on wildlife and on humans 
due to their presence in the aquatic environment [235].  
Investigation on water pollution from emerging contaminants such as endocrine 
disrupting chemicals (EDCs), is one of the important aspects of current environmental 
research due to their potential toxic effects on wildlife and humans [237-239]. These 
compounds exert their effects by: (i) mimicking or antagonizing the effects of 
hormones; (ii) altering the pattern of synthesis and the metabolism of hormones; (iii) 
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modifying hormone receptor levels. Although they may not pose direct acute or chronic 
threats to human or other living organisms, EDCs indirectly interact with the endocrine 
systems that control the body's function resulting in excessive amounts or suppression 
of hormones. This phenomenon is called endocrine disruption, which may involve the 
appearance of: (i) infertility; (ii) sexual underdevelopment; (iii) altered or reduced 
sexual behavior; (iv) attention deficit or hyperactivity; (v) altered thyroid or adrenal 
cortical function; (vi) increased incidents of certain cancers; (vii) birth defects, etc 
[240]. The majority of EDCs are man-made, organic chemicals being introduced to the 
environment by anthropogenic inputs. In addition, EDCs can be naturally occurring in 
the environment, e.g. the female hormones E1 (estrone) and E2 (17β-estradiol) are both 
excreted by females and are hence ubiquitous in the aquatic environment. Such 
compounds may not be removed by sewage treatment works (STW) and may even be 
reactivated through deconjugation during these processes, hence prolonging their 
residence in the aquatic environment. Steroidal estrogens have been found to persist 
through many sewage treatment processes, and it is widely recognized that effluent 
discharges from STW are the main source of EDC inputs to the aquatic environment, 
such as rivers and streams. Although the concentrations of steroidal EDCs are generally 
low in aquatic systems, concentrations of up to 19.4 ng/L have been detected in surface 
waters and levels as high as 5400 ng/L have been found in some STW effluents [241]. 
Beta-blockers or β-blockers are used in the treatment of high blood pressure 
(hypertension) and to treat patients after heart attacks to prevent recurrences. 
Substantial amounts of these pharmaceuticals and their metabolites get into the waste-
water after excretion and finally end up in surface water. Ecotoxicological studies show 
that aquatic organisms are sensitive to these substances [242-245]. Escher et al. 
demonstrated that most beta-blockers had a specific toxicity towards green algae 
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(Desmodesmus subspicatus) [246]. Thus, development of methods for 
removal/separation of beta-blockers from waste-water is also very important. 
Numerous recent studies have examined the removal of emerging pharmaceuticals, 
beta-blockers and EDCs from wastewater. Conventional approaches include ozonation, 
adsorption separation using activated carbon and several other adsorbents, 
biodegradation using constructed wetlands, adsorption and biodegradation using 
membrane reactor, photocatalysis and coagulation-flocculation. It was demonstrated 
that among different treatment methods ozonation and filtration with granular activated 
carbon were effective in removing some pharmaceuticals. Removal efficiencies by 
granular activated carbon (GAC) adsorption processes for pharmaceuticals  have been 
evaluated using either bench [247] or pilot-scale systems [248], in addition to surveys at 
full-scale drinking water treatment plants [249]. Eliminations of pharmaceuticals by 
GAC adsorbers were generally, although not always, found to be satisfactory. Doses of 
10-20 mg/L of powdered activated carbon are expected to result in an advanced 
removal of a broad spectrum of micro pollutants, but highly polar compounds need 
higher doses or can only be removed partly [250].  The working capacity of activated 
carbon greatly decreases in the presence of natural organic matter. However, 
regeneration of adsorbents is questionable. Removal of pharmaceuticals with modified 
mesoporous silica materials have also been investigated [251]. Among the others, 
carbon nanotubes (CNTs) are a relatively new group of adsorbents which are currently 
the focus of intense research [252, 253]. 
The potential of ozonation and of advanced oxidation processes (AOPs) like UV/H2O2 
and O3/H2O2 for partial removing of pharmaceuticals and EDCs in drinking water and 
waste-water was investigated [254, 255]. Initial results from pilot plants utilizing post-
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ozonation revealed removal rates of >95% for many micropollutants [256, 254]. Ozone 
is a selective oxidant which is particularly reactive toward functional groups with high 
electron density such as double bonds, activated aromatic systems, nonprotonated 
secondary and tertiary amines, and reduced sulfur species. Although ozonation results 
only in a partial oxidation, some studies indicate that the initial attack at the reactive 
functional groups destroys the biological activity of compounds, as shown for 
estrogenic or antimicrobial compounds [257, 258]. The major uncertainty of ozonation 
is related to the formation of oxidation by-products from matrix components and 
transformation products from micropollutants. Various studies revealed reaction 
products of micropollutants but their concentration as well as the estrogenic and 
antimicrobial activity of the products was minor compared to the parent compounds 
[257, 258]. 
Another approach for removal of these pharmaceuticals and EDCs includes 
biodegradation utilizing constructed wetlands. Constructed wetlands (CW) are land-
based waste-water treatment systems that consist of shallow ponds, beds, or trenches 
that contain floating or emergent, rooted wetland vegetation [259]. Removal of 
contaminants in CWs occurs through a series of complex physical, chemical and 
microbial interactions, and involves a variety of processes including biodegradation, 
sorption to bed media, sedimentation, microbial and plant uptake, physical interaction 
with organic matter and volatilization [260, 261]. A main limitation of these CWs is the 
large surface area generally required, which limits their application to the sanitation of 
small populations (<2000 inhabitants) or tertiary treatments. Vertical-flow constructed 
wetlands (VFCWs) are more efficient because they operate under aerobic conditions 
and require smaller surface area [262]. 
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Membrane bioreactor (MBR) can be recognized as the next generation of wastewater 
treatment processes because of its excellent effluent quality, low sludge production, 
small foot print, and flexibility in future expansion [263]. Consequently, considerable 
dedicated research efforts have been devoted to the assessment of micropollutant 
removal using MBR [264, 265]. Previous studies have indicated significant variation in 
the removal of micropollutants by MBRs, ranging from near complete removal for 
some compounds (e.g. ibuprofen and bezafibrate) to almost no removal for several 
others (e.g. carbamazepine and diclofenac) [264-266]. In this process, adsorption and 
subsequent biodegradation of the micropollutants are the dominant removal processes 
which are influenced by operational conditions such as hydraulic retention time (HRT), 
sludge retention time (SRT), biomass concentration, temperature and pH [267]. This 
results in a rather variable and uncertain removal performance. 
In recent years, it has been shown that photocatalysis is a promising technology for the 
purification of waste-water [268-271]. The mostly investigated photocatalyst for  
degradation of organic pollutants is TiO2. TiO2 is remarkably active, cheap, non-toxic, 
chemically stable over a wide pH range and is not subject to photocorrosion [269]. The 
photocatalytic degradation of pollutants by means of irradiated TiO2 (ultraviolet range, 
λ≥ 413 nm) is well documented in the literature. It has been described that oxidation 
takes place by either indirect oxidation by surface-bound hydroxyl radicals or directly 
via the valence-band hole [269,  272]. 
To remove pharmaceuticals, beta-blockers and EDCs from waste-water, several unit 
operations are used as the treatment process. Chemical coagulation is one of the most 
used processes as it removes efficiently the amount of high molecular organic material, 
i.e. humic substances, in water. Coagulation is used as a pre-treatment for processes 
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such as sand filtration, activated carbon filtration and ozonation. Chemical coagulation 
has been reported to remove only a small portion of pharmaceuticals [273, 274, 248]. 
Ternes et al. reported less than 10% removal of diclofenac, bezafibrate and 
carbamazepine [248]. According to Adams et al., coagulation was ineffective for the 
removal of sulfamethoxazole [274]. Considering the role of dissolved organic matter 
(DOM), mainly humic substances in the coagulation process can improve the removal 
efficiency toward several pharmaceuticals [275]. 
Separation/ removal of pharmaceuticals, beta-blockers and EDCs from waste-water 
have been studied using several methods. Detailed characteristics of the methods for 
removal of pharmaceuticals, beta-blockers and EDCs from waste-water are summarized 
in the Table 2-8.  
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Table 2-8 List of methods for removal of pharmaceuticals, beta-blockers and EDCs from wastewater. 
 






(CBZ), clofibric acid 
Ground water       Ozonation  Ozone dose 
0.5mg/L, 
 
>97% of diclofenac and 
CBZ, 10-15% of clofibric 
acid were removed 
[248] 
Filtration using granular 
activated carbon (GAC) 
GAC filter height 
of 160 cm 
CBZ showed highest 
adsorption capacity and was 










60% removal of CBZ and 
~30% removal of oxazepam 
 [276] 




~38% removal of CBZ and 
60% removal of OZP 
Carbamazepine and naproxen 
(NAP) 
Surface water Adsorption on amberlite 
XAD-7 (an acrylic ester 
resin) 
pH 7, 20°C, ionic 
strength of 
solution 0.01M 
98% removal of CBZ and 
97% removal of NAP 
 [277] 
Carbamazepine, clofibric acid, 
diclofenac, 
Ibuprofen, ketoprofen 
Surface water Adsorption on mesoporous 
silica, SBA-15 
Acidic media (pH 
3-5) 
85.2% of CBZ, 88.3% of 
diclofenac, 93.0% of 
ibuprofen, 94.3% of 
ketoprofen, and  49% of 
clofibric acid  were removed 
 [278] 
Carbamazepine, clofibric acid, 
salycilic acid, naproxen sodium 




Neutral pH and 
25°C 
Adsorption capacity were 
2.61 µmol/g for CBZ, 2.97 
µmol/g for clofibric acid, 
5.55 µmol/g for salycilic 
acid, 3.29 µmol/g for NAP 
sodium 
  [279] 
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             Table 2-8 (continued) 
Nalidixic acid, norfloxacin Aqueous solution Adsorption on canadian 
river alluvium (CRA) in 
presence of surfactant 
pH 7.1±0.13 Adsorption capacity were 
 7 mg/g for nalidixic acid and 
1.5 mg/g for norfloxacin 
[280] 




88-98% of  NAP and 73-84% 
of CBZ initial concentration 
were adsorbed 
[281] 
Naproxen, carbamazepine Aqueous solution Adsorption on coal-based 
Calgon Filtrasorb 




Adsorption capacity were 600 
ng/mg for NAP, 1000 ng/mg 
for CBZ 
[282] 
Adsorption on coconut 
shell based 
PICACTIF TE (CTIF) 
 
Adsorption capacity were 400 
ng/mg for NAP, 900 ng/mg 
for CBZ 
Oxytetracycline (OTC) and 
carbamazepine 







Adsorption capacities were 
190.2 mg/g for OTC and 7910 
mg/g  for carbamazepine 
(after 200 hours of adsorption) 





Domestic waster Biodegradation and 
adsorption onto the surface 




rate 70 mm Day
-1
 
62 ±3% of NAP, 
53± 2% of diclofenac, 
20± 4% of CBZ were removed 
               
[283] 
Filtration using nonplanted 
Sand filter (SF) 
 66 ±7% of NAP, 
39 ±22% of diclofenac, 














69±14 % of ketoprofen, >96% 
of propranolol, >98% of 
sotalol were removed 
           
[250] 
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                Table 2-8 (continued) 
Carbamazepine and 
sulfamethoxazole 
Synthetic wastewater Powdered activated carbon 




of MBR= 1g/L, 
Ci=30mg/L, 
T=25°C 
92 ± 15% removal of 




           [284] 
Carbamazepine Municipal wastewater Adsorption and 
photocatalytic degradation 
using hydrogen-titanate 
nanofiber (NF) and 
commercial P25 (TiO2) 
catalysts 
UV lamp (8W), pH 
7.5, T= 20±1°C, 
60% removal using NF 
and 30% removal using 
P25 were obtained 
            [285] 
Carbamazepine, 
gemfibrozil 
River water, lake 
water, ground water 
Filtration using GAC 
/ GAC filtration followed 
by UV treatment 
pH 6.95±0.05 71-93% removal of CBZ 
and  44-55% removal of 
gemfibrozil 
            [286] 
75% removal of CBZ and  





Aqueous solution Adsorption on tropical 
horizontal constructed 
wetlands (HSSF CWs) 
planted with Typha 
angustifolia 
Hydraulic residence 
time 4 day 
Removal efficiencies 
were 26.7±7% for CBZ, 
91.3±5.7% for NAP, 
55.4±11.1% for 
diclofenac, 
79.7±11.1% for ibuprofen 
            [261] 





lamp (17W), 5mM 
H2O2 
35% of CBZ was 
removed 




Surface water  Nanofiltration (NF) T=20°C, pressure 
of 724–779 kPa 
 




              [288] 
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        Table 2-8(continued) 
Ibuprofen, bezafibrate, 
diclofenac 
Aqueous solution Chemical coagulation 





 at pH 
4.5  
 
77% of ibuprofen, 50% 
of bezafibrate, 36% of 
diclofenac were removed 
                [275] 
Amoxicillin, atenolol, 
bezafibrate, ibuprofen  
Domestic and 
industrial waste water 
Adsorption on sludge in 









                [289] 
Diclofenac, diazepam, 
naproxen 
Domestic waste water Coagulation-flocculation 25 mg/L FeCl3, 
T=25°C 
70% of diclofenac, 20% 
of diazepam, 
25% of naproxen were 
removed 










30%, 25%  
                [290] 
Ibuprofen, bezafibrate, 
tonalide, galaxolide 





Solid retention time 
(SRT)=55days, 
Hydraulic retention 
time (HRT)=4 days 
>90% removal was 
obtained for all the 
pharmaceuticals 
 
                [264] 
Aspirin, ibuprofen, 
ketoprofen, naproxen 






>90% of aspirin and 
ibuprofen, 
~45% of ketoprofen and 
naproxen were removed 
 
                [291] 
Ibuprofen, ketoprofen, 
naproxen, diclofenac 
Domestic wastewater Biotransformation- 
Biodegradation and 
adsorption by MBR 
/conventional activated 
sludge (CAS) 
HRT=14hours Removal efficiencies of 






                [292] 
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Natural water (lake 
water and effluent 






T=21°C/4°C Removal efficiencies for 
lake water and effluent 
contaminants are 66 and 
81% (CBZ), 
77 and 75% 
(sulphamerazine), 




                       [293] 
Clofibric acid, 
carbamazepine 




Efficient removal was 
obtained 
                        [294] 





















CH2O2 = 25-50 mg 
/L, 
C0 =6µmol/L, pH 
(UV) = 6, 
pH (photo-Fenton) 
= 3.5 
UV provides small 
degradation compared to 
UV/H2O2. Photo-Fenton 

























flow constructed wetlands 
(HFCW) 
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Domestic sewage Combined activated sludge 




flow rate and 
retention time in 
sand are110m/d 
and 1 hour, ozone 
concentration and 
r.t. are 3mg/L and 
27 mins 




                     [297] 
Carbamazepine, 
diclofenac 
Domestic wastewater Activated sludge treatment 
by wastewater treatment 
plant (WWTP) 
SRT upto 100 days Almost 20% of CBZ and 
70% of diclofenac were 
remove 






Aqueous solution Capsular perstraction using 
liquid core microcapsule 
T=25°C, extraction 
time 50 mins 
Removal efficiencies were 
15%,19%, 22%,54 and 
80% 





Aqueous solution Biodegradation by 
submerged MBR  




Removal efficiencies were 
~90%,~100%, ~90%, ~30% 





Synthetic wastewater Biodegradation by 









                       [301] 
Diclofenac Doubly distilled water Oxidation using H2O2 and 
UV irradiation treatment 
Low pressure lamp 
(17W, 
254 nm), 
CH2O2 = 0.1-1.0 
mol/L, pH 7 
100% removal of diclofenac 
with a complete release 
of chlorine was observed 





Sewage waste water Ozonation  O3 dose=10/15 
mg/L 




                         [254] 
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         Table 2-8(continued) 
Clofibric acid Aqueous solution H2O2/UV treatment Low pressure lamp 
(17W, 
254 nm), 
CH2O2 = 1.0 
mol/L, pH 5 
Almost complete 
removal in 60 min 
                            [303] 
Carbamazepine Doubly distilled water H2O2/UV treatment Low pressure lamp 
(254 nm) 
CH2O2 = 5.0 
mol/L, pH 5 
100% removal in 4 min 
was achieved 
                            [287] 
Clofibric acid,  
ibuprofen,  
diclofenac 
River water Ozonation and advanced 
oxidation 
O3 (5mg/L) and 
H2O2(1.8 mg/L) 
Removal efficiencies 
were >95%  





Domestic wastewater Biological treatment, sand 
filtration, chlorination 





were 53%, 81%, 87%, 
60%, 93%,44% 




Municipal waste water Anaerobic/anoxic/aerobic-
membrane bioreactor 
process 
T=25°C, HRT upto 
5 hours, sludge 
retention 
time=20days 
Removal efficiencies of 
the combined processes 
were ~85%,80%,~85% 
and 20% 
                              [306] 
Amoxicilin Aqueous solution Ozonation CO3=0.16 mmol/L;  
pH 2.5–5.0 
Efficient removal and 
some by product was 
observed 





water and river water 
UV irradiation Low pressure lamp 





50-80% removal was 
achieved 
                              [308] 
Paracetamol Distilled water H2O2/UV treatment Low pressure lamp 
(17W, 
254 nm), 
CH2O2 = 5 and 20 
mmol/L, 
pH 2.0–7.0 
Complete removal with 
mineralization between 
21-40% 
                              [309] 
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                     [310] 
Triclosan,  
naproxen,  
ibuprofen,   
carbamazepine 
Drinking water Adsorption on activated 













                      [311] 
Atenolol, atrazine, 
carbamazepine 




Removal efficiencies were 
70%,>95%, 
>95% 












HRT= 35 hours 
Removal efficiencies were 
>70%, 99%, 94%,61% 
                       [313] 
Carbamazepine Drinking water Ozonation pH 7.5; CO3 = 1.5-
2.0mg/L 
High efficiency in removal 
after filtration and 
coagulation/flocculation 




Wastewater effluent Biological degradation 
under anoxic condition on 
constructed wetlands 
HRT= 6 hours, 
flow rate=18,000 
m3/day 
Removal efficiencies were ~100%, ~90%,  
20-80% 






Raw and finished 
drinking water 
Chlorination/ozonation/U
V irradiation  
Free chlorine  dose 
3.5 mg/L, ozone 
dose 2.5 mg/L, UV 
at 40mJ/cm2 
Removal efficiencies of 
chlorination/ozonation/UV irradiation were 
>70%/>70%/30-70% (triclosan),>70%/>70%/ 
<30% (naproxen), >70%/>70%/30-70% 
(diclofenac), 30-70%/>70%/<30% (ibuprofen) 











           Table 2-8 (continued) 
Atrazine and some 
phenylurea herbicides 
Ground water Ozonation and oxidation pH 7.8, ratio of 
H2O2:O3= 3.7g/g 
80% removal of atrazine and phenylurea herbicides [317] 
Fenton treatment 
(Fe2+/H2O2) 
pH 5.5,  
C H2O2= 10mg/L, 
C Fe2+=5.1 mg/L 
75% removal of atrazine and 94% removal of 
phenylurea herbicides  
Carbamazepine Aqueous solution Ozonation Ratio of 
O3:CBZ=10, CO3= 
1mg/L 











Ozonation CO3= 0.3 mg/L, pH 
7.5 
95% removal of all compounds                                 
[308] 
Nonylphenol Aqueous solution Adsorption on coal-based 
Calgon Filtrasorb 




Adsorption capacity of 600 ng/mg                                
[282] 
Bisphenol A (BPA) Distilled water Ozonation T=20°C, contact 
time =1-120 min, 
CO3 = 1.5mg/L 
100% removal was achieved                                
[319] 
Bisphenol A  Aqueous solution Ozonation CO3 = 
7.516µmol/L 
Slower removal rate                                
[320] 
Bisphenol A  Doubly distilled water Photocatalysis 200 W Hg-Xe 
lamp, TiO2 in 
suspension 
100% mineralization of BPA in 20 hours                                
[321] 
Nonylphenol Drinking water Adsorption on GAC GAC preloaded for 
16 weeks, 
Ci=500ng/L 
11-58% of the initial capacity removal was obtained                                
[281] 




                     
        Table 2-8 (continued) 
 Bisphenol A River water, lake water, 
ground water 
Filtration using GAC 
/GAC filtration followed 
by UV treatment 
pH 6.95±0.05 80-99% removal of BPA 
was obtained 
                              [286] 
Bisphenol A Distilled water Photocatalysis Black blue lamp 
(15 W), TiO2 
immobilized in 
PTFE 
98% removal in 1hour 
treatment 
                             [322] 
Bisphenol A Deionized water, 
model natural 
drinking water and 
river water 
UV/H2O2 treatment Medium pressure 
and low 
pressure UV lamp, 
CH2O2 = 200 
mg/L, pH 
6.0–8.0 
Efficient removal was 
achieved by the 
combined treatment 
                              [323] 
Bisphenol A Milli Q/deionized water UV irradiation/ UV 
irradiation and oxidation 
using H2O2 
Low pressure lamp 
(15W, 
254 nm), 
CH2O2 = 0 to 50 
mg/L, pH 
5.3–4.3 
Only UV irradiation was 
not enough to degrade 
BPA, UV/H2O2 
treatment gave a better 
removal of 
estrogenic activity 















>90% removal was 
achieved 
 
                             [264] 
Nonylphenol 
octylphenol, bisphenol A 





were 61-75%, 32-65% 
and >92% 









          Table 2-8 (continued) 
Nonylphenol, 
octylphenol, bisphenol A 
Domestic sewage Combined activated sludge 




flow rate and 
retention time in 
sand are110m/d 
and 1 hour, ozone 
concentration and 
r.t. are 3mg/L and 
27 mins 
Removal efficiency was 
>90% for the EDCs 
 
                            [297] 
Bisphenol A Aqueous solution Biodegradation by 
submerged MBR  




~100% removal of BPA 
was achieved 




Synthetic wastewater Biodegradation by 









                             [301] 
Bisphenol A, 
nonylphenol 
Raw waste water 
samples 
Activated sludge treatment, 




Removal efficiency  
was ~100% 
                              [301] 
Bisphenol A, 
Nonylphenol 
Municipal waste water Anaerobic/anoxic/aerobic-
membrane bioreactor 
process 
T=25°C, HRT upto 
5 hours, sludge 
retention 
time=20days 
Removal efficiency was 
~100% 
                              [306] 




 Almost 90% of the EDC 
was removed 
                              [310] 
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2.6 Adsorption and desorption 
Adsorption is the adhesion of atoms, ions, biomolecules or molecules of gas, liquid, or 
dissolved solids to a surface. It is a surface phenomenon where the adsorbate will form 
a film on the adsorbent‟s surface. Adsorption capacity is directly proportional to the 
availability of surface area of solid for adsorption. There are two mechanisms for 
adsorption to take place. One is physisorption, where in this process; adsorbate becomes 
bonded to the adsorbent by weak van der Waals forces. As the bonding forces are not 
strong, this process can be reversed by heating. The next mechanism is chemisorption, 
where the adsorbate is bonded to the absorbent by strong chemical binding forces. To 
understand adsorption more precisely the adsorption equilibrium and the parameters 
affecting adsorption should be investigated. Desorption is a phenomenon whereby a 
substance is released from or through a surface. However, desorption is also important 
for the recovery of biomolecules from the surface of the particles. Therefore, suitable 
adsorption and desorption parameters should be developed. 
In this study, the solid adsorbent is surface functionalized magnetic nanoparticles 
(MNPs) while the adsorbates are chiral amino acids, pharmaceuticals endocrine 
disrupting compound and the beta-blocker. In this particular closed adsorption system, 
the adsorbate solution and surface functionalized magnetic nanoparticles are mixed 
together till the solution‟s solute concentration is at equilibrium with the adsorbed 
solute concentration. To understand adsorption more precisely adsorption equilibrium 
and the parameters affecting adsorption should be investigated. After completion of the 
adsorption process, desorption of the biomolecules should be studied under different 
conditions. 
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2.6.1 Adsorption isotherm 
Adsorption isotherm describes the amount of adsorbate on the adsorbent surface 
(adsorption capacity) as a function of equilibrium adsorbate concentration in solution at 
constant temperature. The quantity of adsorbate adsorbed on the adsorbent is 
normalized by the mass of the adsorbent to allow comparison of different materials.  
2.6.1.1 Adsorption isotherm models 
2.6.1.1.1 Langmuir model 
Adsorption equilibriums of chemicals on magnetic particles‟ surface can be described 
by Langmuir model [325]. The Langmuir isotherm was theoretically derived, based on 
a number of assumptions: adsorption takes place on fixed homogenous absorption sites 
of equal energy forming a monolayer surface coverage, there are no interactions 
between adjacent species adsorbed, the adsorption capacity of the species to be 
adsorbed is directly proportional to the concentration of the species.  The Langmuir 
model can be described by equation 2-9: 
                                                                                                     [2-9]                                                        
where, Ce is equilibrium concentration, Qe is adsorbate surface concentration , Qm is 
maximum monolayer adsorbate adsorption capacity, kL is Langmuir constant, signifying 
the affinity between adsorbent and adsorbate. The above Langmuir adsorption isotherm 
model works well for cases where there is negligible intermolecular interaction between 
adsorbed solute particles and where only one monolayer of solute can be potentially 
adsorbed. This model can be thought of as a limiting law just like the analogy for ideal 
gas equation. To establish the validity of the assumption that independent interaction 
sites of equivalent affinity are present on the adsorbent surface, several linear 
transformations of equation 2-9 can be employed as follows: 
Qm Ce 
kL +Ce 
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                                                         [2-10] 
Several more sophisticated models to account for deviation from Langmuir adsorption 
behavior had also been developed. Freundlich isotherm model which was proposed by 
Herbert Max Finlay Freundlich is an example of an adsorption isotherm that was 
formulated to account for case that does not follow the Langmuir adsorption behavior. 
2.6.1.1.2 Freundlich model 
Another commonly used model to explain adsorption isotherm of chemicals/ 
biomolecules on magnetic particles‟ surface is Freundlich isotherm model [326]. It is 
derived by assuming a heterogeneous surface with a non-uniform distribution of heat of 
adsorption over the surface and it also takes into account the repulsive interactions 
between adsorbed solute particles. Freundlich Isotherm is purely empirical and 
nonlinear. It is given in the following equation: 





                                         [2-11] 
                      or,            
 
 
                                                                  [2-12] 
where, Ce is equilibrium adsorbate concentration in solution, Qe is adsorption capacity 
of adsorbent and kF, n  are empirical constants for each adsorbent-adsorbate pair. The 
empirical constants, kF and n are temperature dependent. As the temperature increases, 
the constants kF and n changes, the adsorption rate decreases as higher adsorbate 
concentration in solution are required to saturate the surface. The empirical constants 
are determined experimentally via a linear plot of lnQe versus lnCe.  
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2.6.1.1.3 Langmuir-Freundlich model  
 
Some researchers combined Langmuir and Freundlich isotherm to describe the 
adsorption isotherms: 
                               
      




    




                                      [2-13] 
where kd* is the apparent dissociation constant that includes contributions from ligand 
binding to monomer, monomer-dimer, and more highly associated forms of 
biomolecules; QmLF is the maximum binding capacity; and n is the Langmuir-
Freundlich coefficient. The Langmuir-Freundlich model was analyzed by some 
researchers and it was found that the energy distribution function corresponds to a 
symmetrical quasi-Gaussian function [327, 328]. At low concentrations, the model 
reduces to the Freundlich model and in the case of a homogeneous surface; it reduces to 
the Langmuir model.  Because of the presence of more than two adjustable parameters 
in Langmuir-Frendlich equation, experimental data are fitted applying nonlinear least-
squares analysis. 
2.6.2 Adsorption kinetics 
The adsorption of biomolecules from aqueous solutions onto solid surface of particles 
can be considered as a process consisted of several steps: 1) diffusion of solute 
molecules from bulk solution to the surface of solid particles, 2) attachment of target 
molecules to active sites on the surface, 3) rearrangement of biomolecules at the surface 
after adsorption. 
It is also a well-recognized fact that the process of adsorption is a two-regime process 
[329]. At the initial stage, the solid surface is bare and the kinetics of adsorption is 
governed by the diffusion of the molecules from the bulk solution to the surface. The 
Qe 
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mass transport can be interpreted as a Fickian diffusion as the following equation [330]:                          
                                
 
 
                                              [2-14] 
where, Qt is the adsorbed amount of target at different time, t. Ci is the initial 
concentration of target. D is the diffusion constant (cm
2
/s). In the later stage, a barrier of 
adsorbed molecules exists, and the molecules arriving from solution have to diffuse 
across this barrier. This penetration is slow and can be presented as exponential time 
dependence for the later stages: 




)                                                              [2-15] 
where Qe is the adsorbed amount at equilibrium (mg/g) and 1/T is the penetration rate 
constant (mg/g.s). 
Recently, some works investigated adsorption kinetics of organic dyes and hazardous 
materials on modified iron oxide magnetic nanoparticles with the help two kinetic 
models, namely the Lagergren pseudo-first-order and pseudo-second-order model. The 
Lagergren rate equation is one of the most widely used adsorption rate equations for the 
adsorption of solute from a liquid solution. The pseudo-first-order kinetic model is 
expressed by the following equation [331]: 
                                                                                            [2-16] 
 
Integrating this equation for the boundary conditions t = 0 to t = t and Q = 0 to Q = Qt, 
gives: 
                                                                                            [2-17] 
dQ 
dt 
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where Qe and Qt refer to the amount of target molecule adsorbed (mg/g) at equilibrium 
and at any time, t (min), respectively, and k1 is the equilibrium rate constant of pseudo-
first-order sorption (1/min). Another kinetic model is pseudo-second-order model, 
which is expressed by [332]: 
                                        
                                      [2-18] 
Integrating this equation for the boundary conditions t = 0 to t = t and Q = 0 to Q = Qt, 
gives, 









                                                                         [2-19] 
where k2 is the equilibrium rate constant of pseudo-second-order adsorption (g/mg min). 
All these published work provide useful information to study the adsorption of chemical 
and biomolecules on nano-sized magnetic particles. 
2.7 Desorption study 
To check the possibility of regeneration and recyclability of the magnetic nanoparticles, 
it is very important to carry out desorption studies. Generally, desorption condition of 
the sorbate is dependent on the condition at which the sorbate was adsorbed. Thus, 
suitable desorbing agents should be selected to facilitate desorption of the solute. For 
desorption of proteins, sodium dihydrogen phosphate solution, disodium hydrogen 
phosphate solution, sodium thiocyanate solution at different pH are used as desorbing 
agent [333, 334]. For desorption of metals from magnetic nanoparticles, acidic solution 
(citric acid/ acetic acid solution) is used as effective desorbing agent [150]. For 
desorption of organic molecules, dyes where inclusion complexation is predominant, 
alchohol solution such as methanol/ethanol solution is generally used [335, 336].  
dQ 
dt 
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2.8 Scope of the Thesis 
 
The aim of this project is to synthesis cyclodextrin derivatives coated magnetic nano 
particles and to utilize the particles in chiral separation and separation of 
pharmaceutically active compound, endocrine disruptors and beta-blockers. Although 
nano particles have diverse applications in the field of bioscience and biotechnology, 
only limited work has been published on the preparation of cyclodextrin derivatives 
coated magnetic nanoparticles and their use as a tool for separation of chiral 
biomolecules and environmental pollutants. Based on the literature review the scopes of 
the present project are: 
1. Synthesis and characterization of silica and cyclodextrin derivative coated magnetic 
particle: 
Magnetic nanoparticles are synthesized by chemical co-precipitation method using 
FeCl3 and FeCl2 with ammonia under nitrogen environment in a ratio of 2:1. These 
magnetic nanoparticles undergo subsequent coating of silica and carboxymethyl-β-
cyclodextrin under different reaction environment. Characterization of the chemical, 
physical and magnetic properties of the as-synthesized magnetic nanoparticles are 
carried out using FTIR spectroscopy, TEM, XPS, BET method and VSM. 
2. Application of silica and cyclodextrin derivative coated magnetic nanoparticle for 
adsorption of single amino acid enantiomers: 
Tryptophan, phenylalanine and tyrosine are three important chiral amino acids which 
have various applications. Initially, adsorptions of single enantiomers (D-/L-Trp, D-/L-
Phe, D-/L-Tyr) are done at neutral condition utilizing the silica and carboxymethyl-β-
cyclodextrin coated magnetic nanoparticles. Furthermore, adsorption studies of each of 
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the enantiomers are carried out in different conditions (different pH, temperature) to 
summarize the effect of these parameters. This study also helps in obtaining the 
optimum condition for maximum adsorption. Furthermore, kinetic studies are done to 
observe the effect of contact time on the adsorption process. Mechanism for single 
amino acid adsorption on the nanoparticles surface is also explored using FTIR 
spectroscopy. The condition where adsorption capacity difference between the 
enantiomer is maximum is determined from the detailed adsorption study. After that, 
desorption of single amino acid enantiomers is carried out using methanol as desorbing 
agent. 
 3. Chiral separation of racemic amino acids using silica and cyclodextrin derivative 
coated magnetic nanoparticle: 
Chiral separation of the amino acids on the nano adsorbents form their racemic mixture 
is also achieved in this project. Because of the different behaviour of the enantiomers, it 
is very important to study separation of enantiomers from their racemic mixture. 
Selective adsorption capacity of the particles from the racemic mixture of the amino 
acids and enantiomeric excess between the enantiomers are determined using high 
performance liquid chromatography technique. Enantioselective mechanism is also 
reported using several analytical techniques such as FTIR, XPS etc. Inclusion complex 
formation of the particles is also investigated and stability constant (K), Gibbs free 
energy change (-ΔG0) of the inclusion complexation process of the enantiomers (L-/D-
Trp, L-/D-Phe and L-/D-Tyr) with CMCD is accounted. Furthermore, desorption 
efficiency of the adsorbed amino acid enantiomers are also checked using methanol as 
desorbing agent. 
                                                                                              Chapter 2 
71 
 
4. Synthesis, characterization and application of amino-cyclodextrin coated magnetic 
particle for removal of pharmaceuticals and endocrine disruptors from aqueous 
solution: 
Magnetic nanoparticles coated with thiodiglycolic acid (TDGA) are also synthesized in 
this project by chemical co-precipitation method using FeCl3 and FeCl2 in presence of 
TDGA with ammonia solution under nitrogen environment in a ratio of 2:1. These 
magnetic nanoparticles are then coated with amino-cyclodextrin (β-CDen). These 
nanoparticles are characterized using several analytical techniques for example FTIR 
spectroscopy, TEM, XPS, TGA and VSM etc. 
The as-synthesized particles are utilized for detailed adsorption study of two 
pharmaceuticals, carbamazepine and naproxen and one endocrine disrupting compound 
bisphenol A. Carbamazepine and naproxen are generally used for treatment of epilepsy 
and depression. Presence of these pharmaceuticals and EDC in waste-water could be 
cause of chronic environment pollution. Removal of these drugs from aqueous solution 
is then scrutinized using the thiodiglycolic acid and amino-cyclodextrin coated 
magnetic nanoparticle in batch adsorption mode. Equilibrium study and effect of 
different parameters on the adsorption process are carried out in details. Kinetic studies 
of the adsorption of the three compounds are carried out as well. Also, inclusion 
complex formation of the pharmaceuticals and endocrine disrupting chemical with 
amino-cyclodextrin are explored using FTIR spectroscopy. Desorption study of the 
chemicals are also done to evaluate regeneration possibility of the magnetic 
nanoparticles. 
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5. Adsorption separation of beta-blocker, propranolol using silica and cyclodextrin 
derivative functionalized magnetic nanoparticles: 
Beta-blockers are one class of pharmaceuticals that have been widely detected in 
effluent of sewage treatment plants and surface water in the range of ng/L to µg/L [337-
342]. Propranolol is a beta-blocker which is generally used in the treatment of 
hypertension and cardiac arrhythmia. Propranolol is considered to be highly persistent 
and bioaccumulative in the environment and can cause harmful effect to aquatic 
environment. Thus, separation/ removal of propranolol is very important. In the later 
part of this project, adsorption behaviour of beta-blocker, propranolol using silica and 
cyclodextrin derivative coated magnetic nanoparticles is studied in systematic manner. 
Effect of different operating conditions (solution pH, initial sorbate concentration) is 
reported using the coated nanomagnetic particles. Binding constant of propranolol with 
CMCD is also determined using flurometric titrations. Mechanism for adsorption of 
propranolol on the magnetic nanoparticles surface is then studied with FTIR, XPS 
spectroscopy etc. Finally, desorption study of propranolol form the nanoparticles‟ 
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Chapter 3: Materials and Methods 
 
3.1 Materials 
Chemicals used for experimental purposes are listed in Table 3-1. All the chemicals 
were used as received without further treatment. For synthesis purpose and for 
preparation of buffer solutions ultrapure water and de-ionized water were used. 
The physical-chemical properties of tryptophan, phenylalanine, tyrosine, 
carbamazepine, naproxen, bisphenol A and propranolol are listed in Table 3-2 and 
Table 3-3, respectively. 
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Table 3-1 Lists of chemical materials 
 
Name  Chemical formula Grade Supplier company 
Iron (II) chloride tetrahydrate (98%) FeCl2·4H2O GR Alfa-Aesar 
Iron (III) chloride hexahydrate (98%) FeCl3·6H2O GR Alfa-Aesar 
Ammonium hydroxide (25%) NH4OH GR Merck 
Citric acid (99%) C6H8O7 GR Alfa-Aesar 
Tetraethyl orthosilicate (99%) SiC8H20O4 GR Fluka 
β-cyclodextrin hydrate (99%) C42H70O35·H2O GR Sinopharm Chemical 
Sodium dihydrogen phosphate monohydrate 
(99%) 
NaH2PO4.H2O GR Merck 
Di-sodium hydrogen phosphate (99%) Na2HPO4 GR Merck 
Acetic acid, glacial (99.7%) CH3COOH GR Alfa-Aesar 
Sodium acetate (99%) CH3COONa GR Merck 
D- and L-tryptophan (99%) C11H12N2O2 GR Alfa-Aesar 
D- and L-phenylalanine (99%) C6H5CH2CH(NH2)COOH GR Alfa-Aesar 
D- and L-tyrosine (99%) C9H11NO3 GR Alfa-Aesar 
DL-tryptophan (99%) C11H12N2O2 GR Alfa-Aesar 
DL-phenylalanine (99%) C6H5CH2CH(NH2)COOH GR Alfa-Aesar 
DL-tyrosine (99%) C9H11NO3 GR Alfa-Aesar 
Carbamazepine (99.5%) C15H12N2O
 
 GR Sigma 
Naproxen (99%) C14H14O3
 
 GR Alfa-Aesar 
Bisphenol A (99%) C15H16O2 GR Sigma-Aldrich 
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                        Table 3-1 (continued) 
Propranolol hydrochloride (≥99%) C16H21NO2·HCl GR Sigma-Aldrich 
Cyanamide (99%) CH2N2 GR Alfa-Aesar 
2-propanol (99.9%) C3H8O GR Fisher Scientific 
Acetone (99.5%) (CH3)2CO GR Merck 
Methanol (99.5%) CH3OH GR Merck 
Ethanol (99.5%) C2H5OH GR Merck 
P-toluenesulfonyl chloride (99%) C7H7O2SCl GR Lancaster 
Thiodiglycolic acid (98%) C4H6O4S GR Sigma-Aldrich 
Copper (II) sulphate pentahydrate Cu(II)SO4.5H2O GR Hayashi Pure 
Chemical Ind. Ltd. 
N-hydroxybenzotriazole (HOBt) C6H5N3O GR Sigma-Aldrich 
Pyridine C5H5N GR Sigma 
Diethyl ether (≥99.7%) (C2H5)2O GR Sigma-Aldrich 
N-methylpyrolidinone (NMP) C5H9NO GR Fluka 
N,N-dimethyl formamide (DMF) C3H7NO GR Merck 
 
 
Table-3-2 Physical properties of aromatic amino acids [53]. 
 




Isoelectric point Volume (Å
3
) 
Tryptophan 204.23 5.89 227.8 
Phenylalanine 165.19 5.48 189.9 
Tyrosine 181.19 5.66 193.6 
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Table-3-3 Physical-chemical properties of the pharmaceuticals, EDC and beta-blocker [54, 282]. 
 
Property Carbamazepine Naproxen Bisphenol A Propranolol 
hydrochloride 
Melting point 189-192°C 154-156°C 158-159°C 163-165°C 
Boiling point 411°C 403.9°C 220°C 434.9°C 
Solubility in water 17.7mg/L 15.9 gm/L 129 mg/L 150mg/L 
Solvent solubility Soluble in alchohol and 
in acetone 
Soluble in methanol, 
slightly soluble in acetone 
Soluble in acetone, 
methanol, toluene 
Soluble in ethanol, 
methanol 
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3.2.1 Synthesis of bare magnetic nanoparticles (bare MNPs) 
Nanosized magnetic particles were synthesized by chemical co-precipitation method 




 salt was maintained 
at 1:2 [343]. In order to synthesize 1 g of Fe3O4 particle, 0.86 g of FeCl2·4H2O and 2.35 
g of FeCl3·6H2O were dissolved in 40 mL ultrapure water under N2 atmosphere with 
vigorous stirring at speed of 1000 rpm. As the solution was heated to 80°C, 5 mL of 
NH4OH solution was added and the reaction was continued for another 30 mins. The 
resulting suspension was cooled down to room temperature and washed with ultrapure 
water. The product of bare magnetic nanoparticles (bare MNPs) was isolated from the 
solvent by magnetic decantation. The washing-decantation procedure was repeated five 
times to eliminate any unreacted chemicals and dried by freeze-dryer (Martin Christ 
freeze-dryer) for 24 hrs. Yield was 1.005 g. The following chemical reaction occurred - 
                                                              [3-1]        
3.2.2 Silica coated magnetic nanoparticles (Fe3O4/SiO2 MNPs) 
The procedure of silica coating follows a modified method described by Chen et al. 
[344]. Prior to coat the magnetic particle with silica, modification of nanoparticle 
surface with negatively charged citrate groups was done. A solution of the magnetic 
nanoparticles was prepared by mixing 1 g dry bare magnetic nanoparticles in 200 mL 
(0.3M) of citric acid solution and the resulting solution was sonicated for 1 hr followed 
by mechanical stirring for 12 hrs at 400 rpm at room temperature. Subsequently, the 
obtained citric acid modified nanoparticles (CMPs) were washed several times with 
distilled water, isolated with help of a magnet and dried at 60 °C in vacuum for 2 hrs. 
And the weight of the dry product was 1.1 g. 
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Furthermore, 1g of CMP was mixed with 40 mL deionized (DI) water and 200 mL of 2-
propanol and sonication for 15 mins was carried out to maintain proper dispersion. 
Under continuous mechanical stirring, 20 mL of ammonia solution (25%) and 1.5 mL 
tetraethyl orthosilicate (TEOS) were added. The reaction was allowed to proceed at 
room temperature at 650 rpm for 6 hrs. The silica coated core shell magnetic 
nanoparticles (Fe3O4/SiO2 MNPs) were isolated by magnetic decantation to remove the 
unbound silica particles and dried in vacuum after being washed with de-ionized water, 
2-propanol and acetone (weight of dry product: 1.5 gm). 
3.2.3 Synthesis of carboxymethyl-β-cyclodextrin (CMCD) 
 
A derivative of β-cyclodextrin, carboxymethyl-β-cyclodextrin was synthesized 
according to the method proposed by Prabaharan and Jayakumar with slight 
modification [345]. In a typical procedure, 20 g β-CD and 18.6 g sodium hydroxide 
(NaOH) were dissolved in 74 mL de-ionized water. Separately, solution of 
monochloroacetic acid (16.3%) was prepared in 54 mL de-ionized water and then 
mixed with the previous solution. The reaction mixture was heated to 50°C and the 
reaction was continued for 5 hrs under stirring with a magnetic bar. Subsequently, the 
reaction mixture was cooled down to room temperature and the solution was neutralized 
(pH 6~7) by adding dilute hydrochloric acid. Evaporation was done to obtain 
precipitate of unwanted salt (NaCl) and it was removed by vacuum filtration. Then the 
obtained solution without Cl− was poured to superfluous methanol solvent and it 
produced white precipitation. The solid precipitation was filtered and dried under 
vacuum to give carboxymethylated β-CD (CMCD, 12 g). IR (KBr): ν (cm−1): 3140–
3680 (–OH), 2923 (–CH), 1704 (C=O), 960–1200 (C–C, C–O–C).  
 
 
                                                                                    Chapter 3  
                                                                            
79 
 
3.2.4 Coating of CMCD on Fe3O4/SiO2 MNPs 
Grafting of CMCD on Fe3O4/SiO2 MNPs was done via modified carbodiimide 
activation method [346]. 1 g of dry Fe3O4/SiO2 MNPs was mixed with 20 mL of sodium 
phosphate buffer (0.03M, pH~6) and sonicated for 15 mins. Then 125 mg of cyanamide 
was dissolved separately in 5 mL of the same buffer solution and added to the previous 
mixture. Further sonication was done for 15 mins and finally 25 mL of CMCD solution 
(75 mg/mL in same buffer solution) was added and the reaction was continued for 2 hrs. 
The final product of CMCD coated magnetic silica nanoparticles (Fe3O4/SiO2/CMCD 
MNPs) were washed several times with sodium phosphate buffer. Weight of wet 
particles was 1.3 g. Some of the synthesized particles were dried in oven at 60°C and 
used for characterization while the rest were used for adsorption studies.  
The step-by-step reaction procedure to synthesize CMCD modified magnetic silica 
nanoparticles is shown in Figure 3-1. 
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3.2.5 Synthesis of 6-Deoxy-6-(p-toluenesulfonyl)-β-cyclodextrin (Ts-β-CD) 
Mono-tosyl-β-cyclodextrin (Ts-β-CD) was synthesized according to the following 
method. A solution of β-CD (18g, 16mmol) in 100 ml dry pyridine was prepared and 
2.5g of p-toluenesulfonyl chloride (12 mmol) was added to this solution. The reaction 
was carried out at 2-4C for a period of 8 hrs, and then 2 days at room temperature 
[347]. After concentrating the solution under vacuum, the mixture was poured into 
diethyl ether. A white precipitate was collected and purified by repeated crystallization 
from water. This product was finally washed by acetone and dried under vacuum at 
60ºC (weight of dry particles was 4 g).  IR (KBr): 3387 (ν, OH), 2927 (ν, C–H), 1636 
(δ, OH), 1368 (ν, SO2), 1157 (ν, C–O–C), 1029 (ν, C–O). 
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3.2.6 Synthesis of 6 deoxy-6-ethylenediamino-β-cyclodextrin (β-CDen) 
6-Deoxy-6-ethylenediamino-β-cyclodextrin (β-CDen) (en=-NHCH2CH2NH2) was 
synthesized following the procedures described by May et al. [348]. Typically, a 
solution of as-prepared Ts-β-CD (2.0 g, 1.55 × 10-3 mol), KI (0.025 g, 0.15 × 10-3 mol) 
and ethylenediamine (5 × 10
-3
 mol) in dry NMP (5 cm
3
) was stirred at 70C in a flask 
for 6 hrs. The resultant light yellow solution was cooled to room temperature and 
diluted with ethanol (100 cm
3
). The resulting precipitate was collected by vacuum 
filtration, washed successively with ethanol (100 cm
3
) and diethyl ether (50 cm
3
) and 
dried under vacuum to give the crude product. This material was then purified by 
column chromatography and dried under vacuum over P2O5 to give β-CDen in yields of 
55%. IR (KBr): 3388 (ν, OH), 2927 (ν, C–H), 1656 (δ, OH), 1576(ν, NH2), 1156(ν, C–
O–C), 1031 (ν, C–O). 
3.2.7 TDGA coated magnetic nanoparticles (TDGA-MNPs) 
Magnetite nanoparticles were prepared by chemical co-precipitation method under a 
nitrogen atmosphere to avoid possible oxidization during reaction [349]. A complete 
precipitation of Fe3O4 was achieved under alkaline condition, while maintaining a 




 = 1: 2 under an inert environment. In a typical synthesis to 
obtain 1 g Fe3O4 precipitate, 0.86g of FeCl2.4H2O and 2.36g FeCl3.6H2O were 
dissolved in 40 mL of de-aerated Milli-Q water with vigorous stirring at a speed of 
1,000 rpm. As the solution was heated to 80ºC, 100 mg of thiodiglycolic acid (TDGA) 
was added, followed by 5 mL of NH4OH. Further, TDGA was added to the suspension 
in five 0.2 gm amounts over 5 min. The experiment was continued for 30 min at 80ºC 
under constant stirring to ensure complete growth of the nanoparticle crystals. The 
resulting particles were then washed with Milli-Q water at least five times to remove 
any unreacted chemicals (weight of wet particles was 1.2 g). TDGA coated magnetic 
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nanoparticles were synthesized in few batches to get at least 5 g paticles to facilitate 
further modification and adsorption studies. 
3.2.8 β-CDen conjugated magnetic nanoparticles (CDen-MNPs) 
Thiodiglycolic acid (TDGA) coated wet magnetic nanoparticles (4 g) were suspended 
in 50 mL deionized water, and adjusted the pH of the solution to 6.8 after adding β-
CDen or β-CDNH2 (1.6 mmol). A mixture of N-(3-dimethyl (aminopropyl)-N‟-ethyl 
carbodiimide hydrochloride (0.96 mmol) and HOBt (N-hydroxybenzotriazole, 0.96 
mmol) was dissolved in a 6 mL mixture of H2O and DMF (1:1), and added to the 
reactant mixture. The reactant mixture was stirred at room temperature for 48 hrs. The 
CD conjugated powder was isolated from the solvent by magnetic decantation. The 
washing-decantation procedure was repeated three times to remove excess reactants 
used for the coating and weight of wet particles was 4.7 g. Some of the synthesized 
particles were dried for characterization while the rest were used for adsorption studies. 
Figure 3-2 illustrates the synthetic routes for preparation of β-CDen conjugated 
magnetic nanoparticles. 
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3.3 Adsorption experiments 
3.3.1 Adsorption of chiral aromatic amino acids on Fe3O4/SiO2/CMCD 
MNPs 
Tryptophan, phenylalanine and tyrosine are chiral amino acids with aromatic groups. 
To examine the effect of pH and effect of temperature on adsorption capacity of silica 
and CMCD coated magnetic nanoparticle toward the amino acids, detailed adsorption 
studies were performed at different conditions (pH and temperature). 
3.3.1.1 Effect of initial pH  
 
Effect of initial pH was studied in the range of 4-7 at 25°C and ionic strength of 0.03M. 
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sodium phosphate buffer (pH 5, 5.5, 5.6, 5.9, 6, 7) were used for the experiments. Due 
to low solubility of tyrosine, it was difficult to obtain tyrosine solution of concentration 
greater than 2 mM. Hence, to compare adsorption capacities of the synthesized particle 
toward the aromatic amino acid enantiomers, lower initial concentration range (0.25 
mM, 0.5 mM, 1 mM, 1.5 mM, 1.75 mM and 2 mM) of the six amino acid enantiomers 
(D-/L-Trp, D-/L-Phe, D-/L-Tyr) were prepared. Equilibrium study and comparison of 
adsorption capacities of coated magnetic nanoparticles toward the chiral amino acid 
enantiomers were performed by mixing 4 mL of amino acid solution with 50 mg of 
CMCD coated magnetic nanoparticles. To verify reproducibility of the results, 
duplicates of each sample were prepared. 
Some preliminary kinetic studies for adsorption process were conducted and it was 
found that equilibrium was reached in less than 24 hrs. The samples were left in a 
shaker operating at 230 rpm for 24 hrs which was the time to reach adsorption 
equilibrium. When the particles reached equilibrium, supernatant was separated from 
the magnetic particles by magnetic decantation method and filtered through 0.45µm 
syringe filter. The clear solution thus obtained was analyzed by means of a UV–visible 
spectrophotometer (Model UV- 1800) calibrated at the wavelength of maximum 
absorbance (λmax) of the specific amino acid enantiomers. Standard solutions of these 
amino acid enantiomers were prepared and absorbances of those solutions were 
recorded in the UV-visible spectrophotometer for plotting the standard calibration 
curves (absorbance against concentration). Tryptophan, phenylalanine and tyrosine 
show maximum absorbance in the UV spectrum at 280, 258 and 275 nm, respectively. 
From the calibration curve, final concentrations of the amino acid solutions and 
adsorption capacities of the particles toward the amino acid enantiomers were 
calculated.  
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3.3.1.2 Effect of temperature 
After obtaining the optimal condition for adsorption from the effect of initial pH study, 
effect of temperature on adsorption of amino acid enantiomers was studied at three 
different temperatures i.e. 25°C, 35°C and 50°C and at optimum pH (where pH 
corresponds to maximum adsorption capacity of Fe3O4/SiO2/CMCD MNPs toward the 
enantiomers) and ionic strength of 0.03M. Effect of temperature study was carried out 
by mixing 4 mL of amino acid solution of different initial concentrations (0.25 mM to 2 
mM) and 50 mg of wet magnetic nanoparticles. The sample vials were placed in a water 
bath with oscillator, and left to oscillate at a speed of 230 rpm for a period of 24 hrs at 
the desired temperature. Supernatant was collected using magnetic decantation and final 
concentration was obtained using UV-visible spectrophotometer.  
3.3.1.3 Kinetic studies 
For the kinetic experiments, the initial amino acid concentrations were 2 mM and the 
initial solution pH value was 5.9, 5.5 and 5.6 for Trp, Phe and Tyr enantiomers 
respectively (the solution pH was not controlled during the experiments). These amino 
acid solutions mixed with 50 mg of magnetic particles were agitated for a contact time 
varied in the range of 0–24 hrs at a speed of 230 rpm at 25°C. At various time intervals, 
samples were collected after separation of magnetic adsorbents by magnetic decantation 
process and the equilibrium concentration of amino acid solutions were determined as 
mentioned previously. 
3.3.1.4 Desorption studies 
 
Desorption of amino acid enantiomers (L-/D- Trp, L-/D-Phe, L-/D-Tyr) from 
Fe3O4/SiO2/CMCD MNPs was also investigated using methanol as eluent. Adsorption 
of individual amino acids (2 mM) on the functionalized magnetic nanoparticles was 
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carried out first. After 24 hrs, amino acid adsorbed on magnetic nanoparticles were 
separated by magnetic decantation and gently washed with water to remove the 
unbound amino acids. Desorption was then examined by adding 5 mL of methanol as 
eluent and shaking was continued at 230 rpm for 24 hrs, Fe3O4/SiO2/CMCD MNPs 
were collected by magnetic decantation method and the concentration of each amino 
acid in the supernatant was measured. 
 
3.3.2 Enantioselective separation of chiral aromatic amino acids  
3.3.2.1 Adsorption of racemic amino acids 
Sorption resolution experiments were carried out to determine the sorption selectivity 
and capability of Fe3O4/SiO2/CMCD MNPs. To compare enantioselective capacities of 
the magnetic nanoparticles, initial concentration of the amino acid solutions were 
maintained same i.e. 2 mM. 4 mL of racemic amino acid solution (DL-Trp, DL-Phe and 
DL-Tyr) (prepared in mono/disodium phosphate buffer, pH 6) of 2 mM initial 
concentration and 130 mg of wet magnetic nanoparticles were mixed and the samples 
were left in a shaker operating at 230 rpm for 24 hrs which is the time to reach 
adsorption equilibrium. Afterwards, supernatant separated from the magnetic particles 
by magnetic decantation were collected and filtered through 0.45µm syringe filter and 
D- and L-amino acid concentrations in the solutions were analyzed by high 
performance liquid chromatography (HPLC). To verify reproducibility of the results, 
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3.3.2.2 Measurement of enantiomeric excess  
 
All the enantiomeric excess and equilibrium concentration of amino acids were 
quantified on a HPLC-1200 system equipped with a Variable Wavelength Detector 
system (Agilent Technologies). Instrument control and data acquisition were performed 
with the HPLC-1200 ChemStation software. Separations were performed on a 
Phenomenex Chirex column (150 mm×4.6mmI.D.), purchased from Omega Scientific 
Pte Ltd. The mobile phases were prepared by mixing 2 mM copper sulphate solution 
with methanol (70:30). All the solutions were filtered through 0.45µm filter. Detection 
wavelength was set at 258 nm. Flow rate of mobile phase was set at 0.7 mL/min. The 
test samples (DL-Trp, DL-Phe and DL-Tyr) were dissolved in 0.03 M sodium 
phosphate buffer with initial concentration of 2 mM and the injected volume was 20 µL 
and temperature was set at 18°C. The column was equilibrated by washing with copper 
sulphate and 2-propranol (95:5) at flow rate of 1 mL/min for 1 hr after every run to 
ensure good performance of the column. All the chiral analyses were performed in 
triplicate to check accuracy. For the evaluation of enantioseparation, the following 
parameters were determined: k1 and k2 (the retention factors of the eluted enantiomers) 
were calculated using the formula (t1 −t0)/t0 and (t2 −t0)/t0 (where t0 is the time at which 
the first baseline disturbance by the solvent peak occurred), α (the selectivity factor) 
was calculated using k2/k1, while Rs (the resolution) was evaluated using the formula 
1.18 (t2 −t1)/(wh1 +wh2), where wh1 and wh2 are the half peak widths [350]. Sorption 
selectivity (expressed in enantiomeric excess, e.e.) and uptake (Qe) of 
Fe3O4/SiO2/CMCD MNPs could be expressed by equation 3-2 and equation 3-3, 
respectively [351]: 
                                 
     
     
                                                                            [3-2] 100% 
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   -     
 
                                                                            [3-3] 
Where, CD and CL denote equilibrium D- and L-amino acid concentrations in the bulk 
solution (mM), respectively. Ci and Ce represent initial and equilibrium concentrations 
of aromatic amino acids in the bulk solution (mM), and V and w are the solution volume 
(mL) and the weight of dry magnetic particles (mg).  
3.3.2.3 Flurometric experiments 
The flurometric titrations using a series of solutions containing L/D- Trp, L/D- Phe and 
L/D- Tyr (3×10
-5
 mol/L) and varying amounts of CMCD (0-9.68 x10
–4
 mol/L) were 
carried out in aqueous buffer solution (pH 6) at 25 °C with excitation at 280 nm, 258 
nm and 275 nm for Trp, Phe and Tyr enantiomers and observation at 358 nm, 260 nm 
and 280 nm.  
 
3.3.3 Adsorption of pharmaceuticals and EDCs on CDen MNPs 
Carbamazepine, naproxen and bisphenol A are some of the emerging contaminants with 
aromatic groups. Initially, kinetic studies were done to obtain the time for completion of 
the adsorption process. Furthermore, detailed adsorption studies of these compounds 
were carried out at different pH to obtain effect of pH on adsorption capacity of CDen-
MNPs towards the pharmaceuticals and EDC. 
3.3.3.1 Kinetic studies and effect of pH studies 
The kinetics of adsorption process of emerging contaminants (naproxen, carbamazepine 
and bisphenol A) were investigated in a batch equilibrium mode by adding 100 mg of 
wet CDen-MNPs into 5 mL of CBZ, NAP and BPA solutions with concentration of 20 
ppm. Samples for adsorption experiments were prepared in de-ionized water. The 
Qe 
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solution pH was adjusted by 0.01M NaOH or 0.01M HCl. The solutions mixed with 
wet magnetic particles were agitated for a contact time varied in the range of 0–7 hrs at 
a speed of 230 rpm at 25°C. At various time intervals, samples were collected after 
separation of magnetic adsorbents by magnetic decantation and the equilibrium 
concentration of sorbates were determined as mentioned previously. The residual 
concentrations of CBZ, NAP and BPA in solutions were determined by Shimadzu UV– 
visible spectrophotometer (Model 1800) and absorbance values were recorded at 285, 
271 and 276 nm, respectively. The amounts of solute adsorbed per unit mass of 
adsorbent were calculated from the differences between the initial and the final solute 
concentrations in solution before and after adsorption. Each experiment was repeated 
twice, and reproducibility was found to be fairly good. The amount of CBZ, NAP and 
BPA adsorbed onto CDen-MNPs was calculated by a mass balance relationship, 
                 
         
 
                                                                     [3-4] 
where V (mL) is the volume, Ci and Ce (ppm) are the initial and equilibrium solution 
concentration of BPA, NAP or CBZ and w (mg) is the dry mass of the solid. 
Effect of pH on adsorption of the PhACs and EDCs were examined over the pH range 
from 3-11 at 25°C at initial concentration of 20 ppm. 
3.3.3.2 Equilibrium studies 
 
Since these pharmaceuticals are present in low concentration in waste-water, adsorption 
studies were carried out in low concentration range i.e. 5-20 ppm range. The procedure 
for equilibrium study was basically identical to those of kinetic experiments. The 
solutions of pharmaceuticals and EDC with different concentrations (5-20 ppm) were 
mixed with 100 mg of wet CDen-MNPs at pH 7 and 25°C. The solution pH was 
Qe       
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adjusted by adding 0.01M NaOH or 0.01M HCl solution. Then the sample solutions 
were stirred by a horizontal laboratory shaker at 230 rpm and after equilibrium was 
reached, the MNPs were removed by magnetic decantation from the solution before 
measurements. The equilibrium concentrations of CBZ, NAP and BPA in solutions 
were determined by UV–visible spectrophotometer by recording absorbance at 285, 271 
and 276 nm, respectively. Adsorption capacities of adsorbent toward the sorbates were 
obtained from the differences between initial and equilibrium solute concentrations in 
solution before and after adsorption.  
3.3.3.3 Adsorption of a mixture of pharmaceuticals 
Adsorption of a mixture of the three selected pharmaceuticals (CBZ, NAP and BPA) 
was conducted by introducing 100 mg of coated magnetic nanoparticles into 5 mL 
solution of three pollutants at the same concentration at pH 7 and concentration of 20 
ppm. The supernatant was collected by magnetic separation and the supernatant 
solutions were then filtered (0.45 µm), extracted and analyzed by the Agilent HPLC-
1200 series. Analysis with HPLC was carried out using methanol and water (60:40) 
mobile phase at flow rate of 0.5 mL/min. Column temperature was maintained at 30ºC 
and detection was done at 286 nm. 
3.3.3.4 Desorption of pharmaceuticals and EDC 
Desorption of CBZ, NAP and BPA from CDen-MNPs was also investigated using 
ethanol as eluent. Adsorption of individual PhACs and EDC (20 ppm) on CDen-MNPs 
was carried out first. After 4 hrs, PhACs or EDC-adsorbed magnetic nanoparticles were 
separated by magnetic decantation and gently washed with water to remove the 
unbonded contaminants. Desorption was then examined by adding 5 mL of ethanol as 
eluent to the either pollutant-sorbed CDen-MNPs. After shaking at 230 rpm for 6 hrs, 
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CDen-MNPs were collected magnetically and the concentration of each pollutant in the 
supernatant was measured. 
3.3.3.5 Preparation of inclusion complex for investigation by FTIR 
spectroscopy 
The complex of CBZ, NAP and BPA with β-CDen in 1:1 molar ratio was prepared in 
water. To be more precise, 19.84 mg (0.084 mmol) of CBZ, 19.35 mg (0.084 mmol) of 
NAP, 19.17 mg (0.084 mmol) of BPA were added to 5 mL de-ionized water in three 
separate glass vials where 100 mg (0.084mmol) of CDen were added later on. The vials 
were sealed and the mixture was stirred at 25°C for 2 days. Afterwards, the residue 
containing inclusion complexes were separated using vacuum filtration and solid 
samples were obtained by freeze drying. The freeze dried complexes were investigated 
using FTIR spectroscopy. 
 
3.3.4 Adsorption of beta-blocker, propranolol onto Fe3O4/SiO2/CMCD 
MNPs 
3.3.4.1 Adsorption experiments 
The adsorption of beta-blocker, propranolol was investigated using a batch equilibrium 
mode by adding 60 mg of wet Fe3O4/SiO2/CMCD MNPs into 4 mL of propranolol 
hydrochloride solutions with different concentrations (10– 50 ppm) at pH 7 and 25oC. 
Samples for equilibrium adsorption studies were prepared in de-ionized water. The 
solution pH was adjusted by 0.01M NaOH or 0.01M HCl. After preparation of 
propranolol solution, samples were stirred by a horizontal laboratory shaker at 230 rpm 
and after the equilibrium was reached, the MNPs were removed by magnetic 
decantation from the solution before measurements. Some initial kinetic studies were 
done and it showed that adsorption reached equilibrium within 1 hr. The residual 
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concentrations of propranolol hydrochloride in solutions were determined by Shimadzu 
UV–visible spectrophotometer (Model 1800) and absorbance values were recorded at 
289 nm. The amounts of solute adsorbed per unit mass of adsorbent were calculated 
from the differences between the initial and the final solute concentrations in solution 
before and after adsorption following equation 3-4.  
Effect of pH on adsorption of propranolol was examined over the pH range from 3-11 
at initial concentration of 50 ppm.   
The procedure for kinetic experiments was basically identical to those of equilibrium 
tests. The solutions mixed with 60 mg of wet magnetic particles were agitated at a 
speed of 230 rpm at 25
o
C. At various time intervals, samples were collected after 
separation of magnetic adsorbents by magnetic decantation and the equilibrium 
concentration of sorbate were determined as mentioned previously. The amount of 
propranolol adsorbed onto Fe3O4/SiO2/CMCD MNPs was calculated by a mass balance 
relationship following equation 3-4. 
3.3.4.2 Flurometric experiments 
The flurometric titrations using a series of solutions containing propranolol 
hydrochloride (4.5× 10
-5
 mol/L) and varying amounts of CMCD (0–4.7×10-4 mol/L) 
were carried out in aqueous buffer solution (pH 7) at 25°C with excitation at 283 nm 
and observation at 343 nm.  
3.3.4.3 Desorption studies 
Desorption studies of beta-blocker, propranolol was carried out using 50% methanol 
solution when adsorption was carried out at pH 7 (sodium phosphate buffer solution). 
To ensure that equilibrium was achieved for adsorption, shaking was done for 5 hrs and 
the supernatant was separated from the magnetic particles by help of a magnet. Then 
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the particles were washed using Milli Q water. Magnetic particles containing 
propranolol was then mixed with 5 mL of 50% methanol solution. After 6 hrs of 
incubation at 25°C, the supernatant was collected and analyzed in UV-Visible 
spectrophotometer at 289 nm.  
 
3.4 Analytical Methods 
The analytical methods used in this experiment are described in the following sections. 
3.4.1 Fourier-transform Infrared (FTIR) Spectroscopy 
Fourier Transform Infrared Spectroscopy is a technique that provides information about 
the chemical bonding or molecular structure of materials, whether organic or inorganic. 
Structural information of a molecule can be determined using infrared spectroscopy. 
The vibrational movements e.g., bending, stretching of the various types of bonds (O-H, 
C=O etc.) correspond to the absorption of certain wavelengths in the infrared region of 
electromagnetic radiation. Infrared spectroscopy is used more for qualitative than 
quantitative purposes. The region of the infrared spectrum obtained is usually from 400 
to 4000 cm
-1
. The region of the spectrum below 1500 cm
-1
 is the fingerprint region, in 
which the bands for each compound are unique. Hence, it is considered that two 
molecules are identical if they share the same „Fingerprint‟ in this region. The region 
above 1500 cm
-1
 is called the functional group region, where vibrational modes of the 
functional groups are observed. The Shimadzu Infra-Red spectrometer (Model no. 400) 
was used to characterize all the synthesized particles at room temperature. A small 
portion of samples were grinded with approximately 225/230 mg of potassium bromide 
powder into a smooth, fine powder. This powder was subjected to high pressure and 
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compressed into a thin pellet. The pellet was placed into the spectrometer and scanned 
over a broad wavelength ranging from 4000 to 400 cm
-1
. 
3.4.2 Transmission Electron Microscopy (TEM)  
Transmission electron microscopy (TEM) is a technique which involves shining a beam 
from a light source, through an electromagnetic lens which focuses the electrons into a 
very thin beam, and then finally through an ultra-thin specimen, interacting with the 
specimen as it passes through. This result in the formation of an image due to the 
interaction of the electrons transmitted through the specimen. The image is magnified 
and focused onto an imaging device, such a layer of photographic film, or can be 
detected by a sensor such as a CCD camera. Characterization of size and morphology of 
the samples were carried out using transmission electron microscopy. Dilute sample of 
magnetic nanoparticles were suspended in ethanol and ultrasonicated. Suspension 
containing the dispersed magnetic particles was thinly coated on copper grids. The 
copper grids were left to dry for 24 hrs at room temperature and finally the samples 
were analyzed using Field Emission TEM (JEOL 2011F) machine (at an acceleration 
voltage of 200 kV).  
3.4.3 X-ray Diffraction (XRD) analysis 
X-Ray diffraction of samples was measured using Shimadzu XRD 6000 spectrometer 
(using Cu Kα λ 1.5418 Å radiations). This is a method to determine arrangement of 
atoms within a crystal in which a beam of X-ray strikes a crystal and diffracts it in 
many specific directions. From angles and intensities of those diffracted beams, the 
mean position of atoms in the crystal can be determined which is a characteristic 
property of the specific compound. Some valuable information like chemical bond, 
disorder of the structure can also be determined through this analysis. Even, a 
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crystallographer can produce a three dimensional structure of density of electrons 
within the crystal structure. 
3.4.4 Vibrating Sample Magnetometer (VSM) 
The vibrating sample magnetometer has become a widely used instrument for 
determining magnetic properties of a large variety of materials: diamagnetics, 
paramagnetics, ferromagnetics, ferromagnetics and antiferromagnetics as a function of 
magnetic field and temperature. Wet magnetic particles were freeze-dried (Martin 
Christ freeze-dryer) for 24 hrs and then used for VSM measurement (Lakeshore, model 
no.665). A plastic cylinder cell containing the sample was attached on a rod in the 
applied magnetic field from -15,000 to 15,000 Oe, in which the rod was vibrating in a 
certain rate. The magnetization curve of the magnetic particles at room temperature was 
then plotted with the changes of magnetic field strength and its direction. 
3.4.5 Brunauer-Emmett-Teller (BET) method 
The specific surface area was measured by BET analyzer (Model: Quantachrome 
NOVA 4200e). The Brunauer-Emmett-Teller (BET) theory explains the physical 
adsorption of gas molecules on a solid surface, which serves as an important basis for 
the measurement of the specific surface area of a material. Surface cleaning (degassing) 
of the dried solid magnetic particles were carried out by placing the sample in a glass 
cell and heating at 120°C under vacuum for 12 hrs before the measurements. Once 
clean, small amount of gas molecules were admitted in steps into the sample chamber 
and then stick to the surface of solid particles, which was carrying out in an external 
bath maintained by liquid nitrogen. As the equilibrium adsorbate pressure approach 
saturation, surfaces of magnetic particles become completely occupied by adsorbate. 
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Knowing the density of the adsorbate, it is easy to calculate the specific area of the 
magnetic particles. 
3.4.6 Zeta Potential analysis 
The magnitude of the zeta potential gives an indication of the potential stability of the 
colloidal system. For example, if the particles have low zeta potential, there is no force 
to prevent the particles coming together and flocculating, whereas if all particles in the 
suspension have large negative/positive zeta potential, they will tend to repel each other 
and there is no tendency to flocculate. The zeta potentials of coated magnetic particles 
and amino acid solution (Trp, Phe and Tyr) at different pHs were measured using 
Malvern ZEN2600 Zetasizer Nano ZS analyzer. Samples were prepared by diluting 20 
mg wet magnetic particles/amino acids in 100mL of 10
-3
 M NaCl solution at different 
pH adjusted with diluted HNO3 or NaOH solution. 
3.4.7 Thermogravimetric Analysis (TGA) 
TGA is a thermal analysis technique used to measure changes in the weight of a sample 
as a function of temperature/time. The thermogravimetric analysis was performed on a 
thermal analysis system (Model: TA 2050). For TGA measurements, 12/15 mg of the 
dried sample was loaded into the system; weight loss of dried sample was monitored 
under N2 from room temperature to 800°C at a rate of 10°C/min. 
3.4.8 X-ray Photoelectron Spectroscopy (XPS) 
The working principle of X-ray photoelectron spectrophotometer is based on having a 
primary X-ray beam of precisely known energy impinged on sample atoms, inner shell 
electrons are then ejected and the energy of the ejected electrons is measured. The 
difference in the energy of the impinging X-ray and the ejected electrons gives the 
binding energy of the electron to the atom which is used to identify the element 
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involved. XPS measurements were made on an Axis Ultra DLD (Kratos) spectrometer 
with Al mono Kα X-ray source (1486.71 eV photons) at a constant retard ratio of 40. 
The sample was mounted on the standard sample studs by means of double sided 
adhesive tape. The core-level signals were obtained at a photoelectron take-off angle 
90° (with respect to the sample surface). The X-ray source was run at a reduced power 
of 75W. The pressure in the analysis chamber was maintained at 5×10
-8
 Torr or lower 
during each measurement.  All binding energies (BEs) were referenced to the C1s 
neutral carbon peak at 284.6 eV. 
3.4.9 Fluorescence 
Fluorescence is the phenomenon in which absorption of light of a given wavelength by 
a fluorescent molecule is followed by the emission of light at longer wavelengths. The 
distribution of wavelength-dependent intensity that causes fluorescence is known as the 
excitation spectrum, and the distribution of wavelength-dependent intensity of emitted 
energy is known as emission spectrum. The fluorescence measurements of amino acids 
and beta-blocker were carried out with fluorescence spectrometer (Quantamaster, GL-
3300 & GL-302 laser systems) with a 10-mm path length sample cuvette. The 
excitation wavelength was set and emission was scanned in the range specific for the 
samples. The scan rate was 0.25 nm/min
-1
 with a 10 nm bandpass for both excitation 
and emission.  




 Chapter 4: Characterization of silica and carboxymethyl-β-
cyclodextrin bonded magnetic nanoparticles 
 
4.1 Introduction 
The stabilization of the iron oxide particles is crucial to obtain magnetic colloidal 
ferrofluid that is stable against aggregation in both biological medium and magnetic 
field. The stability of magnetic colloidal suspension results from the equilibrium 
between attractive and repulsive forces. Theoretically, four kinds of forces can 
contribute to the interparticle potential in the system. van der Waals forces induce 
strong short-range isotropic attractions. The electrostatic repulsive forces can be 
partially screened by adding salt to the suspension. The theoretical description of these 
two forces is known as the Derjaguin-Landau-Verwey-Overbeek (DLVO) theory [352]. 
For magnetic suspensions, magnetic dipolar forces between two particles must be 
added. These forces induce anisotropic interactions, which are found to be globally 
attractive if the anisotropic interparticle potential is integrated over all directions. 
Finally, steric repulsion forces have to be taken into account for non-naked particles 
[353]. Stabilization of magnetic particles can be achieved by playing on one or both of 
the two repulsive forces: electrostatic and steric repulsion [354]. 
The formation of Fe3O4 nanoparticles by co-precipitation of ferrous and ferric cations in 
alkaline condition is a classical method and widely practiced. Generally, long-chain 
surfactants such as oleic acid, lauric acid, dodecyl phosphonate, hexadecyl 
phosphonate, and dihexadecyl phosphate are used to stabilize the nanoparticles and 
disperse them in organic solvents. In the past few years, much work has been done to 
fabricate magnetic composite particles by encapsulating magnetite nanoparticles with 
organic polymers through monomer polymerization or by coating magnetite 




nanoparticles with inorganic matrixes such as silica and titanium dioxides through a sol-
gel approach [355-357]. The sol-gel approach has been frequently employed for coating 
magnetite nanoparticles with inorganic matrix, especially silica, and proved to be a 
robust way to fabricate magnetic nanocomposites, because surface of magnetite has 
strong affinity toward silica. Furthermore, silica coatings provide magnetite 
nanoparticles with a chemically inert surface, which is especially important in 
biological applications [358, 105]. Some works have been done to prepare silica-coated 
magnetite nanoparticles through a sol-gel approach. Wang et al. synthesized magnetite 
particles by co-precipitation method and directly coated them with silica in a basic 
alcohol/water mixture [359]. Aliev et al. synthesized silica-coated magnetite particles 
through a slow sol-gel process using sodium silicate as the silica source [360]. The 
above methods could lead to silica coated magnetite particles. However, the structure 
and morphology of resultant composites could not be well controlled because the 
magnetite nanoparticles were used directly as seeds without any treatment and they can 
spontaneously aggregate in the liquid reaction systems. In order to synthesize well-
dispersed silica coated magnetite nanoparticles with well-defined structures, surface 
modification of magnetite nanoparticles is needed to increase their dispersing stability 
in reaction media. Philips et al. synthesized core-shell silica-coated magnetite particles 
via sol-gel approach by using surfactant stabilized magnetite nanoparticles as seeds 
[104]. Through an analogous approach, Lu et al. reported the formation of silica on the 
surface of magnetite nanoparticles stabilized with oleic acid [105]. Although surfactant 
stabilized magnetic nanoparticles could be used to prepare silica-coated magnetic 
nanoparticles via sol-gel approach, the coating process is difficult to control because 
surfactant molecules are easy to desorb from magnetic nanoparticles by alcohol 
dissolution. Thus, for coating with silica using modified Stöber method, it is necessary 




to render the particles well dispersed in polar solvents. So in this work, citric acid was 
chosen to modify the magnetic particles which allow formation of a stable aqueous 
dispersion by reducing the aggregation tendency of magnetite and ultimately will lead 
to obtain well-dispersed core-shell nanoparticle after coating with silica. 
Many nanostructural compounds and composites have been constructed by utilizing 
cyclodextrin (CD) as the surface modifier. Wang et al. utilized α-CD as an inclusion 
host to modify the surface of oleic acid-coated magnetite nanoparticles to “pull” them 
from hydrophobic solvents to aqueous phase [152]. Hou et al. and Xia et al. used a 
similar inclusion complex mechanism to form spherical magnetite aggregates with 
controllable size by changing the concentration of β-CD [158, 160]. Moreover, CD was 
also used to coat magnetite nanoparticles as a surfactant to make the particles more 
biocompatible [361].  Fan et al. used β-cyclodextrin bonded silica as the sorbent for on-
line SPE-HPLC analysis of 4-nitrophenol from water samples [362]. However, little or 
no work has been done so far using cyclodextrin bonded magnetic nanoparticles to 
separate chiral biomolecules or beta-blockers to our knowledge.  Benefit of using 
cyclodextrin bonded magnetic silica particles is tributed by the combined properties of 
the particles such as magnetic properties of Fe3O4, biocompatibility of silica shell and 
chiral recognition properties of cyclodextrin. 
In this work, novel nano-adsorbents were prepared using surface modified Fe3O4 as the 
core and silica and cyclodextrin derivatives as the shell. Surface of magnetic silica 
nanoparticles is modified by grafting with carboxymethyl-β-cyclodextrin (CMCD) via 
carbodiimide activation. The size, structure, and magnetic properties of the resultant 
magnetic nanoparticles were characterized by TEM, XRD, and VSM. Moreover, 




binding of silica and cyclodextrin derivative to the magnetic nanoparticles was 
confirmed by FTIR and XPS. 
4.2 Results and discussion 
4.2.1 Characterization of silica and CMCD coated magnetic nanoparticle 
4.2.1.1 FTIR spectroscopy 
The FTIR spectra of bare MNPs, CMPs, Fe3O4/SiO2 MNPs and Fe3O4/SiO2/CMCD 
MNPs are presented in Figure 4-1. It is shown that the characteristic absorption band of 
Fe–O bonds in the tetrahedral sites of bare magnetic nanoparticles is 586 cm−1. The 
broad band at 3300-3500 cm
−1
 is due to –OH stretching vibrations. Compared to the 
bare magnetite nanoparticles (Figure 4-1(a)), two new absorption peaks at 1631 and 
1392 cm
-1
 appear in the FTIR spectra of citric acid treated magnetite nanoparticles 
(Figure 4-1(b)), which are characteristics of the carboxylate [363]. The existence of the 
characteristic Si-O-Si stretching at 1091 and 1087 cm
−1
 on Fe3O4/SiO2 MNPs (Figure 4-
1(c)) and Fe3O4/SiO2/CMCD MNPs (Figure 4-1(d)) respectively, are evidences to 
confirm the formation of the silica shell [344]. In the spectra of Fe3O4/SiO2 MNPs and 
Fe3O4/SiO2/CMCD MNPs, other characteristic absorption bands such as Si–OH 
stretching, Si–O bending and Si–O–Si bending, are shown at 960, 794, 464 cm−1 and at  




respectively [164]. Characteristic Fe-O peak of bare MNPs at 
586 cm
-1
 is shifted to 578 and 576 cm
−1
 in the spectrum of Fe3O4/SiO2 MNPs and 
Fe3O4/SiO2/CMCD MNPs, respectively. Thus, undoubtedly it can be said that the silica 
shell is linked to the surface of the magnetic nanoparticles by Fe-O-Si chemical bond 
[344]. In the spectrum for Fe3O4/SiO2/CMCD MNPs (in Figure 4-1(d)), the most 
important asymmetric and symmetric C-H stretching bands are found at 2854 and 2924 
cm
-1
 respectively, which prove successful grafting of CMCD on silica coated magnetic 
particles and the characteristic peaks of CMCD in the region of 900-1200 cm
-1
 might 




have overlapped with the broad and strong peak due to silica coating. The two other 
main characteristic peaks are observed at 1623 and 1400 cm
−1
 due to bands of COOM 
(M represents metal ions) groups, which indicate that the COOH groups of CMCD 
reacted with the surface OH groups of Fe3O4/SiO2 MNPs resulting in the formation of 
the silica carboxylate [364]. Therefore, the above results indicate that the magnetic 
particles are successfully coated by silica and CMCD which was further evidenced by 
XPS. In the spectrum of Fe3O4/SiO2 MNPs, a short band is observed at 3168 cm
-1
 while 
in the spectrum of Fe3O4/SiO2/CMCD MNPs this band is absent, rather a broad band is 
seen which indicates the presence of O-H groups (originated from hydroxyl groups of 
CMCD) on the surface of the particles. 
 
 
Figure 4-1 FTIR spectra of (a) bare MNPs, (b) CMPs, (c) Fe3O4/SiO2 MNPs, (d) 
Fe3O4/SiO2/CMCD MNPs. 
 




4.2.1.2 TEM images and surface area measurements 
TEM images and size distributions of bare MNPs, CMPs and Fe3O4/SiO2/CMCD 
MNPs are presented in Figure 4-2. From Figure 4-2(a) and Figure 4-2(b), it is clear that 
the synthesized bare nanoparticles and CMPs are well dispersed, but also in some areas 
bigger structures with non-spherical morphology are observed, more likely resulting 
from aggregation/ coalescence of individual nanoparticles which is also evident from 
other research works [365]. The average size of bare nanoparticles and CMPs are about 
11 nm and 12 nm correspondingly. Figure 4-2(c) depicts the TEM image and 
corresponding size distribution of Fe3O4/SiO2/CMCD MNPs. Images of bare and coated 
MNPs were taken using HRTEM machine and afterwards, size of at least 100 particles 
from different areas were measured and average size of the particles were calculated 
using following equation: 
  
  
∑       
∑  
 
where,       ni = No. of particles within the same size range 
                                           di = Particle diameter of the same size range 
                                          di
’
=Average particle size 
 It can be clearly seen that these magnetite silica nanoparticles are nearly all in core-
shell structures with dark core of magnetite and grey porous silica shell. These 
nanoparticles have also been observed as well-shaped spherical or ellipsoidal. The 
average diameter of the Fe3O4/SiO2/CMCD MNPs is around 29 nm (thickness of silica 
layer ~9 nm). However, the thickness of silica shell of the Fe3O4/SiO2 particles can be 
conveniently adjusted by controlling the addition amount of silica source (TEOS) 
through the seeded sol-gel approach. No detectable layer due to CMCD can be observed 
on the surface of magnetite silica nanoparticles. 






































































































Figure 4-2 (c) TEM image and (d) size distribution of CMPs (scale bar is 20 nm). 






















































Figure 4-2 (e) TEM image and (f) size distribution of Fe3O4/SiO2/CMCD MNPs (scale 













The specific surface areas of the magnetic nanoparticles‟ were calculated based on 
standard Brunauer-Emmett-Teller (BET) method. The BET surface area of bare and 
Fe3O4/SiO2/CMCD MNPs are 105 and 74 m
2
/g, respectively. As compared with bare 
MNPs, Fe3O4/SiO2/CMCD MNPs exhibit smaller BET surface area. The decrease of 
surface area could be ascribed to the presence of silica shell and CMCD on the particle 
surface.  
4.2.1.3 X-ray Diffraction analysis 
Figure 4-3 shows XRD patterns of the prepared CMPs, Fe3O4/SiO2 MNPs and 
Fe3O4/SiO2/CMCD core-shell nanoparticles. The XRD patterns of the synthesized 
particles show five characteristic peaks at 2θ = 30.22°, 35.56°, 43.08°, 57.48°, 63.08° 
related to their corresponding indices (220), (311), (400), (511) and (440), respectively. 
These data describe that resultant nanoparticles are pure Fe3O4 with spinel structure 
[349]. So, the coating process did not induce any phase change of Fe3O4. Average 
crystal size of the nanoparticles is calculated from the most intense peak, corresponding 
to the indice (311) according to the Debye–Scherrer‟s formula, [D = 0.9λ/(βcos θ), 
where β expresses the half width of XRD diffraction lines and λ is the X-ray 
wavelength (0.154 nm) and θ is the half diffraction angle of 2θ]. For CMPs, the average 
crystal size is found to be 11.5 nm, slightly less than that measured from the TEM 
image. After coating with silica and CMCD, intensities of the corresponding diffraction 
peaks for magnetic nanoparticles shown in Figure 4-3 are reduced because of the layer 
of silica and CMCD on the particle surface. Also, the presence of mesoporous silica 
oxide shell is evident from the broader hump in between 2θ=20° to 25° [366].  





Figure 4-3 XRD patterns of (a) CMPs, (b) Fe3O4/SiO2 MNPs, (c) Fe3O4/SiO2/CMCD 
MNPs. 
 
4.2.1.4 XPS results 
In order to concretely study the combination of magnetic particle cores and silica and 
CMCD shells of core–shell structured materials, x-ray photoelectron spectra (XPS) of 
samples are analyzed. Figure 4-4 presents the XPS wide spectra of (a) CMPs, (b) 
Fe3O4/SiO2 MNPs, (c) Fe3O4/SiO2/CMCD MNPs. The wide scan spectrum shows the 
Fe2p, O1s, C1s, Si2p peaks of magnetic particles at around 709, 529, 284 and 102 eV.  






Figure 4-4 XPS wide scan spectra of (a) CMPs, (b) Fe3O4/SiO2 MNPs, (c) 
Fe3O4/SiO2/CMCD MNPs. 
 
From Figure 4-4(b), the peak of Si2p (100.75eV) can be seen on Fe3O4/SiO2 MNPs 
core–shell structure materials, which comes from the silica coating. As depicted from 
Figure 4-5(b), the binding energy of O1s of CMPs is 527.25 eV, which is in agreement 
with previously reported values [344]. This value is of Fe3O4/SiO2 MNPs is less by 3 
eV compared to CMPs (Figure 4-5(b)). The formation of Fe–O–Si bond on the surface 
of the particles makes the electronic density of O combined with Fe decrease, so the 
binding energy of O1s for a core–shell particle has a chemical shift of 3 eV.  
 






Figure 4-5 XPS wide scan spectra of (a) Si2p of Fe3O4/SiO2 MNPs, (b) O1s of CMPs 
and Fe3O4/SiO2 MNPs, (c) C1s spectrum of Fe3O4/SiO2/CMCD MNPs. 
 
 
XPS analysis was also applied to find the chemical binding in the synthesized 
Fe3O4/SiO2/CMCD MNPs. The C1s deconvoluted spectrum is shown in Figure 4-5 (c). 
The C1s spectrum can be curve-fitted into four peak components with binding energy 
of about  284.6, 286, 287.9 and  288.7 eV, attributable to C–C (aromatic)/C–H, C–O/ 
C–O–C (alcoholic hydroxyl and ether), C=O (carbonyl) and COO- (carboxyl) species, 
respectively [164]. The C–O/C–O–C and C=O peaks are the characteristics of CMCD. 
Moreover, the presence of COO
-
 peak at 288.7 eV indicates that the COOH functional 
a b 
c 




groups on CMCD reacted with surface OH groups to from metal carboxylate (COOM). 
Thus, the modification of magnetic silica surface with CMCD was confirmed.  
4.2.1.5 VSM results 
The diagram of magnetization verses magnetic field (M-H loop) at 25 °C for bare 
MNPs and Fe3O4/SiO2/CMCD MNPs are depicted in Figure 4-6. This figure shows 
almost zero coercivity and no residual magnetism, which proves the superparamagnetic 
properties of the synthesized magnetic nanoparticles. Superparamagnetic particles do 
not have permanent magnetic moments in the absence of an external field but can 
respond to an external magnetic field. The saturation magnetization of bare MNPs was 
found to be 75.7 emu/g which is much lower than its bulk counter parts (92 emu/g) 
[367]. It is well known that the energy of magnetic particles in an external field is 
proportional to their size via the number of magnetic molecules in a single magnetic 
domain. When this energy becomes comparable to the thermal energy, thermal 
fluctuations significantly reduce the total magnetic moments at a given field [368]. This 
phenomenon is more important for the nanoparticles due to their large surface area to 
volume ratio. Therefore, the smaller saturation magnetization value for the 
nanoparticles compared to the bulk materials is reasonable. The saturation 
magnetization of Fe3O4/SiO2/CMCD MNPs was 45 emu/g of particles, which is lower 
than that of bare magnetic nanoparticles. This might result from binding of silica and 
CMCD on the particle surface, which might have quenched the magnetic moment 
[369]. In addition, magnetic molecules on the surface have deficiency of complete 
coordination and thus increase the surface spin disorientation [368]. This disordered 
structure in the amorphous materials and at the interface might have caused a decrease 
in the effective magnetic moment. 





Figure 4-6 Magnetization vs magnetic field curves for (a) bare MNPs and (b) 
Fe3O4/SiO2/CMCD MNPs obtained by VSM at 25°C. 
 
4.2.1.6 Zeta potential measurement 
The magnitude of the zeta potential gives an indication of the potential stability of 
colloidal system. Measurement of zeta potential of bare and coated magnetic 
nanoparticles is very important to understand the interaction of the particles with target 
molecules. In this work, zeta potential of bare, Fe3O4/SiO2 MNPs and 
Fe3O4/SiO2/CMCD MNPs were first measured in a wide range of pH i.e. pH 2-11. The 
pH value of isoelectric point (pI) of silica particles synthesized by stöber method was 
reported as 3 [370]. Figure 4-7 represents the zeta potential of the magnetic particles. 
As shown in Figure 4-7, the pH value of isoelectric point (pI) of uncoated Fe3O4 
nanoparticles is about 6.8, consistent with the values reported in literature. After being 
grafted with silica and CMCD, the pI has been shifted to 2.45 and 2.86, respectively 
indicating that the grafting of silica and CMCD onto uncoated MNPs is successful. 
Moreover, magnetic nanoparticles modified with silica and CMCD yields acidic surface 




since pI is lower than that of uncoated MNPs and this surface acidity is due to the 
introduction of several oxygen-containing functional groups [371]. 
 
Figure 4-7 Zeta potential of bare MNPs, Fe3O4/SiO2 MNPs and Fe3O4/SiO2/CMCD 
MNPs (20mg/100mL) in 10
-3 




Bare iron oxide magnetic nanoparticles were prepared by chemical co-precipitation 
method and surface of the magnetic particles underwent subsequent modification with 
silica and CMCD through modified Stӧber method and carbodiimide activation method, 
respectively. The particles were characterized using Transmission Electron Microscopy 
(TEM), X-ray Diffractometer (XRD) and Vibrating Sample Magnetometer (VSM). The 
results showed that the Fe3O4/SiO2/CMCD MNPs are of nanometer size with a mean 
diameter of 29 nm and have superparamagnetic properties. FTIR Spectroscopy, XPS 
and zeta potential measurements proved the attachment of silica and CMCD on the 
particle surface. These surface functionalized magnetic nanoparticles can be used as a 
tool for the separation of chiral amino acids and beta-blocker.  
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 Chapter 5: Adsorption/desorption of chiral aromatic amino acids onto 




In Chapter 4, preparation and characterization of silica and carboxymethyl-β-
cyclodextrin bonded magnetic nanoparticles have been presented in details. With 
respect to practical applications and implications, adsorption of chiral amino acids is 
very much relevant. Chiral amino acids are one of the most important biomolecules 
because of their relevance in nature and their chemical richness. Enantiomers of chiral 
amino acids are generally represented as L- or D-enantiomer. It is well known that in 
nature amino acids occur in L-forms and they play important role in the food and 
pharmaceutical industries. D-forms were discovered in species of lower animals, 
mammalian organs and blood [372]. Some of D-amino acids were also detected in 
various vegetables and fruits. 0.6-3.8% of D-alanine was found in freshly pressed plant 
juices [373]. In the field of neuroscience, Okuma and Abe found significant amounts of 
the D-amino acids in the nerve tissues and eyes of crustaceans [374] and Nagata et al. 
found D-serine in mouse and rat in different regions of brain [375]. Furthermore, D-
amino acid was also found in peripheral organs of mice [376]. It has been recognized 
that enantiomers have identical physical and chemical properties except for optical 
rotation. Because of these similarities, chiral discrimination of enantiomers is a very 
challenging task. Therefore analysis of D-/L-amino acids is of increasing importance in 
biological science.  
In 1999, total market for proteinogenic amino acids was 1.5 million tons, revenue of 
around €3.5billion. Their use in human nutrition and health covers 40% of market; 
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animal nutrition sector corresponds to 55%. Consumption of high amount of D-
tryptophan causes frequent weight gain and subsequent diseases. L-lysine, L-threonine 
and L-tryptophan are important additives in modern animal feed. L-glutamic acid, L-
phenylalanine, L-aspartic acid are used as additives for foodstuffs. Total content of D-
phenylalanine and D-tyrosine were significantly greater in patients suffering from 
chronic renal failure. Thus, in this work, separation of proteinogenic aromatic amino 
acids was mainly focused because of their use in modern food additives. This part of the 
work deals with adsorption separation of chiral aromatic amino acid enantiomers (D-/L-
tryptophan, D-/L-phenylalanine and D-/L-tyrosine) utilizing surface functionalized 
magnetic nanoparticles (Fe3O4/SiO2/CMCD MNPs). 
 This part of the present work is based on study of adsorption of chiral aromatic amino 
acid enantiomers‟ on surface functionalized magnetic nanoparticles. Some researchers 
studied chiral separation of the complexes formed by native and modified CDs with the 
pharmaceutical molecules and amino acids. Although there are some studies regarding 
adsorption of amino acids using several adsorbents (i.e. insoluble cyclodextrin polymer 
[53], β-cyclodextrin bonded silica particles [52], minerals [377], solid surfaces such as 
steel [378], gold [379], copper  [380] etc.), little or no work has been done so far using 
cyclodextrin bonded magnetic nanoparticles to separate chiral aromatic amino acid 
enantiomers to our knowledge. In the present work magnetic nanoparticles were used as 
adsorbent for detailed adsorption study of chiral aromatic amino acid enantiomers at 
different conditions of pH and temperature. Desorption of the abovementioned 
enantiomers was also done in the present work. 
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5.2 Results and discussion 
5.2.1 Adsorption of chiral aromatic amino acid enantiomers 
5.2.1.1 Equilibrium study of single amino acid enantiomers  
Silica and CMCD coated magnetic nanoparticles were utilized for adsorption of chiral 
amino acid enantiomers namely, D-/L-tryptophan (Trp), D-/L-phenylalanine (Phe) and 
D-/L-tyrosine (Tyr). Figure 5-1 represents structures of the amino acid enantiomers 
used in this work. Since there are dissimilarities in structures of the amino acids; it is 
expected that it will result in difference in adsorption capacities of the particles towards 
the six enantiomers [381]. As the solubility of tyrosine is very low, equilibrium studies 
were carried out at different low initial concentrations (0.25 mM - 2 mM)  of D- and L-
Trp, D- and L-Phe and D- and L-Tyr under neutral condition (pH 7) and the results are 
shown in Figure 5-2.  
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Figure 5-1 Structures of amino acid enantiomers: (a) L-Trp, (b) D-Trp, (c) L-Phe, (d) 
D-Phe,(e) L-Tyr and (f) D-Tyr. 
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Figure 5-2 Adsorption equilibrium isotherms for: (a) L- and D-Trp, (b) L- and D-Phe, 
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It can be summarized from Figure 5-2 that maximum equilibrium adsorption capacities 
of the nano adsorbent were 0.185 mmol/g, 0.034 mmol/g, 0.105 mmol/g, 0.027 mmol/g, 
0.073 mmol/g, 0.008 mmol/g for L-Trp, D-Trp, L-Phe, D-Phe, L-Tyr and D-Tyr, 
respectively at pH 7. The equilibrium adsorption capacities (at maximum equilibrium 
concentration studied) of Fe3O4/SiO2/CMCD MNPs are higher for the L-enantiomers 
than the corresponding D-enantiomers.  
Based on equilibrium adsorption capacities, it can be stated that Fe3O4/SiO2/CMCD 
MNPs offer good discrimination (equilibrium discrimination ratio > 1) toward the 
enantiomers (equilibrium discrimination ratio = equilibrium adsorption capacity for L-
amino acid/ equilibrium adsorption capacity for D-amino acid). Armstrong et al. 
suggested that for chiral recognition of any molecule by β-CD there are a number of 
prerequisites [381]. For example, to form an inclusion complex, there must be a 
relatively tight fit between the complexed moiety and β-CD and the chiral center or one 
substituent of the chiral center must be near and interact with the hydroxyl groups of 
mouth of the cyclodextrin cavity. Tang et al. showed that difference in structure and 
hydrophobicity of aromatic amino acid molecules resulted in difference in adsorption 
on cross-linked β-CD polymer [53]. It can be seen from Figure 5-1 that differences 
between three dimensional structures of D- and L-enantiomers are in the position of 
primary amine groups. When these aromatic amino acid enantiomers interact with β-
CD, hydrophobic aromatic rings can form inclusion complex to the hydrophobic cavity 
of β-CD. Hydrophobic interactions are mainly involved in the formation of inclusion 
complex with cyclodextrin. Furthermore, substituents of the chiral center can interact 
with hydroxyl groups at the mouth of β-CD and hydrogen bond can be formed. In this 
case, primary amine group at the chiral center of D-enantiomers might have positioned 
less favorably for hydrogen bonding, which might have resulted in less adsorption 
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capacities of the particles toward D-enantiomers. Armstrong et al. studied the inclusion 
complex formation of Propranolol enantiomers using X-ray crystallography and found 
that due to less favorable position of the secondary amine group for hydrogen bonding, 
L-propranolol interacted less with β-cyclodextrin molecule than D-propranolol [381]. 
Difference in favorability of hydrogen bond formation resulted in selective adsorption 
between D-/L-enantiomers. 
Equilibrium results were better fitted to Freundlich isotherm model. The Freundlich 
isotherm is expressed using the following equation: 





                                                     [5-1] 
Here Qe is the equilibrium adsorption capacity of the adsorbent (mmol/g), Ce is the 
equilibrium concentration of the solute being adsorbed (mM), while kF (L/g) and n are 
empirical constants dependent on the nature of sorbent and solute and temperature. By 
taking logarithm of both sides of equation, it can be written as  
                           
 
 
                                                        [5-2] 
Hence a plot of lnQe versus lnCe should be linear with slope equal to 1/n and intercept 
equal to lnkF. 
Parameters of Freundlich model are shown in Table 5-1 and correlation coefficients 
varying from 0.973 to 0.998 indicate that the adsorption of amino acid enantiomers on 
the Fe3O4/SiO2/CMCD MNPs was consistent with the Freundlich isotherm equation, 
which indicates that the adsorption mechanism is a heterogeneous adsorption. 
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Table 5-1 Parameters of Freundlich equation for adsorption of amino acids at pH 7. 
 







L-Trp 0.175 0.390 0.998 
D-Trp 0.021 0.738 0.993 
L-Phe 0.097 0.828 0.997 
D-Phe 0.018 0.604 0.973 
L-Tyr 0.051 1.022 0.996 
D-Tyr 0.005 0.965 0.987 
 
5.2.1.2 Adsorption at different pH 
Since Fe3O4/SiO2/CMCD MNPs shows good adsorption capacity towards the single 
amino acid enantiomers, adsorption characteristics of the magnetic nanoparticles should 
be explored under different conditions to obtain the optimum condition for maximum 
adsorption. Furthermore, adsorption studies at different conditions may help to achieve 
the condition where difference between adsorption capacities toward the D- and L-
enantiomers is maximum to facilitate chiral separation of the enantiomers from the 
racemic mixture. Thus, effect of pH on adsorption of amino acid enantiomers (L-/D-
Trp, L-/D-Phe, L-/D-Tyr) on magnetic particles was studied in detail. Isoelectric point 
(pI) of L-Trp, L-Phe and L-Tyr were determined following the procedure for pI 
determination of protein molecules [334]. pI of Trp, Phe and Tyr were found to be 
around 5.9, 5.5 and 5.6, respectively, which are in agreement with values reported in 
literature and have been shown in Figure 5-3 [382]. The values of zeta potential of 
Fe3O4/SiO2/CMCD MNPs are 12 mV at pH 2 and -43 mV at pH 7 (Figure 4-7). The 
larger value of zeta potential may affect the adsorption of amino acids. Thus, solution 
pH was changed from 4 (below the pI of amino acids) to 5.9/5.5/5.6 (pI of Trp, Phe and 
Tyr), and finally to 7 (above the pI of amino acids).  
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Figure 5-3 Zeta potential of L-Trp, L-Phe and L-Tyr (20mg/100mL) in 10
-3
 M NaCl at 
different pH. 
 
Adsorption isotherms for the six enantiomers (L- and D-Trp, L- and D-Phe, L- and D-
Tyr) at pH 4, 5, 5.9/5.5/5.6 are shown in Figures 5-4, 5-5, 5-6 and corresponding 
adsorption capacities of the magnetic particles are listed in Table 5-2. Equilibrium 
results of adsorption studies at different pH were also fitted well to Freundlich isotherm 
equation and corresponding parameters of Freundlich isotherm equation are listed in 
Table 5-3.  Results of adsorption studies for the six enantiomers at pH 7 are shown in 
Figure 5-2. It can be observed that pH has some effect on the adsorption of amino acids 
on the magnetic particle. With the increase of pH from 5.9/5.5/5.6 to 7, adsorption 
capacities of magnetic particles toward the amino acids decreased significantly. The 
maximum adsorption of the single amino acid enantiomers occurred at pH 5.9/5.5/5.6 
for Trp, Phe and Tyr enantiomers, respectively which is close to isoelectric point of the 
amino acids. When pH was decreased from 5.9/5.5/5.6 to 4, the adsorbed amount of 
                                                                                          Chapter 5  
                                                                                         
123 
 
amino acid on magnetic particles also decreased. It is known that hydrophobic 
interaction has major role in amino acid adsorption phenomena [53]. The hydrophobic 
cavity of CMCD on magnetic nanoparticles offers hydrophobic surface which favours 
the interaction between coated magnetic particle and amino acid. At the isoelectric 




groups in the structure 
(according to the definition of zwitterion) and as the Fe3O4/SiO2/CMCD MNPs were 
negatively charged at pH 5.9/5.5/5.6, so probably, there were some additional ionic 
interactions between the amino acids and the nano adsorbents which resulted in 
maximum adsorption at pI of the amino acids. 
Since at pH 4, the magnetic nanoparticles and amino acids were oppositely charged, 
electrostatic interaction could enhance the adsorption. But, in this case, thermodynamic 
parameters played major role here, e.g. size, shape and hydrophobicity of the molecule 
to form inclusion complex [53]. As a result, inclusion complexation was more dominant 
than electrostatic/ionic interaction and it resulted in better adsorption capacity toward 
amino acids. 
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Figure 5-4 Adsorption equilibrium isotherms of (a) L- and (b) D-Trp at pH 4, pH 5, pH 
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Figure 5-5 Adsorption equilibrium isotherms of (a) L- and (b) D-Phe at pH 4, pH 5, pH 
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Figure 5-6 Adsorption equilibrium isotherms of (a) L- and (b) D-Tyr at pH 4, pH 5, pH 
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Table 5-2 Adsorption capacities of magnetic particle towards single enantiomer at 
different pH. 
 




















L-Trp 0.110 0.135 0.298 0.185 
D-Trp 0.012 0.018 0.046 0.034 
L-Phe 0.050 0.091 0.175 0.105 
D-Phe 0.015 0.018 0.031 0.027 
L-Tyr 0.009 0.060 0.099 0.073 
D-Tyr 0.001 0.006 0.013 0.008 
(*pI (isoelectric point) of Trp, Phe and Tyr are 5.9, 5.5 and 5.6, respectively) 
 
Equilibrium results of adsorption studies at different pH are better fitted to Freundlich 
isotherm model. Parameters of Freundlich model are shown in Table 5-3. 








 pI  
 
    
kF 1/n R
2
 kF 1/n R
2
 kF 1/n R
2
 
L-Trp 0.079 0.614 0.991 0.120 0.463 0.979 0.296 0.579 0.992 
D-Trp 0.008 0.320 0.984 0.014 0.342 0.977 0.028 0.857 0.998 
L-Phe 0.033 0.871 0.990 0.071 0.768 0.994 0.145 0.980 0.999 
D-Phe 0.008 0.965 0.990 0.014 0.532 0.992 0.017 1.117 0.997 
L-Tyr 0.008 0.325 0.965 0.031 1.445 0.997 0.063 1.036 0.999 
D-Tyr 0.0008 0.908 0.988 0.003 0.813 0.986 0.006 1.072 0.998 
 
As compared, remarkable difference exists between the adsorption capacities of the D- 
and L-enantiomers of tryptophan, phenylalanine and tyrosine at all the pH (pH 4, pH 5, 
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pH 5/9/5.5/5.6, pH 7) and this difference becomes more prominent at the pI. Adsorption 
capacity differences are 0.251 mmol/g, 0.143 mmol/g and 0.085 mmol/g enantiomers of 
tryptophan, phenylalanine and tyrosine, respectively. Based on these results, it can be 
mentioned that Fe3O4/SiO2/CMCD MNPs offers good discrimination toward the 
enantiomers. Results from effect of pH study are summarized based on difference 

























Figure 5-7 Effect of pH on adsorption: (a) D- and L-Trp, (b) D- and L-Phe, (c) D- and 
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5.2.1.3 Adsorption at different temperatures 
After obtaining the optimum pH for adsorption of the amino acids, further equilibrium 
studies were carried out at different temperatures at the isoelectric point of the 
corresponding enantiomers, which is the optimum pH. The effect of temperature on 
adsorption of single amino acid enantiomers on Fe3O4/SiO2/CMCD MNPs is shown in 
Figures 5-8, 5-9 and 5-10 at 25, 35 and 50°C, ionic strength 0.03M. It can be observed 
that the amount of adsorbed amino acid enantiomer per unit amount of the nanoparticle 
decreased with increasing temperature. Similar observation was reported in the 
literature [53]. Noteworthy, adsorption capacities of the nanoparticle toward L-Trp, L-
Phe and L-Tyr at 35°C and 50°C were less than those at 25°C. Comparison of 
adsorption capacities of the nano adsorbents toward the six enantiomers at different 
temperatures are presented in Table 5-4 and 5-5, respectively. As the temperature 
increased, higher adsorbate concentration in solution was required to saturate the 
surface of the nano adsorbents. Thus adsorption capacity decreased. However, 
equilibrium results of adsorption studies at different temperature were also fitted well to 













                                                                                          Chapter 5  




























Figure 5-8 Adsorption equilibrium isotherms of (a) L- and D-Trp at 25°C, 35°C and 
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Figure 5-9 Adsorption equilibrium isotherms of (a) L- and (b) D-Phe at 25°C, 35°C and 
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Figure 5-10 Adsorption equilibrium isotherms of (a) L- and (b) D-Tyr at 25°C, 35°C 
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Table 5-4 Adsorption capacities of magnetic particle toward single enantiomers at 
different temperatures. 
 
Amino acid Adsorption 














L-Trp 0.298 0.237 0.044 
D-Trp 0.046 0.024 0.011 
L-Phe 0.175 0.143 0.023 
D-Phe 0.031 0.021 0.012 
L-Tyr 0.099 0.070 0.012 
D-Tyr 0.013 0.010 0.004 
 
 










    
kF 1/n R
2
 kF 1/n R
2
 kF 1/n R
2
 
L-Trp 0.296 0.579 0.992 0.220 0.893 0.994 0.030 0.701 0.971 
D-Trp 0.028 0.857 0.998 0.013 0.949 0.987 0.006 0.822 0.964 
L-Phe 0.145 0.980 0.999 0.113 0.915 0.983 0.015 0.629 0.984 
D-Phe 0.017 1.117 0.997 0.013 0.766 0.998 0.005 1.434 0.998 
L-Tyr 0.063 1.036 0.999 0.040 1.132 0.995 0.006 1.016 0.997 
D-Tyr 0.006 1.072 0.998 0.005 0.944 0.991 0.002 0.842 0.972 
 
Based on the results of effect of pH and effect of temperature study, it can be mentioned 
that significant difference is observed between the adsorption capacities of the D- and 
L-enantiomers of tryptophan, phenylalanine and tyrosine at pH close to the isoelectric 
point of the enantiomers and 25°C. Results from effect of temperature study are 
summarized in Figure 5-11. 
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Figure 5-11 Effect of temperature on adsorption: (a) D- and L-Trp, (b) D- and L-Phe, 
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5.2.1.4 Comparison of adsorption capacities of different amino acids 
Adsorption capacities of the particles for amino acid enantiomers were compared in low 
concentration range and Figure 5-12 shows the results of equilibrium study for L- and 
D-Trp, L- and D-Phe and L- and D-Tyr up to concentration of 2 mM. From our results, 
it can be concluded that adsorption capacities of Fe3O4/SiO2/CMCD MNPs toward 
amino acids are in the order: L-Trp>L-Phe>L-Tyr and D-Trp>D-Phe>D-Tyr [383]. This 
is due to the structures and hydrophobicity of amino acid molecules and the CMCD 
molecule. Tang et al. suggested that molecular volume and hydrophobicity play 
important roles in interaction among the amino acids and β-CD polymers [53]. Since 
the cavity volume of β-CD ([A°3], 262) is comparable to that of tryptophan (volume 
[A°
3
], 227.8) and tryptophan is most hydrophobic among the three amino acids, 
interaction between tryptophan and CMCD molecule is the strongest. As it is seen from 
Figure 5-1, the hydroxyl group in structure of tyrosine molecule decreases the 
hydrophobicity of the molecule but increases volume of the molecule slightly. So, 
volume of tyrosine molecule is slightly bigger than that of phenylalanine, but 
hydrophobicity of phenylalanine is much higher than tyrosine as shown in Table 5-6. 
Thus the adsorption capacities of Fe3O4/SiO2/CMCD MNPs toward L- and D- 
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Figure 5-12 Adsorption isotherms for (a) L-Trp, L-Phe, L-Tyr and (b) D-Trp, D-Phe, D-























for side chain 
burial (kcal/mol) 
Trp 227.8 37+199 4.11 2.9 
Phe 189.9 39+155 3.46 2.3 
Tyr 193.6 38+116 2.81 1.6 
 
Maximum adsorption capacities of silica and CMCD coated MNPs (Fe3O4/SiO2/CMCD 
MNPs) toward the single amino acid enantiomers are: L-Trp-0.298 mmol/g, D-Trp-
0.046 mmol/g, L-Phe-0.175 mmol/g, D-Phe- 0.031 mmol/g, L-Tyr- 0.099mmol/g, D-
Tyr- 0.013 mmol/g. Some data are found in literature regarding adsorption of amino 
acids on cross-linked β-cyclodextrin polymer. Maximum adsorption capacities are: L-
Trp- 0.256 mmol/g, L-Phe-0.260 mmol/g, L-Tyr-0.017 mmol/g [53]. Comparing 
adsorption capacities, it can be mentioned that adsorption capacities of 
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Fe3O4/SiO2/CMCD MNPs are higher than adsorption capacities of cross-linked β-
cyclodextrin polymer toward L-Trp and L-Tyr. 
5.2.2 Adsorption kinetics 
The adsorption kinetics of the L-/D-Trp, L-/D-Phe and L-/D-Tyr onto the 
Fe3O4/SiO2/CMCD MNPs were carried out at the pI of the enantiomers and 25
o
C. The 
main objective of the study was to determine how adsorption capacity of the solid 
changes with time via studying how the concentration of amino acid solution changes 
with time. The initial concentration of D- and L-enantiomers provided the necessary 
driving force to overcome the mass transfer resistance of the enantiomers between the 
aqueous and solid phases. Figures 5-13, 5-14 and 5-15 show the effect of contact time 
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It can be observed that equilibrium was reached in approximately 20 hrs for the 
enantiomers. Within the first 5 hrs of the reaction, 70-80% of the maximum adsorption 
capacity had been reached. 
The Lagergren rate equation is one of the most widely used adsorption rate equations 
used to describe the adsorption rate of a solute from a solution. It is based on an 
empirical model, where a rate law is proposed and integrated to predict the time course 
of concentration. In this study, the adsorption kinetics of the amino acids onto 
Fe3O4/SiO2/CMCD MNPs was fitted well with Lagergren pseudo-second order model. 
Lagergren pseudo-second-order model is expressed by [332]: 
                                
                                                                          [5-3] 
 
 
Integrating the equation for the boundary conditions t = 0 to t = t and Q = 0 to Q = Qt, 
gives, 










                                                                               [5-4]                                                            
where k2 is the equilibrium rate constant of pseudo-second-order adsorption 
(g/mmol.hour). The slope and intercept of the plot of t/Qt versus t are used to calculate 
k2 and Qe,cal. The corresponding kinetic parameters from the model are listed in Table 
5-7. It is found that the correlation coefficients (R
2
) for the pseudo-first-order kinetic 
model are less than 90% indicating a poor pseudo-first-order fit to the experimental data 
(data not shown). On the other hand, the correlation coefficient (R
2
) for the pseudo-
second-order adsorption model has high value (>98%), and the Qe values (Qe,cal) 
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Qe values (Qe,exp). These facts suggest that the adsorption data are well represented by 
pseudo-second-order kinetic model. 















 Qe (mmol/g) 
L-Trp 1.745 0.300 0.998 0.298 
D-Trp 9.816 0.048 0.982 0.046 
L-Phe 0.940 0.183 0.986 0.175 
D-Phe 29.71 0.029 0.997 0.031 
L-Tyr 4.250 0.110 0.996 0.099 
D-Tyr 36.69 0.014 0.988 0.013 
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5.2.3 Desorption studies 
The success of an adsorption process usually depends on the regeneration step of the 
adsorbent from the economic point of view. Regeneration of the adsorbed solute from 
the adsorbent is generally accomplished by one of two general methods. One is to 
change a physical operating condition, namely temperature, of the adsorber, which 
affects the equilibrium interaction between the adsorbent and the solute. The other is to 
perform a chemical reaction in the adsorber to change the nature of adsorbed 
component so that it can be desorbed and removed from the system readily. In general, 
there are many regeneration techniques such as thermal, steam, acid, base, and solvent 
regenerations. In this study, methanol was used as desorbing agent. Figure 5-16 shows 
the result of desorption efficiency of L-Trp, L-Phe and L-Tyr after adding methanol as 
desorbing agent. Around 90%, 89% and 88% of adsorbed L-Trp, L-Phe and L-Tyr were 
desorbed using methanol solution, respectively. Furthermore, 80%, 78% and 75% 
desorption of D-Trp, D-Phe and D-Tyr were achieved using methanol (Figure 5-17). 
Desorption of D-enantiomers were less than those of L-enantiomers which could be due 
to less affinity of the D-enantiomers to methanol. Further work should be done to 
increase the desorption percentage using other solvents like ethanol, IPA (isopropyl 
alchohol). Complete desorption of the amino acid could be achieved by repeated 
desorption steps. Some researchers also found that addition of alchohol solution was 
effective as desorbing agent for desorption of Trp and Phe solution from non-ionic 
polymeric adsorbent [384]. In this case desorption might have been facilitated by the 
greater affinity of amino acids in methanol than the adsorbent.  It should be noted that 
desorption equilibrium of enantiomers were achieved within about 20 hrs, similar to the 
adsorption equilibrium.  
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Figure 5-16 Desorption of L-Trp, L-Phe, L-Tyr from Fe3O4/SiO2/CMCD MNPs in 
methanol. Adsorption condition:  Fe3O4/SiO2/CMCD MNPs 50 mg; L-Trp/L-Phe/L-
Tyr: 2 mM; pH 6; temperature 25°C, contact time 24 hrs. Desorption condition 
Fe3O4/SiO2/CMCD MNPs: 50 mg; temperature 25°C, contact time 24 hrs. 
 
 
Figure 5-17 Desorption of D-Trp, D-Phe, D-Tyr from Fe3O4/SiO2/CMCD MNPs in 
methanol. Adsorption condition:  Fe3O4/SiO2/CMCD MNPs 50 mg; L-Trp/L-Phe/L-
Tyr: 2 mM; pH 6; temperature 25°C, contact time 24 hrs. Desorption condition 
Fe3O4/SiO2/CMCD MNPs: 50 mg; temperature 25°C, contact time 24 hrs. 
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5.2.4 Adsorption mechanism 
For understanding of the amino acid/magnetic nanoparticle interaction, FTIR data are 
introduced to gain insight into the adsorption mechanism. Analysis of FTIR spectra 
depicts direct evidence of functional groups present on the adsorbent surface. 
Therefore, careful examination of the FTIR spectra of adsorbent surface after 
adsorption reaction provides information regarding the surface groups that might have 
participated in the adsorption reaction. 
 
Figure 5-18 FTIR spectra of L-tryptophan. 
 
Figure 4-1(d) and Figure 5-18 depict the FTIR spectra of Fe3O4/SiO2/CMCD MNPs and 
L-Trp, respectively before adsorption. Since L-Trp and D-Trp are chiral enantiomers; 
their spectra before adsorption are similar. The spectra of Fe3O4/SiO2/CMCD MNPs 
after adsorption of L-Trp and D-Trp are shown in Figure 5-19 and Figure 5-20, 
respectively. In Figure 5-18, the absorption peak with the maximal frequencies is at 
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 which may be attributed to the N-H stretching vibrations of tryptophan. 
Other stretching vibrations are observed at 2500-3000 cm
-1
 (O–H of carboxylic acid), 
1666 cm
−1
 (C=C), 1357 cm
−1
 (C–N), and 1099 cm−1 (C–O) [385]. The shape of the 
stretching vibration peak at 3404 cm
-1
 in native L-Trp (Figure 5-18) is changed after 
adsorption and it became more intense for particles that adsorbed with L-Trp than D-
Trp. Also the peak at 3037 cm
−1
 in the spectra of L-Trp which can be assigned to the 
presence of C-H stretching vibrations (from phenyl ring) is red shifted to 3024 cm
−1
 
(Figure 5-19) indicating the formation of complex between L-Trp and CMCD. On the 
other hand, a small peak for C-H group (from phenyl ring) is observed at 3056 cm
-1
 in 
the FTIR spectra (Figure 5-20) of Fe3O4/SiO2/CMCD MNPs after adsorption of D-Trp, 
which supports our experimental observation that adsorption of L-Trp on coated 
magnetic nanoparticles is higher than D-Trp. Again, the peaks at 1666 and 1652cm
−1
 in 
the spectra of the Trp-CMCD complex (Figure 5-19 and Figure 5-20) could be 
attributed to C=C stretching vibrations. Last but not the least, Figure 5-19 and Figure  
5-20 illustrate that the intensities of native N-H stretching vibrations on L-Trp after 
formation of complex is changed (in both L-Trp and D-Trp after adsorption on 
particles),  which could be attributed due to the complex formation of the amino groups 
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Figure 5-20 FTIR spectra of Fe3O4/SiO2/CMCD MNPs after adsorption of D-
tryptophan. 
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Adsorptions of D-/L-Trp, D-/L-Phe and D-/L-Tyr were studied on silica and CMCD 
coated nano-sized magnetic particles at various pH and temperature conditions. Higher 
adsorption occurred at pH close to the isoelectric point of the amino acids and at 25°C. 
Maximum difference between adsorption capacities of L- and D-enantiomers were also 
obtained at the same conditions. Adsorption of amino acid enantiomers reached 
equilibrium within 20 hrs and kinetics of adsorption followed the pseudo-second-order 
model. Results of equilibrium study showed that the synthesized particles can 
preferentially adsorb L-enantiomers of aromatic amino acids than the corresponding D 
ones. Experimental data of equilibrium adsorption studies were fitted well to Freundlich 
model. Desorption studies showed that the enantiomers was desorbed using methanol as 
eluent. Finally, FTIR studies showed that coated nanoparticles bonded to amino acid 
enantiomers to form complexes. The amino groups of the amino acids might have 
formed complexes with the CMCD molecules. Since this study shows that 
Fe3O4/SiO2/CMCD MNPs can selectively adsorb amino acid enantiomers; these 
particles can be utilized for chiral separation of aromatic amino acids.  
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Chapter 6: Enantioselective separation of chiral aromatic 




Chirality in nature and living systems is of great impact for a variety of active 
compounds interacting with them. The molecular building blocks of life, such as amino 
acids and sugars that form peptides, proteins and polysaccharides exist in chiral 
structures.  Thus, in recent years, chiral analysis has received increased attention in 
many research fields including pharmaceutical, clinical, environmental and food 
analysis since enantiomers show different physiological activities depending on their 
configurations [386-389]. Generally, enantiomerically pure compounds are obtained 
either from available chiral starting materials generated during a reaction by 
asymmetric catalysis or by chiral resolution of the enantiomers using various separation 
methods. Asymmetric synthesis is, in principle, the most cost effective method of 
producing single-isomer products. Although asymmetric synthesis is the ultimate way 
to obtain the compounds and has been intensively developed [390], it has one 
limitation: it gives high enantiomeric purity only for exceptionally enantioselective 
reactions. Resolution of racemates is still considered as a powerful method for 
production of enantiomerically pure compounds. Various methods can be applied for 
separation of enantiomers and/or for the determination of enantiomeric composition of 
chiral compounds. Among others, various chromatographic methods including high 
performance liquid chromatography (HPLC) [391], gas chromatography (GC) [389], 
supercritical fluid chromatography (SFC) [392], simulated moving bed (SMB) 
chromatography [393], various electromigration capillary methods [394], enzymatic or 
non-enzymatic dynamic kinetic resolutions [395], membrane separation [396], 
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crystallization [397], methods using molecularly imprinted polymer (MIP)s [230] have 
been successfully utilized. 
Magnetic nanoparticles can be good candidate for enantioselective separation of chiral 
biomolecules due to their unique size, large surface area, biocompatibility, low toxicity, 
superparamagnetic properties and well understood surface chemistry. Currently, iron 
oxide (Fe3O4) nanoparticle is one of the most popular materials among them and has 
been widely used in the fields of biology and medicine such as targeted drug delivery 
[230], enhanced resolution magnetic resonance, protein and enzyme immobilization 
[398], bio-separation etc. These superparamagnetic materials possess an advantage of 
not retaining any magnetization after removal of external magnetic field. But these 
magnetic nanoparticles suffer from the problem of agglomeration. Considerable interest 
has been focused on the surface modification of superparamagnetic iron oxide 
nanoparticles to prevent agglomeration of the particles, increase the stability and 
provide biocompatibility. Recently, surface functionalized magnetic nanoparticles are 
found to be good adsorbents for magnetic field induced separation of some chiral 
enantiomers. Choi et al. demonstrated that magnetic silica nanoparticles tagged to a 
chiral selector (S-/R- -N-(2,2-dimethyl-5-ethoxydimethylsilylpentanoyl)-proline-3,5-
dimethylanilide) could be utilized in magnetic field induced separation of enantiomers  
of N-(3,5-dinitrobenzoyl)alanine (Ala), valine (Val) and leucine (Leu) N-propylamide 
[399]. Enantiomeric excess was determined and it varied between 17-80%. In the work, 
chiral separation was not studied for aromatic amino acid enantiomers. Furthermore, 
magnetite nanoparticles (MNPs) immobilized with an appropriate chiral catalyst or 
enzyme was also successfully utilized for asymmetric reactions or enzymatic kinetic 
resolutions [365, 400]. Novel magnetite nanoparticle supported chiral Ruthenium(II) 
complexes were prepared that catalyze heterogeneous asymmetric hydrogenation of 
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aromatic ketones with remarkably high activity and enantioselectivity (e.e. 95-98%) 
[400]. Furthermore, chiral DMAP (hypernucleophilic‟ 4-N,N-dimethylaminopyridine) 
variant immobilized on magnetite nanoparticles  was capable of promoting the kinetic 
resolution of sec-alcohols with synthetically useful selectivity under process-scale 
friendly conditions (ambient temperature, low catalyst loading, and acetic anhydride as 
the acylating agent), which allowed the isolation of resolved alcohols with good to 
excellent enantiomeric excess (e.e 82-99%) [365]. 
The cyclodextrins (CDs) are a series of cyclic oligosaccharides composed of α(1–4)-
linked D-glucopyranose units and these compounds are torus-shaped with a hydrophilic 
external surface and a hydrophobic internal cavity. Such structural characteristics allow 
CDs and their derivatives to form stable inclusion complexes with a variety of 
compounds through host-guest interactions [18]. But due to relative low solubility of 
natural cyclodextrins in water as well as in organic solvents, their direct use is greatly 
limited. Several synthetic strategies have been developed to modify natural cyclodextrin 
to improve their performance as host to specific guest molecules and to increase their 
solubility in water [401]. Usefulness of cyclodextrin in enantioseparation is attributed 
by several main advantages over the other adsorbents. The outstanding one of 
cyclodextrins is their ability to form inclusion complexes. The capability to form 
inclusion complexes with wide variety of guest molecules make CDs valuable and 
useful in many research areas such as  resolution of enantiomers using HPLC [402], 
enantioseparation in electrophoresis [403], targeted drug delivery [30, 404, 163], 
removal of contaminants  from aqueous  solution [405] etc. Banerjee et al. first 
synthesized magnetic nanocarriers by grafting cyclodextrin onto gum arabic modified 
magnetic nanoparticles (GAMNPs) for ketoprofen release study [163]. Cao et al. also 
fabricated β-CD functionalized Fe3O4/amino-silane core-shell nanoparticles layer-by-
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layer approach which can act as drug carriers [151]. However, to the best of our 
knowledge, detailed studies of the adsorption characteristics of aromatic amino acid 
enantiomers and chiral resolution of amino acids utilizing superparamagnetic Fe3O4 
nanoparticles bearing cyclodextrin moieties from phosphate buffer solution are very 
scarce in the literature. 
Amino acid enantiomers or their derivatives are frequently found in food stuffs and 
many drugs as well. Enantiomers of different optical activities might have different 
interactions with our body since chiral drugs present different activity, toxicity, 
transport mechanism and metabolic route. Thus, resolution of aromatic amino acid 
enantiomers is of prime importance. In previous chapter, we have reported adsorption 
behavior of the chiral aromatic amino acid enantiomers (D-/L-tryptophan (Trp), D-/L-
phenylalanine (Phe), D-/L-tyrosine (Tyr)) on magnetic silica nanoparticles bonded to 
carboxymethyl-β-cyclodextrin (CMCD) from phosphate buffer solution at neutral 
condition in order to understand the host-guest interaction in-depth. We herein report 
chiral separation of DL-Trp, DL-Phe and DL-Tyr utilizing cyclodextrin derivative 
functionalized magnetite silica nanoparticles.  Selective adsorption capacity of the 
particles toward the enantiomers from their racemic mixture was examined using high 
performance liquid chromatography. Enantioselective mechanism was investigated 
using several analytical techniques for example FTIR, XPS etc. Finally, inclusion 
complex formation of the particles was scrutinized and stability constant (K), Gibbs 
free energy change (-ΔG0) of the inclusion complexation of the enantiomers (L-/D-Trp, 
L-/D-Phe and L-/D-Tyr) with CMCD were determined. 
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6.2 Results and discussion 
6.2.1. Enantioseparation of aromatic amino acids 
6.2.1.1 Adsorption separation of single enantiomers and racemic amino 
acids  
 
Initially, adsorption capacity of the magnetic nanoadsorbent toward single amino acid 
enantiomers (D-/L-Trp, D-/L-Phe and D-/L-Tyr) was investigated in chapter 5. Thus, in 
Figure 5-1, three dimensional structures of D- and L-amino acids were presented 
whereas in Figure 6-1, three dimensional structures of D- and L- amino acid and 
racemic amino acids are presented. Since chiral resolution is based on the stability 
difference of CMCD-amino acid complexes, effect of initial amino acid concentration 
was investigated at pH 6 and all the adsorption data are given in Figure 6-2, where 
adsorption capacity of Fe3O4/SiO2/CMCD MNPs (mmol/g of solid) are plotted against 
the equilibrium concentration of amino acids in the bulk solution (mM). Adsorption 
capability of the Fe3O4/SiO2/CMCD MNPs toward single enantiomers, i.e. D- and L-
amino acid varies significantly as the initial amino acid concentration increases. 
Sorption capacities of the as-synthesized particles are in the order: L-Trp>L-Phe>L-
Tyr. Adsorption capacities of the Fe3O4/SiO2/CMCD MNPs are 0.29 mmol/g, 0.04 
mmol/g, 0.17 mmol/g, 0.03 mmol/g, 0.09 mmol/g and 0.01 mmol/g toward L-Trp, D-
Trp, L-Phe, D-Phe, L-Tyr and D-Tyr, respectively. Noteworthy, differences in the 
adsorption capacities of these adsorbents toward L- and D-enantiomers of the amino 
acids are obtained due to the difference in three dimensional structures of L- and D-
enantiomers [381].  
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Figure 6-1 Schematic structures of the molecules: (a) DL-Trp, (b) L-Trp, (c) D-Trp, (d) 
DL-Phe, (e) L-Phe, (f) D-Phe, (g) DL-Tyr, (h) L-Tyr, (i) D-Tyr. 
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Figure 6-2 Adsorption equilibrium isotherms for: (a) L-Trp, (b) D-Trp, (c) L-Phe, (d) 
D-Phe, (e) L-Tyr and (f) D-Tyr at pH 6 (25°C and ionic strength 0.03M). 
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Amino acids are widely used as the analytical samples for the study of derivatized-β-
cyclodextrin selectors [406-408]. In this study, the Fe3O4/SiO2/CMCD MNPs were 
evaluated for enantioseparation of three racemic aromatic amino acids (DL-Trp, DL-
Phe and DL-Tyr). The separation results and conditions are summarized in Table 6-1. 
As shown in Table 6-1, all the aromatic amino acids could be resolved by the 
Fe3O4/SiO2/CMCD MNPs and significant selectivity and resolution was obtained for 
separation of the enantiomers by the column. Noteworthy, the enantiomeric excesses of 
Trp, Phe and Tyr after adsorption onto the modified magnetic nanoparticles were 94%, 
73% and 58%, respectively. These good separation results show that the 
Fe3O4/SiO2/CMCD MNPs substantiate fine chiral recognition abilities towards aromatic 
amino acid enantiomers. Good inclusion complexation might have occurred by the 
penetration of benzene ring into cyclodextrin cavity, while its chiral center being close 
to the hydroxyl groups on the cyclodextrin rims favoring hydrogen bond formation with 
the carboxylate and amine moieties [408].  
As mentioned, enantiomeric excesses of Trp, Phe and Tyr enantiomers after adsorption 
onto the modified magnetic nanoparticles were 94%, 73% and 58%, respectively. 
Enantiomeric excess can vary sometimes from 17% to 80% [399]. In this case, 
hydrophobicity and size/shape of the molecules played role for adsorption of the amino 
acids. Enantiomeric excess of Trp enantiomers is higher than those of other two 
aromatic amino acid enantiomers. Molecular volume and hydrophobicity play important 
roles in interaction among the amino acids and β-CD polymers [53]. Since the cavity 
volume of β-CD ([A°3], 262) is comparable to that of tryptophan (volume [A°3], 227.8) 
and tryptophan is most hydrophobic among the three amino acids, interaction between 
tryptophan and CMCD molecule should be the strongest. As a result, adsorption was 
higher and enantioselectivity was also higher. As it is seen from Figure 6-1, the 
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hydroxyl group in structure of tyrosine molecule decreases the hydrophobicity of the 
molecule but increases volume of the molecule slightly. So, volume of tyrosine 
molecule is slightly bigger than that of phenylalanine, but hydrophobicity of 
phenylalanine is much higher than tyrosine as shown in Table 5-6. The larger the 
hydrophobicity of this group, the better the chiral recognition.  As a result, enantiomeric 
excess of Phe enantiomers was higher than that of Tyr enantiomers. 
Furthermore, adsorption capacities of the magnetic particles are 0.208 mmol/g for L-
Trp, 0.036 mmol/g for D-Trp, 0.141 mmol/g for L-Phe, 0.026 mmol/g for D-Phe, 0.079 
mmol/g for L-Tyr and 0.009 mmol/g for D-Tyr after adsorption of racemic amino acids 
i.e. DL-Trp, DL-Phe and DL-Tyr. Adsorption capacities of Fe3O4/SiO2/CMCD MNPs 
toward amino acids are in the order: L-Trp>L-Phe>L-Tyr and D-Trp>D-Phe>D-Tyr. 
Considering the racemic condition, adsorption capacities of the Fe3O4/SiO2/CMCD 
MNPs are less than those of single enantiomers. The representative chromatograms of 
racemic amino acid resolution (2 mM) before and after adsorption are shown in Figure 
6-3.1- 6-3.3. 




k1 k2 α Rs e.e 
(enantiomeric 
excess) 
DL-Trp 20.98 25.97 1.23 2.54 94% 
DL-Phe 12.05 17.51 1.45 5.70 73% 
DL-Tyr 5.21 6.83 1.31 2.69 58% 
 
 
Chiral separation results of the racemic amino acids in terms of enantiomeric excess 
obtained in this study compared with other results reported in literature are shown in 
Table 6-2. 
  
                                                                                         Chapter 6  
                                                                                           
156 
 
Table 6-2 Comparison of enantiomeric excess obtained using Fe3O4/SiO2/CMCD 
MNPs with other chiral selectors reported in literature for chiral separation of amino 
acids. 
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58% This study 





21.9 ± 0.3% [412] 
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Figure 6-3.1 Chromatogram for HPLC separation of (a) DL-Trp (2 mM) before 
adsorption, (b) DL-Trp after adsorption onto the modified magnetic nanoparticles. 
Column Chirex Phenomenx, (150 mm×4.6mmI.D.), maintained at 18°C, mobile phase 
2 mM copper sulphate: methanol (70:30).Isocratic elution was carried out as described 
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Figure 6-3.2 Chromatogram for HPLC separation of (a) DL-Phe (2mM) before 
adsorption, (b) DL-Phe after adsorption onto the modified magnetic nanoparticles. 
Column Chirex Phenomenx, (150 mm×4.6mmI.D.), maintained at 18°C, mobile phase 
2 mM copper sulphate: methanol (70:30).Isocratic elution was carried out as described 
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Figure 6-3.3 Chromatogram for HPLC separation of (a) DL-Tyr (2mM) before 
adsorption, (b) DL-Tyr after adsorption onto the modified magnetic nanoparticles. 
Column Chirex Phenomenx, (150 mm×4.6mmI.D.), maintained at 18°C, mobile phase 
2 mM copper sulphate: methanol (70:30). Isocratic elution was carried out as described 
in the experimental condition at flow rate of 0.7 mL/min. Detection UV 258 nm. 
 
6.2.1.2 Linearity, limits of detection, reproducibility of the developed 
method  
In order to validate our proposed method for analysis of DL-amino acids, the 
reproducibility of migration time and peak area were studied. The relationship between 
D/L-amino acid concentration and UV-absorbance was determined by a series of D- 
and L-amino acid (Trp, Phe, Tyr) standard solutions. The regression equations and 
correlation coefficients showed an excellent linear relationship at 0-2 mmol/L for the 
(a) 
(b) 
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analytes. The chromatograms of racemic amino acids as shown in Figure 6-3.1- 6-3.3 
clearly indicate that baseline resolution of racemic DL-Trp, DL-Phe and DL-Tyr can be 
achieved in 68 min, 50 min and 20 min. Determination of final concentration of the 
separated amino acids was done by the calibration equation with correlation coefficient 
in the range of 0.996–0.999 as shown in Table 6-3. This establishes that for a given 
sample of DL-amino acid, precise number of moles can be calculated from the 
integrated peak areas. Table 6-3 gives the analytical parameters of this method. In the 
range of 0.01–2 mmol/L good linearities were found for D-Trp, L- Trp, D-Phe, L-Phe, 
D-Tyr, L-Tyr. The RSDs of the peak areas for calibration curves were between 2.95% 
and 4.78% for the tested amino acids. 




















































*RSD-Relative Standard Deviation 
y- concentration of amino acid enantiomer 
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6.2.1.3 Investigations on the mechanism of sorption resolution by XPS and 
FTIR spectroscopy 
To explore the enantioselectivity mechanism of CMCD and silica modified magnetic 
nanoparticles for aromatic amino acids enantiomers, analysis of FTIR spectra of the 
modified Fe3O4 nanoparticles after adsorption of racemic DL-Trp, DL-Phe and DL-Tyr 
solution and in absence of the amino acids were performed. As shown in Figure 6-4, an 
obvious shift from 1635cm
-1
(CMCD, OH in-plane bending vibration absorption) to 
1627 cm
-1
 could be observed after adsorption of DL-Trp solution, which is ascribed to 
the inclusion complexation of CMCD and guest molecules. As for DL-Trp, peaks at 
3047 cm
-1




, and 1456 
cm
-1(benzene‟s structure skeleton vibration) disappeared after  adsorption on CMCD 
modified Fe3O4 nanoparticles. This latter result provides evidence that indole group of 
DL-Trp entered hydrophobic cavity of CMCD. As shown in Figure 6-4, obvious shifts 
from 1635 cm
-1





 could be observed after adsorption of DL-Phe and DL-Tyr solution, 
respectively. As for DL-Phe, peaks at 3064 cm
-1





, and 1444 cm
-1
  (benzene‟s structure skeleton 






, and 1454 cm
-1
 
disappeared after mixing with CMCD modified Fe3O4 nanoparticles. All these results 
provide evidence that phenyl group of DL-Phe and phenol group of DL-Tyr also 
penetrated into the hydrophobic cavity of CMCD. Thus, hydrophobic portion of these 
aromatic amino acids interacted with the hydrophobic cavity of CMCD. No change in 
the Si-O-Si stretching vibration after adsorption of racemic amino acid solution proves 
that amino acid molecules had interactions only with CMCD on the magnetic 
nanoparticles‟ surface.  
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Figure 6-4 FTIR spectra of (a) DL-Trp after adsorption, (b) DL-Trp, (c) 
Fe3O4/SiO2/CMCD MNPs, (d) DL-Phe, (e) DL-Phe after adsorption, (f) DL-Tyr, (g) 
DL-Tyr after adsorption. 
 
. 
Furthermore, to ascertain the adsorption site of chiral amino acids on magnetic 
nanoparticles surface, electronic structure of tryptophan, phenylalanine and tyrosine 
before and after adsorption were investigated by XPS. Phenylalanine, tyrosine, and 
tryptophan contain large rigid aromatic groups on the side chain, known as phenyl, 
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phenol, and indole groups, respectively.  Schematic structures of these compounds are 
shown in Figure 6-1. Tryptophan has two nitrogen atoms, one in the amino group and 
one in the indole side chain. Phenylalanine and tyrosine each has one nitrogen atom in 
structure and the presence of hydroxyl group at the benzene ring makes structure of 
tyrosine different than that of phenylalanine. For better understanding, carbon atom at 
the chiral centre which is also bonded to the amino group is labelled as Cα, while the 
carboxylic carbon atom is not labelled. Oxygen atoms are present as carbonyl oxygen 
and hydroxyl oxygen atoms. XPS analyses results for N1s, C1s and O1s spectra are 
presented in Table 6-4. The most fascinating XPS spectra of these molecules are those 
of N1s. In the DL-Trp molecule, there are two nitrogen atoms but three peaks can be 
deconvoluted from experimental N1s spectra, at 399.2, 399.7, and 400.7 eV in Figure 6-
5.1 (a) , which is in agreement with literature [416, 351]. The highest binding energy 
peak corresponds to the N atom in the pyrrole ring of Trp for bonding N-C (pyrrole) 
[416]. The other two peaks at lower binding energy are related to the nitrogen for bonds 
N-H and N-Cα. After adsorption of DL-Trp on magnetic nanoparticles, these nitrogen 
molecules‟ binding energy shifted to higher eV and most importantly, the binding 
energy shift of nitrogen atom at N-C(pyrrole) (1.25eV) and N-H (1.75eV) are higher 
than the binding energy change of nitrogen atom at the N-Cα (0.4 eV). Thus it can be 
interpreted that the nitrogen atom at the side chain interacted with the secondary 
hydroxyl group of cyclodextrin cavity and nitrogen atom at the pyrrole ring interacted 
with the hydrophobic cavity. The N1s XPS spectrums of DL-Phe and DL-Tyr show two 
peaks due to N-H and N-Cα bonding (Figure 6-5.2, 6-5.3 and Table 6-4). Shifting of 
nitrogen atom at N-H bonding of DL-Phe and DL-Tyr after adsorption to higher eV also 
describes that the amino group at the chiral centre interacted well with the hydroxyl 
group of cyclodextrin rim. Because of the favorability of hydrogen bond formation, the 
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electron density of nitrogen atom is greatly reduced. As a result, the BE of N 1s 
increases considerably. 
On the other hand, O1s spectra of Fe3O4/SiO2/CMCD MNPs shows two oxygen peaks 
at 530.3 eV and 532.8 eV due to presence of C=O group and hydroxyl oxygen, 
respectively which originates from the presence of CMCD on the magnetic 
nanoparticles surface. Molecular dimensions and functional structure of cyclodextrin 
molecule are depicted in Figure 6-6(a) and 6-6(b), respectively. As a consequence of 
the 4C1 conformation of the glucopyranose units, all secondary hydroxyl groups are 
situated on one of the two edges of the cyclodextrin ring, whereas all the primary ones 
are placed on the other edge. After adsorption of DL-Trp, DL-Phe and DL-Tyr on the 
magnetic nanoparticles surface, binding energies of hydroxyl oxygen slightly shifted to 
higher energy which also represent that interaction with secondary hydroxyl group of 
cyclodextrin rim on the magnetic nanoparticles took place (data shown in Table 6-4). 
Apart from this, there‟s no major binding energy shift of C1s spectra of 
Fe3O4/SiO2/CMCD MNPs before and after adsorption.  
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Figure 6-5.2 XPS N1s spectra of (a) DL-Phe, (b) DL-Phe after adsorption. 
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Initially, analysis was done with single enantiomers (Chapter 5) and then interaction 
point was investigated by analyzing the racemic mixture before and after adsorption. 
FTIR analysis showed that the hydrophobic portion penetrated into hydrophobic cavity. 
And XPS analyses further showed that amino group interacted with the secondary 
hydroxyl group. The magnetic nanoparticles selectively adsorbed L-enantiomers of the 
amino acids from their racemic mixture which could be due to favorability of hydrogen 
bond formation between secondary hydroxyl groups of cyclodextrin molecule and 
amino group of L-enantiomers compared to that of D-enantiomers [381]. As depicted 
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from Figure 6-1, differences between three dimensional structures of D- and L-
enantiomers are in the position of primary amine group. In this case, primary amine 
group at the chiral center of the D-enantiomers might have positioned less favorably for 
hydrogen bonding, which might have resulted in less adsorption capacities of D-
enantiomers followed by subsequent chiral separation of DL-amino acid. Structure of 
beta cyclodextrin and simplified adsorption mechanism of L-Trp and D-Trp onto 
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Table 6-4 XPS data analyses for adsorption of racemic amino acids. 
 







DL-Phe  DL-Phe (after 
adsorption) 
DL-Tyr  DL-Tyr 
(after 
adsorption) 
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Figure 6-6 (a) Structure of β- cyclodextrin, (b) molecular dimensions and functional 
structural scheme of β-cyclodextrin, (c) simplified schematic showing adsorption 
mechanism of L-Trp onto Fe3O4/SiO2/CMCD MNPs, (d) simplified schematic showing 
adsorption mechanism of D-Trp onto Fe3O4/SiO2/CMCD MNPs. 
 
6.2.2 Flurometric titrations 
At the optimum experimental conditions, fluorescence intensity of inclusion complexes 
in aqueous solution was measured and corresponding fluorescence spectral changes 
upon addition of different concentrations of CMCD to the L-Trp solution are shown in 
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fluorescence intensity of D-Trp, L- and D-Phe and L- and D-Tyr also gradually changed 
with increasing concentration of CMCD (data not shown). When concentration of 
CMCD was increased, fluorescence maximum of L-Trp-CMCD was slightly blue 
shifted with a gradual increase in fluorescence. This behavior could be attributed to the 
enhanced dissolution of the guest molecule, through the hydrophobic interaction 
between guest molecule and non-polar cavity of CMCD. As a result, fluorescence 
intensity increased as CMCD concentration was increased. Similar changes were 
observed while studying inclusion complex formation of amino acid with native β-CD 
[417].  
It is also crucial to determine the stoichiometric ratio of inclusion complex formation. 
Employing the conventional double reciprocal method, stoichiometry and inclusion 
constant for the host guest combination from analysis of sequential changes of 
fluorescence intensity is determined at various host concentrations using the following 
equation [418, 419]: 
 
                      
 
 -  
 
 
(  -  )      
 
 
(  -  )
                                          [6-1] 
 
Where, F is the determined fluorescence intensity of the amino acid solution at each 
CMCD concentration. Fo and F∞ are the fluorescence intensity in the absence of CMCD 
and when all the amino acid molecules were included, respectively. K is the stability 
constant for inclusion complex formation and [CD]0 denotes the concentration of 
CMCD solution. K can be calculated from a plot of 1/(F-F0) vs. 1/[CD]0. Figure 6-7 (b) 
shows the double reciprocal plots of 1/(F-F0) versus 1/[CD]0 for L-Trp inclusion 
complexation with CMCD at pH 6. The plot exhibits good linearity (the linear 
regression coefficient R
2
 = 0.996). This verifies the formation of inclusion complexes 
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with a stoichiometry of 1:1 between L-Trp and CMCD. It is also observed that the other 
enantiomers (D-Trp, L-Phe, D-Phe, L-Tyr and D-Tyr) formed inclusion complexes with 
CMCD with same stoichiometry (1:1). The inclusion complex stability constant (K) of 
CMCD with L-Trp is estimated to be 1000 M
-1
. The stability constant (K) was 
measured form curve fitting method while Gibbs free energy changes (-ΔG°) for the 
inclusion complexation of CMCD with L-/D-enantiomers were determined from the 
equation: ΔG° = −RT lnK (K=stability constant) [420]. The stability constants along 
with free energy changes (-ΔGo) between CMCD and the amino acid enantiomers 
obtained are listed in Table 6-5.  
 
Figure 6-7 (a) Fluorescence spectrum of L-tryptophan upon addition of CMCD of 
various concentrations at 25°C; [L-tryptophan]=3×10
-5
 mol/L, concentration of CMCD: 
(1) 0, (2) 1.06x10
–4
 mol/L, (3) 2.27x10
–4
 mol/L, (4) 5.69x10
–4
 mol/L, (5) 7.26x10
–4
 
mol/L, (6) 9.68 x10
–4
 mol/L (from 1 to 6),  (b) double reciprocal plot for L-Trp 
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Table 6-5 The Stability Constants (K) and the Gibbs Free Energy Changes (-ΔGo) for 
the inclusion complexation of L-and D-Trp, L-and D-Phe and L- and D-Tyr with 
CMCD in 0.03 mol/L phosphate buffer Solution (pH 6) at 25°C, determined by 
flurometric titrations. 
 









L-Trp 1000 3 17.11 
D-Trp 650 2.69 16.05 
L-Phe 600 2.77 15.80 
D-Phe 450 2.65 15.12 
L-Tyr 300 2.47 14.09 
D-Tyr 250 2.39 13.63 
 
One of the most important features of inclusion complexation is the simultaneous 
operation of several weak interactions between the guest and host, which have been 
proved by the extensive studies on molecular recognition by cyclodextrins [420]. In the 
present case, hydrogen-bonding and hydrophobic interactions of the hydrophobic part 
and functional sidearm attached to the edge of cyclodextrin cavity are considered to be 
jointly responsible for the inclusion complexation. As can be seen from the Table 6-5, 
stability constant for inclusion complex formation is higher for Trp enantiomers than 
the other enantiomers, which might have resulted in better adsorption capacities of the 
nanoparticles toward the Trp enantiomers. And the values of stability constants for L-
enantiomers are higher than those of D-enantiomers which also confirm our previous 
observations regarding higher adsorption capacities of the magnetic particles toward L-
enantiomers. Finally the negative values of Gibb‟s free energy change show the 
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In short, silica and carboxymethyl-β-cyclodextrin functionalized Fe3O4 magnetic 
nanoparticles were utilized for enantioselective separation of racemic aromatic amino 
acid solution. The as-synthesized magnetic nanoparticles preferentially adsorbed L-
enantiomers of Trp, Phe and Tyr than the D-enantiomers and offered significant 
enantiomeric excess in aqueous system. XPS and FTIR spectroscopy were applied to 
investigate the enantioselective mechanism and it was found that hydrophobic portion 
of amino acid penetrated completely into the cyclodextrin cavity and the amino group 
of the amino acid molecules formed hydrogen bond. Apparently, hydrophobicities of 
the amino acids influenced the interaction with cyclodextrin molecules to different 
degrees and thus resulted in different enantiomeric excesses. Flurometric studies also 
supported the observation of higher binding of CMCD to L-enantiomer compared to D-
enantiomers.  The proposed method offers promising synthesis of adsorbents, rapid 
analysis, high enantiomeric excess and reliable quantitative assay. Thus, the as-
synthesized CMCD functionalized magnetic nanoparticles with all significant properties 
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Chapter 7: Adsorptive removal of emerging contaminants 
from aqueous solutions using superparamagnetic Fe3O4 
nanoparticles bearing aminated β-cyclodextrin 
 
7.1 Introduction 
Over the last decade, environmental pollution by pharmaceutically active compounds 
(PhACs) and endocrine disrupting chemicals (EDCs) in different water sources and 
industrial effluents aroused the public concern [421, 282]. Pharmaceuticals are class of 
emerging environmental contaminants that are increasingly being used in human and 
veterinary medicine [363].
 
EDCs are anthropogenic chemicals with the potential to 
elicit negative effects on the endocrine systems of humans and wildlife. Their 
occurrence is most often a result of municipal waste-water discharge, as these 
compounds are not completely removed in sewage treatment plants [422]. Wide range 
of PhACs and EDCs were found ubiquitously up to µgL
−1
 level in aqueous 
environment, soil, waste-water, surface water, sediments, groundwater and even 
drinking water [278, 423]. Due to the adverse effects on living creatures and persistency 
of these emerging contaminants in environment, removal of these contaminants is of 
great importance. 
Several treatment techniques for the removal of PhACs and EDCs from environmental 
matrices have been investigated, including coagulation-flocculation, adsorption, 
chlorination, electrochemical oxidation, ozonation, and photocatalytic oxidation 
[253,424-428]. Among these methods, adsorption has become one of the most 
promising techniques, due to its convenience, efficiency and economy. Moreover, 
adsorption to remove pollutants without disturbing quality of water or leaving behind 
any toxic degraded products has competed with electrochemical, biochemical or 
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photochemical degradation processes. So far, removal of PhACs and EDCs have been 
achieved by adsorption using activated carbons [282, 427], carbon nanomaterials [429], 
zeolites [423], minerals [430], hybrid particles [431, 432], inorganic-organic modified 
bentonite [279], mesoporous silica based materials [433] etc. However, these types of 
adsorbents suffer from separation inconvenience though some have high adsorption 
capacities. Therefore, efforts are still needed to carry out investigation for new 
promising adsorbents with high capacity and recognition and ease of separation. 
Recently, functionalized magnetic nanocomposites have received many attentions for 
use in adsorption of both organic and inorganic pollutants [150, 434, 435]. Magnetic 
nanoadsorbents can bind with non-magnetic target molecules via some intermediates 
forming complex which can be easily separated and recovered from multiphase 
systems, opening the door for sorbent regeneration, safe disposal of waste and/or 
recovery of loaded species. For effective removal of toxic contaminants from waste-
water, functional magnetic nanomaterials are synthesized by anchoring immobilized 
polymer, inorganic or organic molecules to surface. For example, Guo et al. prepared 
magnetic molecularly imprinted polymers based on kaolinite/Fe3O4 for selective 
adsorption and separation of BPA [436].  Ispas et al. developed biomagnetic capsule 
platform with immobilized enzyme as an environmentally benign method incorporating 
both sensing and removal capabilities for BPA [437]. However, to the best of our 
knowledge, detailed studies of adsorption characteristics of pharmaceuticals and EDCs 
from aqueous solution onto superparamagnetic Fe3O4 nanoparticles bearing 
cyclodextrin moieties are very scarce in literature.  
β-cyclodextrin (β-CD) is a cyclic oligosaccharide consisting of 7 D-glucopyranose units 
joined together by α (1–4) linkage forming a torus-shaped ring structure with a 
hydrophilic exterior and a hydrophobic cavity. They can form inclusion complexes with 
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a wide variety of compounds in their hydrophobic cavity [18]. While some research 
have been done using cyclodextrin functionalized magnetic nanoparticles for drug 
delivery [163, 151] and biomolecule purification [438], very little attention has been 
paid to their explicit application to remove PhACs and EDCs  from waste-water. 
The aim of this study was to investigate the adsorption characteristics for removal of 
PhACs and EDCs from aqueous solutions using β-CDen (en: -NHCH2CH2NH2) 
functionalized Fe3O4 nanospheres (CDen-MNPs), in which β-CDen  provides the ability 
to adsorb organic pollutants through inclusive host-guest interactions, while Fe3O4 
nanoparticles serve as magnetic separators. Two PhACs- carbamazepine (CBZ) and 
naproxen (NAP) and one EDC- Bisphenol A (BPA) were chosen as model 
contaminants as they are ubiquitous in waste-water effluent, surface water and 
groundwater [282]. CBZ is a basic therapeutic agent for treatment of epilepsy, 
trigeminal neuralgia, bipolar affective disorder and acute mania [253]. NAP is a 
nonsteroidal anti-inflammatory drug which has been shown to be persistent in 
environment [439]. BPA is one of the endocrine disrupters which can affect 
reproductive behavior of both human and animals [440]. BPA is commonly found in 
aquatic and terrestrial environments because of its widespread use as an intermediate 
compound in preparation of epoxy resins and polycarbonates [441]. Physicochemical 
properties of CBZ, NAP and BPA are presented in Table 7-1. In this study, influence of 
several parameters such as initial pH, contact time were investigated on adsorptive 
removal of CBZ, NAP and BPA from aqueous solutions. Adsorption behaviors of 
CDen-MNPs with these emerging contaminants were studied using both equilibrium 
and kinetic viewpoints. Finally, desorption of pharmaceuticals and EDC was studied 
with ethanol to assure regeneration possibility of the magnetic particles. 
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 Data from reference [282] 
b
 Data from reference [442] 
c 
Data from reference [443] 
 
7.2 Results and discussions 
7.2.1 Characterization of as-synthesized magnetic nanoparticles 
In this study, β-CDen (en = -NHCH2CH2NH2) was grafted on the surface of magnetic 
nanoparticles via layer-by-layer method. Initially, Fe3O4 nanoparticle surface was 
functionalized with thiodiglycolic acid (TDGA) which provides carboxylic acid (-
COOH) functional groups for linking amino containing CD molecules. The thiol group 
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affinity for iron. β-CDen was grafted on the surface of TDGA coated magnetic 
nanoparticles through amide (-NH-CO-) bond formation. HOBt and EDC were added in 
the reaction mixture to promote the amide bond formation between carboxylic acid 
groups on the magnetic particle surface and amino group on cyclodextrin.  Figure 7-1 
illustrates the synthetic routes for preparation of β-CDen conjugated magnetic 
nanoparticles. When CDen-MNPs were added into solution containing PhACs and 
EDCs, immobilized β-CDen adsorbed the micropollutant through inclusion and 
hydrophobic interactions. The pollutant-adsorbed particles were then separated from 
solution by applying an external magnetic field. 
 
Figure 7-1 Schematic illustration of the fabrication of the β-CDen modified magnetic 
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7.2.1.1 FTIR analysis 
 
The reaction pathway for grafting β-CDen on the surface of TDGA-MNPs was verified 
by FT-IR studies. Figure 7-2 shows IR spectra of TDGA-MNPs, CDen-MNPs and β-
CDen in the range of 400-4000 cm
-1 
wave number. It is shown that the characteristics 
adsorption band of Fe–O bonds in the tetrahedral sites of TDGA-MNPs is 586 cm-1. 
Strong absorption band at 3427 cm
-1 
is due to O-H stretching vibration. However, the 
TDGA coating over the surface of TDGA-MNPs can be confirmed with the bands at 
1633 cm
-1
 from carbonyl C=O stretching present in TDGA. The above characteristic 
bands can be observed with a little shift after the modification with β-CDen. In the 
spectrum for CDen-MNPs, the characteristics peaks at 1030, 1080 and 1153 cm
-1
 can be 
observed due to immobilized β-CDen on the surface. The peak at 1030 cm−1 is due to α-
1,4-bond skeleton vibration of β-CDen and the peak at 1080 and 1153 cm−1 correspond 
to the antisymmetric glycosidic νa(C–O–C) vibrations and the coupled ν(C–C/C–O) 
stretch vibration, respectively. Thus, the comparison between FTIR spectra of TDGA 
and β-CDen coated magnetite nanoparticles gives evidence for successful grafting of β-
CDen on the magnetite surface which is further supported by XPS and thermal analysis. 
 
Figure 7-2 FTIR spectra of (a) TDGA modified magnetic nanoparticles (TDGA-
MNPs), (b) β-CDen conjugated magnetic nanoparticles (CDen-MNPs) and (c) β-CDen. 
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7.2.1.2 TEM images 
 
High Resolution TEM (HRTEM) was applied to characterize the size and morphology 
of the nano-magnetic nanoparticles. Typical TEM image of CDen–MNPs is shown in 
Figure 7-3. It shows that magnetic nanoparticles bonded with β-CDen are sphere-like 
shaped or ellipsoidal particles with nano-size. The mean diameter calculated from the 





























Figure 7-3 (a) TEM image and (b) particle size distribution of CDen-MNPs. (Scale bar 
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7.2.1.3 XRD analysis 
 The crystal structures of uncoated MNPs, TDGA-MNPs and CDen–MNPs were 
characterized by X-ray diffraction (XRD) as shown in Figure 7-4. The six characteristic 
peaks at 2θ = 30.5, 35.9, 43.4, 53.4 57, and 63.1 are related to their corresponding 
indices (220), (311), (400), (422), (511), and (440), respectively. For all the samples, 
absence of the peaks (110) (2θ = 21.22) and (104) (2θ = 33.15) indicates that both 
goethite (α-FeOOH) and hematite (α-Fe2O3) did not form in the as-synthesized samples 
since the two compounds present characteristic diffraction peak of (110) and (104), 
respectively [151, 444]. This revealed that the resultant nanoparticles were pure Fe3O4 
with a spinel structure and the grafting of β-CDen onto TDGA-MNPs did not result in 
the phase change of Fe3O4. The crystal size of CDen-MNPs can be evaluated from 
XRD pattern by using Scherrer‟s equation, [D= (0.9λ/βcosθ)]; where D is the average 
crystalline diameter, 0.9 is the Scherrer constant, λ is the X-ray wavelength, β is the 
angular line width of half-maximum intensity and θ is the Bragg‟s angle in degree. 
Here, the (311) peak of the highest intensity was used to evaluate crystal size of the 
magnetic particles and the average crystal size of CDen-MNPs was calculated to be 
10.4 nm which is slightly less than that observed from the TEM images.  
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Figure 7-4 XRD patterns of (a) uncoated MNPs, (b) TDGA modified magnetic 
nanoparticles (TDGA-MNPs), (c) β-CDen modified magnetic nanoparticles (CDen–
MNPs). 
 
7.2.1.4 X-ray photoelectron spectroscopy (XPS) analysis 
XPS analysis was applied to find the chemical binding in the as-synthesized TDGA-
MNPs and CDen-MNPs.  Wide scan spectra of TDGA and β-CDen bonded magnetic 
nanoparticles are shown in Figure 7-5. The binding energy of S2p of both samples is 
161.3 eV, which indicates the deposition of thiodiglycolic acid on magnetic surface. 
The appearance of nitrogen (N1s) bands implies the grafting of β-CDen on the surface 
of TDGA modified magnetic nanoparticles. The C1s deconvoluted spectra are also 
shown in Figure 7-5. The C 1s core-level spectrum of TDGA-MNPs can be curve-fitted 
into three peak components with binding energies at about 284.6, 285.7 and 288.7 eV, 
attributable to the C–C, C–S and O–C=O species, respectively. For CDen-MNPs, the 
C1s spectrum can be curve-fitted into five peak components with binding energy of 
about  284.6, 285.7, 286, 288.2 and  288.7 eV, attributable to C–C, C–S and C–O/C–O–
C (alcoholic hydroxyl and ether), O=C–N, and O–C=O (carboxyl) species, respectively 
[164]. The C-S peak confirms the deposition of thiodiglycolic acid on the magnetic 
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surface. The C–O/C–O–C peaks are the characteristic of β-CDen. Moreover, the peak 
for O=C-N at 288.2 eV indicates that β-CDen reacted with the free COOH functional 
groups on TDGA-MNPs through amide bond formation. Thus, the modification of 
magnetite surface with β-CDen was confirmed.  
 
Figure 7-5 XPS wide scan and C1s deconvoluted spectra for TDGA-MNPs (a-b) and 
for CDen-MNPs (c-d). 
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7.2.1.5 Thermogravimetric (TGA) analysis 
The amount of β-CDen grafted on the surface of magnetic nanoparticles was estimated 
from the thermogravimetric analyses of uncoated, TDGA coated, and β-CDen coated 
nanoparticles. As shown in Figure 7-6, the TGA curve of uncoated MNPs shows weight 
loss of 2.2 % over the temperature range 30–200oC which might be due to the loss of 
residual water in the sample. The total weight loss over the full temperature range is 
estimated to be 3.3% due to the loss of adsorbed water as well as dehydration of the 
surface –OH groups. The TGA curves for TDGA-MNPs exhibits two steps of weight 
loss, contributed from the loss of residual water in the sample in 30–200oC and the loss 
of TDGA (~3.5%) in the range of 200–450 oC. From the TGA curve for CDen-MNPs, a 
drastic drop of 9.5% can be seen in the range 190–430oC and it is contributed from the 
thermal decomposition of thiodiglycolic acid and β-CDen moieties. Below 200 oC, the 
rate of weight loss is relatively slow owing to the loss of residual water adhering to the 
sample surface and adsorbed in the β-CD cavities. So far, the TGA curves also confirm 
successful grafting of β-CDen molecules on the surface of nanoparticles. From these 
data, the amount of β-CDen grafted onto the surface of CDen-MNPs was estimated to 
be 0.050 mmol g
−1
. 
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Figure 7-6 TGA curves of (a) uncoated Fe3O4 nanoparticles (MNPs), (b) TDGA 
modified magnetic nanoparticles (TDGA-MNPs), and (c) β-CDen modified magnetic 
nanoparticles (CDen–MNPs). 
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7.2.1.6 VSM analysis 
The magnetization curve for the uncoated Fe3O4 nanoparticles and CDen-MNPs at 
room temperature is shown in Figure 7-7. The magnetic hysteresis loop of the sample 
indicates no remanence and reveals its superparamagnetic nature, which is beneficial to 
their dispersibility and redispersibility in the solution. Superparamagnetism is the 
responsiveness to an applied magnetic field without retaining any magnetism after 
removal of the applied magnetic field. The saturated magnetization of samples is quite 
high, which guarantees quick response of these nanoparticles to external magnetic 
fields. However, the saturated magnetization obtained for CDen-MNPs (57.1 emu/g) at 
same field was lower than that of uncoated Fe3O4 (75 emu/g). This is mainly attributed 
to the existence of non-magnetic materials (TDGA and β-CDen layer) on the surface of 
nanoparticles. Thus both the superparamagnetic property and high magnetization of the 
as-prepared nanoparticles are ideal for practical applications. 
 
Figure 7-7 Magnetization curve for (a) unmodified MNPs, (b) β-CDen modified 
magnetic nanoparticles (CDen–MNPs). 
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7.3 Adsorption study 
7.3.1 Effect of initial pH 
Effect of pH on removal of PhACs and EDCs by CDen-MNPs were explored in this 
work, because solution pH was known to affect properties of both adsorbents and 
adsorbates. Figure 7-8 shows adsorption capacities of magnetic nanoadsorbents toward 
CBZ, NAP and BPA at different pH. For CBZ, adsorption capacity of nanoadsorbent 
was not affected by solution pH in the tested pH range (pH 3 to 11). But, when solution 
pH increased from 3 to 11, adsorption capacity of acidic pharmaceutical, NAP reduced 
gradually. For BPA, adsorption capacity of the sorbent decreased as pH was increased 
from 9 to 11. Adsorption of contaminants onto CDen-MNPs can be controlled by both 
non-electrostatic and electrostatic interaction. CBZ, NAP and BPA were present in 
either neutral or ionized forms, depending upon solution pH. Speciation of chemicals 
can be determined by the Henderson–Hassel Balch equations [54].  
For an acid, the Henderson–Hassel Balch equation is, 
 
          (
* -+
    
)                                                                    [7-1] 
For a base, the equation is, 
                                    (
   
     
)                                                                [7-2] 
 where, pKa is acid dissociation constant of weak acid BH
+
. Ratio of conjugated acid 
and base can be calculated using solution pH and pKa value for the compound. In the 
case of CBZ (pKa = 13.9), it exists as a neutral compound in tested pH range (Figure 7-
9). Thus its binding onto CDen-MNPs is solely attributable to nonelectrostatic 
interaction involving hydrogen bonding, hydrophobic and van der Waals interactions. 
For acidic pharmaceutical, NAP where the pKa values is 4.15 (Table 7-1), the chemical 
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is neutral (HA) at pH ≤ 3 and anion (A-) at pH > 6. Thus, adsorption of NAP onto 
CDen-MNPs is highest at pH 3 due to favourable hydrophobic interaction between 
adsorbent and the neutral adsorbate. As pH increased from 3 to 11, less favourable 
interaction occurred between ionized NAP molecules and hydrophobic cyclodextrin 
molecule, hence, adsorption capacity of CDen-MNPs toward NAP decreased. 
It can be also seen that when pH value of solution was lower than 9, adsorption of BPA 
by CDen-MNPs was not influenced by pH values while increase in pH above 9 resulted 
in a gradually decreased adsorption. It was reported that interaction forces between 
BPA and cyclodextrin molecules are hydrogen bonding, van der Waals force and 
hydrophobic interaction [445]. However, a decreasing trend at a higher pH ranging 
from 8 to 11 was also observed when insoluble cross-linked cyclodextrin polymers 
were used as adsorbents [446]. The result could be elucidated by the pKa value of BPA  
ranging from 9.6 to 10.2 [443], implying that ionization of BPA occurred at around pH 
9–11 to form the phenolate and bisphenolate anions as shown in Figure 7-9. Its 
hydrophobic character would be lowered greatly on the formation of anion. The 
phenolate anions have fewer tendencies to be included in the hydrophobic cavity of 
cyclodextrin; hence adsorption capacity of CDen-MNPs was reduced.  
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Figure 7-8 Effect of pH on adsorption capacity of CBZ, NAP and BPA. Experimental 
conditions: [CBZ]0, [BPA]0 and [NAP]0: 20 ppm; volume of solution: 5 mL; contact 
time: 4 hrs; temperature: 25
o
C. 
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Figure 7-9 The species distribution diagrams of NAP, CBZ and BPA. 
 
7.3.2 Effect of contact time and adsorption kinetics  
For effective designation and representation of the on-going adsorption process, study 
of kinetics of the adsorption process was carried out. Figure 7-10(a) shows the influence 
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of contact time on adsorption of CBZ, NAP and BPA. High adsorption rate was 
observed at the initial stage due to rapid attachment of adsorbates to the surface of 
adsorbents. In case of BPA, above 95% of the equilibrium adsorption value occurred in 
the first 40 min. And, in case of NAP, more than 95% of equilibrium value occurred in 
the first 60 min. And thereafter rate of adsorption of CBZ was found to be slow and the 
equilibrium was reached and remained constant at nearly 2 hrs contact time. One 
possible reason for difference in rate of adsorption of CBZ, NAP and BPA onto 
magnetic nanoparticles could be different size of molecules with respect to cavity size 
of β-CD. The size of targeted contaminant is important because molecular diameter in a 
size range similar to molecular size of adsorbent is one important factor that determines 
the progression of adsorption of a given adsorbent. Xiao et al. found that molecular 
sizes and structures of three pharmaceuticals, namely levofloxacin, aspirin and 
acetaminophen influenced sorption rates on cyclodextrin based polymer [447]. Among 
three organic molecules studied here, diameter of BPA molecule is the smallest (3.83Å) 
[443], thus the adsorption of BPA onto CDen-MNPs reached equilibrium very fast. 
Since size of the CBZ molecule (7.60 Å) and NAP molecule (7.60 Å) are comparable to 
the cavity size of β-CD (7.8 Å) [311], it took more time to reach adsorption equilibrium 
for these two pharmaceuticals. However, adsorption of NAP onto these nanoadsorbents 
was faster than that of CBZ. This could be related to their molecular structures which 
might affect their inclusion into cavity of β-CDen. Noteworthy, the naphthalene moiety 
of NAP is of the planar structure, whereas the benzene rings in the carbamazepine 
structure are nonplanar. In this study, shaking time of 4 hrs was used in all further 
adsorption experiments to ensure equilibrium. 
The data of adsorption kinetics of CBZ, NAP and BPA onto CDen-MNPS were 
examined with Lagergren pseudo-second-order model. The Lagergren rate equation is 
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one of the most widely used adsorption rate equations for adsorption of solute from a 




                           









                                                                      [7-3]                                                           
Where k2 is equilibrium rate constant of pseudo-second-order adsorption (g/(mg.min)). 
Slope and intercept of the plot of t/Qt versus t were used to calculate the second-order 
rate constant, k2 (Figure 7-10 (b)). Correlation coefficient (R
2
) for pseudo-second-order 
adsorption model has high value (>99%), and Qe values (Qe,cal) calculated from pseudo-
second-order model are more consistent with the experimental Qe values (Qe,exp). These 
facts suggest that adsorption data are well represented by pseudo-second-order kinetic 
model and overall rate of the adsorption process appears to be controlled by the 
chemical interactions. Pseudo-second-order adsorption of some selected 
pharmaceuticals and EDCs have also been reported for many adsorbents such as 
mesoporous silica SBA-15 [278], magnetic molecularly polymers (MMIPs) based on 
kaolinite/Fe3O4 composites [436] and multiwalled carbon nanotube [253]. Parameters 
of pseudo-second-order rate model for adsorption of CBZ, NAP and BPA on the 
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Figure 7-10  (a) Effect of contact time on adsorption capacities of CBZ, NAP and BPA 
at pH 7 and 25
o
C; (b) Linear plot of pseudo-second-order kinetic model for CBZ, NAP 
and BPA adsorption. 
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Table 7-2 Adsorption kinetic parameters of CBZ, NAP and BPA onto CDen-MNPs at 





















CBZ 20 0.160 1.328 0.999 1.31 
NAP 20 0.260 1.090 0.999 1.07 
BPA 20 1.051 0.912 0.999 0.90 
                                     a
 experimental 
                                     b
 calculated 
 
7.3.3 Isotherm test and role of physicochemical properties of pollutants 
The equilibrium isotherms for the adsorption of CBZ, NAP and BPA in single solute 
system by TDGA-MNPs and CDen-MNPs at pH 7 and 25
o
C are shown in Figure 7-11. 
From various isotherm equations that may be used to analyze adsorption data in 
aqueous phase, the Langmuir-the theoretical equilibrium isotherm and the Freundlich-
the empirical equilibrium isotherm are the most common models. The Langmuir 
equation can be expressed as [325]:  
                         









                                                                       [7-4]                                                          
                                          
where Qe is amount of adsorbed material at equilibrium (mg/g), Ce the equilibrium 
concentration in solution (ppm), Qm the maximum capacity of adsorbent (mg/g), and kL 
is the “affinity parameter” or Langmuir constant (L/mg).  
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On the other hand, Freundlich isotherm gives an empirical expression encompassing 
surface heterogeneity and exponential distribution of active sites and their energies. The 
linear form of Freundlich equation, which is an empirical equation derived to model 
heterogeneous adsorption, can be represented as follows [326]:  
                                   
 
 
                                                                     [7-5] 
Where, Qe and Ce are defined as above, kF is Freundlich constant (L/g), and n is 
heterogeneity factor. The adsorption isotherm parameters for PhACs and EDC are 
represented in Table 7-3.  
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Figure 7-11 The adsorption isotherm of (a) CBZ, (b) NAP and (c) BPA on CDen-MNPs 
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Table 7-3 Adsorption isotherm parameters for NAP, CBZ and BPA onto CDen-MNPs 



















Qm (mg/g) 1.656 0.677  2.186 0.593  2.162 0.872 
kL (L/mg) 0.095 0.030  0.080 0.063  0.037 0.042 
R
2 
0.975 0.972  0.980 0.964  0.926 0.967 
Freundlich (1/n) 0.564 0.765  0.579 0.632  0.736 0.707 
kF (L/g) 0.212 0.026  0.249 0.048  0.105 0.049 
R
2 
0.998 0.995  0.995 0.995  0.993 0.998 
 
 
As can be seen from Figure 7-11, maximum adsorption capacities of TDGA-MNPs 
towards CBZ, NAP and BPA are 0.307, 0.244 and 0.378 mg/g, respectively at 25°C and 
pH 7, whereas those using CDen-MNPs are 1.304, 1.074 and 0.899 mg/g, respectively 
at the same experimental conditions. Thus, CDen-MNPs could adsorb CBZ, NAP and 
BPA more than twice than that by TGDA coated magnetic nanoparticles indicating that 
modification of magnetite surface with β-CDen which had hydrophobic cavity had 
enhanced adsorption capacities. However, all the experimental data were fitted well 
with Freundlich isotherm model than Langmuir model (R
2
 > 0.99). Thus, the adsorption 
process is governed by heterogeneous adsorption.  
The isotherms in Figure 7-11 show that in the investigated concentration range, 
absorbabilities of the three target compounds on CDen-MNPs decreased as their 
hydrophobicity, which can be expressed as their octanol–water partition coefficients 
(logKow) increased (Table 7-1). It was reported that logKow is an important factor in 
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evaluation of adsorption capacity for a given micropollutant; and a micropollutant with 
a higher logKow value should have higher sorption affinity on CDen-MNPs [282]. 
Considering the logKow values, the absorbabilities of these pollutants on CDen-MNPs 
would have been in the order of BPA > NAP > CBZ instead of CBZ > NAP > BPA. 
The relatively lower adsorption affinity of NAP compared to CBZ found in this study 
could be mainly attributed to dissociation of acidic naproxen at pH values. This result is 
in agreement with the observation reported by Yu et al. [282]. Adsorption capacity of 
nano-adsorbent bearing cyclodextrin moieties toward CBZ, NAP and BPA is based on 
two factors, namely, the hydrophobicity (conditioned by the value of octanol water 
partition coefficient, Kow) and ionization of the molecules (determined by values of pH 
and pKa). Both parameters Kow and pKa are taken into account for calculation of logD. 
logD is a pH-dependent modified octanol water partition coefficient and is relevant for 
solutes that are partly dissociated or protonated. It can be calculated using following 
equations. For acidic molecules logD is determined as: 
                                          
                                                    [7-6] 
                                                         
Whereas for basic molecules logD is: 
 
                                            
                                               [7-7] 
 
The modified logD value for NAP decreases from 3.15 at pH 3 to 0.33 at pH 7 while 
logD values for CBZ, and BPA are constant at pH 3-7 (Table 7-1) based on above 
equation [443, 54]. According to the modified hydrophobicity values, BPA is most 
hydrophobic at pH 7 and hydrophobicity of CBZ is higher than that of NAP. The 
chemical structure of CDen-MNPs (Figure 7-1) suggests that presence of ionizable 
groups on the surface is very limited. Thus, hydrophobic interaction between β-CDen 
                                                                                         Chapter 7  
                                                                                            
201 
 
and target molecules should be dominating. As a result, higher adsorption capacities of 
CDen-MNPs toward more hydrophobic CBZ than that of NAP are justified. However, 
hydrophobicity would not explain the lowest adsorption affinity of BPA on CDen-
MNPs, though BPA is a neutral compound at pH 7. There might be other interactions 
between CDen and BPA molecules. Yu et al. also observed that nonylphenol-an 
endocrine disrupter was least absorbable among naproxen, carbamazepine and 
nonylphenol on activated carbon, though nonylphenol has high logKow value [282]. To 
elucidate the underlying mechanisms for BPA adsorption results in relation to the other 
two compounds in this study, FTIR spectra were obtained for β-CDen and solid 
complex residues containing inclusion complexes of CBZ/β-CDen, NAP/β-CDen and 
BPA/β-CDen (see section 7.3.6).  
7.3.4 Adsorption of a mixture of pharmaceuticals and EDCs 
As the emerging contaminants usually occur in the environment as a mixture, the 
investigation of adsorption of a mixture of these contaminants is necessary as a 
succeeding step for further application. Figure 7-12 represents the results for adsorption 
results of a mixture of two pharmaceuticals and one EDC onto CDen-MNPs as a 
function of initial concentration. At pH 7, adsorption capacities of the adsorbent were 
higher for CBZ than those of NAP and BPA. In other word, adsorption capacities of 
CDen- MNPs toward CBZ, NAP and BPA are in the same order as obtained in single 
adsorption study. At initial concentration of 20 ppm for each component, adsorption 
capacity of the CDen-MNPs toward CBZ, NAP and BPA were 0.51, 0.45 and 0.34 
mg/g, respectively. It can be interpreted that there exist some kind of binding or 
interactions among CBZ, NAP and BPA and CDen-MNPs which induce adsorption of 
the three compounds at the same time on surfaces of these magnetic adsorbents. At pH 
7, there should be more favourable interaction among neutral CBZ and the adsorbents 
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bearing pendant hydrophobic β-CDen moieties than those of NAP and BPA. 
Considering the mixed condition, adsorption capacities of CDen-MNPs were somewhat 
smaller than that of individual cases.  
 
Figure 7-12 Adsorption of a mixture of CBZ, NAP and BPA onto CDen-MNPs as a 
function of initial concentration. (Contact time, 4 hrs; temperature, 25
◦
C; pH 7). 
 
7.3.5 Desorption study 
 
Desorption study was done in this work to explore the regeneration and reusability of 
modified magnetic nanoparticles. Desorption of the CBZ, NAP and BPA was 
demonstrated using ethanol as desorbing agent. It was found that desorption efficiency 
achieved was around 80% 75% and 89% for CBZ, NAP and BPA using ethanol as 
eluent. Alcohol solution was used by researchers to desorb organic pollutants from 
other cyclodextrin-based adsorbents. For example, Aoki et al. also found that 4-
nonylphenol ethoxylates (NPEs) was successfully released from chitosan bearing 
cyclodextrin beads using 50% ethanol solution [445].  
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Figure 7-13 Desorption of CBZ, NAP and BPA from CDen–MNPs in ethanol. 
Adsorption conditions: CDen–MNPs: 100 mg; CBZ, NAP and BPA concentration: 20 
ppm; temperature: 25
o
C; pH: 7; contact time: 4 hrs. Desorption conditions: CDen–
MNPs: 100 mg; temperature: 25
o
C; contact time: 6 hrs. 
 
7.3.6 Interaction of pharmaceuticals/EDC and β-CDen 
Inclusion complexes among the pharmaceuticals and β-CDen were investigated with 
FTIR spectroscopy to gain insight of the interaction among the molecules. FTIR spectra 
obtained for β-CDen and solid complex residues containing inclusion complexes of 
CBZ/β-CDen, NAP/β-CDen and BPA/β-CDen are shown in Figure 7-14. To be more 







. It is very interesting to note that, presence of CBZ, NAP 
and BPA does not cause significant shifts of the FTIR bands in the residues containing 
complexes of CBZ/β-CDen, NAP/β-CDen and BPA/β-CDen in the range of 
wavenumber 900-1750 cm
-1 
as compared to bands in native CBZ/NAP/BPA (Figure 7-
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14, Table 7-4). It can be interpreted that not much strong interaction exists between 
CBZ, NAP and BPA and C–C, C–O–C, OH groups of β-CDen. Firstly, the νC–O of 
residues increases of about 1–6 cm-1 as compared to that of native CBZ/NAP/BPA. 
These shifts may be associated with the intramolecular hydrogen bonds formed between 
these groups of β-CDen in the presence of CBZ, NAP and BPA [448]. Bonenfant et al. 
also observed that FTIR spectra of nonylphenol ethoxylates/ β-CD and nonylphenol/β-
CD inclusion complex residues shows small differences with native β-CD in the 
wavenumber region of 800-1400 cm
-1 
[448]. Hence, it can be suggested that hydrogen 
bonding is less dominant in formation of inclusion complex.  
In the spectra, bands observed in the region 2800-3250  cm
-1
 are associated with 
asymmetric and symmetric ν CH2 stretching vibrations (ν CH2) and bands identified in 
the region 900-1750 cm
-1
 are assigned to C–O, C–C, C–O–C stretching, and O–H in 
planar angular deformation vibrations (νC–O, νC–C, νC–O–C, and (δO–H) of 







 and 8 cm
-1 for the residues of CBZ/β-CDen, NAP/β-CDen and BPA/ β-
CDen which indicates van der Waals interaction took place between β-CDen and BPA 
than those of CBZ and NAP (Figure 7-14, Table 7-4). Van der Waals interaction is 
considered to be weak compared to hydrogen bonding or electrostatic interaction and as 
a result of this weak van der Waals interaction between BPA and β-CDen, adsorption 
capacities of the magnetic particles toward BPA was less. According to Alvira et al., 
van der Waals interactions are considered to contribute to the formation of inclusion 
complexes with β-CD [449]. Mimeault and Bonenfant have shown that the 
strengthening of the van der Waals interactions in the alkyl chains causes shifts of νCH2 
in the inclusion complexes [450].  
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Figure 7-14 FTIR spectra of (a) CBZ/β-CDen inclusion complex, (b) CBZ, (c) NAP/β-
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Table 7-4 Maximum wavenumber of FTIR bands of CBZ, CBZ/β-CDen inclusion 
complex, NAP, NAP/β-CDen inclusion complex, BPA, BPA/β-CDen inclusion 






























δ O-H  1335 1346 1335  1335 1335 
ν C-O 1154 1156 1158 1159 1150 1156 1158 
ν C-C  1079  1081  1079 1082 
ν C-O-C  1028  1028  1030 1028 
 
7.4 Conclusions 
In summary, β-CDen (en: -NHCH2CH2NH2) functionalized Fe3O4 nanospheres (CDen-
MNPs) were successfully synthesized, in which β-CDen  had the ability to adsorb 
pharmaceutically active compounds (PhACs) and endocrine disrupter (EDCs) through 
inclusive host-guest interactions, while the Fe3O4 nanoparticles served as magnetic 
separators. Successful grafting of β-CDen onto magnetic particles was ascertained from 
the results of FTIR, TGA and XPS analyses.  Analyses by TEM and VSM indicated 
that the as-synthesized nanoparticles were superparamagnetic with mean diameter of 
11.5 nm. The solution pH and physicochemical properties of each pollutant greatly 
affected the adsorption process
 
on CDen-MNPs. Absorbabilities of these pollutants on 
CDen-MNPs were found in the order of CBZ > NAP > BPA. The kinetics and 
equilibrium of pharmaceutical and EDC adsorption were best described using pseudo-
second-order equation and Freundlich isotherm model, respectively. Desorption studies 
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showed that ethanol solution can be used as desorbing agent with multiple desorbing 
steps. Our results indicate that these as-synthesized magnetic nanoadsorbents would 
have great potentials in removal of pharmaceuticals and endocrine disrupting chemicals 
from waste-water. 
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Chapter 8: Adsorption/desorption of beta-blocker 




In the recent decades, pharmaceutical compounds received immense concern as 
emerging micropollutants for contamination of aquatic environments [236]. Among the 
pharmaceuticals, beta-blockers (sometimes written as β-blockers) or beta-adrenergic 
blocking agents constitute a class of drugs used for various indications. As beta 
adrenergic receptor antagonists, they are widely used to treat a variety of cardiovascular 
diseases by diminishing the effects of epinephrine (adrenaline) and other stress 
hormones  on the β-adrenergic receptor in the body, primarily in the heart [451]. 
Nonetheless, with low retention in human body and not completely eliminated by the 
conventional waste-water treatment process, these beta blockers have been widely 
detected in effluent of sewage treatment plants and surface water in the range of ng/L to 
µg/L [337-340, 452, 341, 342, 453, 454].  Some published data show that beta-blockers 
are likely to cause harmful effects on aquatic organisms, such as fish, algae, and 
invertebrates even at low concentrations [455]. Propranolol, a beta-adrenergic blocking 
agent, is widely used in the treatment of cardiovascular diseases (hypertension, cardiac 
arrhythmia). Propranolol is available in generic form as propranolol hydrochloride; 
some of the properties of propranolol hydrochloride are presented in Table 8-1. It is 
considered to be of low volatility, highly persistent [456, 457], and bioaccumulative 
[458]. Moreover, it was found that propranolol had the highest acute and chronic 
toxicity within the class of the beta-blockers [459]. So development of more effective 
technologies to remove propranolol from aqueous environment is of prime importance. 
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Among the other methods, photo degradation has been utilized by many researchers as 
a way of removal of beta-blockers from aqueous solution [460, 461]. But photo 
degradation is accompanied by many disadvantages such as high energy consumption, 
generation of secondary products, complicated reaction pathways. Compared to other 
methods, adsorption has become one of the most promising techniques for removal of 
pharmaceuticals from aqueous solution, due to its convenience, less/ no energy 
consumption, efficacy etc. Adsorption has been used for the removal of 
pharmaceuticals from wastewaters, primarily focusing on the use of activated carbon as 
the adsorbent [427]. Efficiency of pharmaceutical removal have also been examined 
using mesoporous silica based materials [278], inorganic-organic modified bentonite 
[279] etc. However high cost of manufacturing and regeneration of these adsorbents 
limit the application to some extent. Hence, development of alternative adsorbents 
which are effective, abundant and affordable is a research hot spot now. Recently, many 
studies have focused on use of superparamagnetic nanoparticles as alternative 
adsorbents for sorption separation/ removal of organic and inorganic contaminants 
[434] etc. These superparamagnetic materials possess an advantage that they do not 
retain any magnetization after removal of external magnetic field.   In addition, it is 
desired that the magnetic nanoparticles remain nonaggregated and are stable against 
oxidation from the point of these technological and medical applications. Because the 
nanoparticle surface can influence its behavior in the biological environment, suitable 
coating is very necessary to prevent such limitations [344]. If considered as surface 
modifying agent, silica particles are not toxic and are also highly biocompatible. They 
are regularly used as food additives and components of vitamin supplements. In 
addition, amorphous silica particles have surfaces decorated with hydroxyl groups 
which not only render them intrinsically hydrophilic but also provide platform for 
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further surface functionalization. On the other hand, cyclodextrins (CDs) are torus 
shaped cyclic oligosaccharides consisting of α-(1, 4) linked D-glucopyranose units. The 
most common cyclodextrins are α, β and γ-cyclodextrin, which contain six, seven and 
eight glucose units, respectively. A characteristic feature of cyclodextrin is the presence 
of an internal hydrophobic cavity with a remarkable capacity to form inclusion 
complexes whose stability constants depend on the polarity, size and shape of the guest 
molecule included [25].  Studies have been reported for adsorption of beta-blocker 
propranolol onto other adsorbent such as modified attapulgites [58], cyclodextrin 
polymer [60]. However to the best of our knowledge, reports about silica and 
cyclodextrin coated magnetic nanoparticles used in separation of beta-blocker are rather 
limited. 
 The primary objectives of this study were to investigate the sorption behavior of 
propranolol onto silica and carboxymethyl-β-cyclodextrin modified magnetic 
nanoparticles to evaluate their feasibility for removing propranolol from aqueous 
solution in ppm concentrations. Factors affecting adsorption of propranolol onto the 
nanoadsorbents were systemically investigated and the sorption kinetics and sorption 
isotherms for propranolol were studied in detail. Adsorption mechanism was explored 
in details using XPS and FTIR spectroscopy as well. Finally, desorption study and 
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 Data from reference [54] 
 
8.2 Results and discussion 
8.2.1 Adsorption of propranolol 
8.2.1.1 Effect of initial pH 
The sorption of propranolol onto Fe3O4/SiO2/CMCD MNPs as a function of initial 
solution pH was also investigated in the pH range of 3–11 (Figure 8-1). 
Fe3O4/SiO2/CMCD MNPs were synthesized according to the procedures described in 
section 3.2.1-3.2.4 and Figure 3-1 shows the schematic representation of the reaction 
pathway. As can be seen in Figure 8-1, sorption capacities of propranolol onto the 
nanoadsorbent increased with increasing pH. In the case of propranolol (pKa = 9.42), it 
exists as a positively charged molecule in the tested pH below its pKa and it exists as 
negatively charged molecule above its pKa (Figure 8-2) [58]. In the prepared sample, 












Figure 8-1 Effect of pH on the sorption of propranolol onto the four sorbents (T = 25°C, 
C0 = 50 ppm, sorbent dosage = 60 mg/4 mL) 
 
 
Figure 8-2 Species distribution of propranolol. 
 
It was reported that interaction forces between propranolol and cyclodextrin molecules 
are hydrogen bonding and hydrophobic interaction [60]. Adsorption capacity of the 
nano-adsorbent bearing cyclodextrin moieties toward the beta-blocker, propranolol is 
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based on two factors, namely, the hydrophobicity of the drug (conditioned by the value 
of the octanol water partition coefficient, Kow) and the ionization of the molecule 
(determined by the values of pH and pKa). Both parameters Kow and pKa can be taken 
into account for the calculation of logD. LogD is a pH-dependent modified octanol 
water partition coefficient and is relevant for solutes that are partly dissociated or 
protonated [57]. It can be calculated using equations 8-1 and 8-2. For acidic molecules 
logD is determined as: 
 
                                          
                                            [8-1] 
Whereas for basic molecules logD is: 
                                             
                                            [8-2] 
The modified logD value of propranolol at pH 3, 7 and 9 are found as -2.94, 1.06, 2.92 
[54]. According to the modified hydrophobicity values, hydrophobicity of propranolol 
increases from pH 3 to pH 9. Noteworthy, the chemical structure of Fe3O4/SiO2/CMCD 
MNPs (Figure 3-1) suggests that the presence of ionizable groups on the surface is very 
limited. Thus, hydrophobic interaction between CMCD and propranolol molecules 
should be dominating. As a result, higher adsorption capacities of Fe3O4/SiO2/CMCD 
MNPs toward propranolol at higher solution pH are justified. 
8.2.1.2 Effect of contact time and adsorption kinetics  
To investigate the effect of contact time on the ongoing adsorption process, detailed 
kinetic studies were carried out for adsorption of propranolol onto Fe3O4/SiO2/CMCD 
MNPs. Adsorption of propranolol was investigated in the initial concentration of 50 
ppm, pH 7 at temperature 25
o
C. Figure 8-3 shows the influence of contact time on the 
adsorption of propranolol. It can be seen that adsorption was increased instantly at 
initial stage due to rapid attachment of the adsorbates to the surface of the adsorbents. 
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In the case of propranolol, around 96% of the equilibrium adsorption value occurred in 
the first 40 min. And thereafter equilibrium was reached within 1 hr contact time. 
Gazpio et al. also observed that maximum adsorption capacity of cyclodextrin polymer 
toward propranolol was obtained after 20 min stirring time [60]. It is well known that 
cyclodextrin molecules show specific adsorption characteristics which can be explained 
by inclusion complex formation. As it is said before, inclusion complexation is a 
complicated process that depends on different properties of the guest molecule, such as 
polarity, size and ability to closely fit within the cavity, together with various 
interactions involving van der Waals, dispersive forces, dipole–dipole interactions, 
electrostatic forces and hydrogen bonding. The formation constant for the inclusion 
complexes of naphthalene with β-CD at 25 °C is 676 M-1 [60]. This high binding 
constant for inclusion complexation of β-CD and naphthalene ring might have resulted 
in fast adsorption saturation through inclusion complex formation between β-CD and 
propranolol. 
The data of adsorption kinetics of propranolol onto Fe3O4/SiO2/CMCD MNPs were 
examined with Lagergren pseudo-second-order model. The Lagergren rate equation is 
one of the most widely used adsorption rate equations for adsorption of solute from a 













                                                      [8-3]                                                           
where, k2 is the equilibrium rate constant of pseudo second- order adsorption 
(g/mg.min). Slope and intercept of the plot of t/Qt versus t were used to calculate the 
second-order rate constant, k2. It was found that the correlation coefficient (R
2
) for  
pseudo-first-order kinetic model has low value (< 90%) for propranolol adsorption and 
t
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a very large difference exists between Qe,cal and Qe,exp, indicating a poor pseudo-first-
order fit to the experimental data (data not shown). On the other hand, the correlation 
coefficient (R
2
) for pseudo-second-order adsorption model has high value (>99%), and 
Qe values calculated (Qe,cal)  from pseudo-second-order model are more consistent with 
the experimental Qe values (Qe,exp) than those calculated from pseudo-first-order model 
(Table 8-2). These facts suggest that the adsorption data are well represented by 
pseudo-second-order kinetic model. The pseudo-second-order adsorption of propranolol 
was also reported for other adsorbents such as modified attapulgites [58].  
 
Table 8-2 Adsorption kinetic parameters of propranolol onto Fe3O4/SiO2/CMCD MNPs 
at 25°C and pH 7. 
 
Pollutant Initial conc. 
Ci (ppm) 















Propranolol 50 0.307 2.094 0.999 2.078 








Figure 8-3 Effect of contact time on adsorption capacity of propranolol at pH 7 and 
25
o
C and fitting for pseudo-second-order kinetics model (inset Figure 8-3). 
 
 
8.2.1.3 Adsorption isotherm 
The equilibrium isotherms for the adsorption of propranolol in single solute system by 
both Fe3O4/SiO2/CMCD MNPs and bare MNPs at pH 7 and 25
o
C are shown in Figure 
8-4. From the various isotherm equations that are used to analyze adsorption data in 
aqueous phase, the Langmuir-the theoretical equilibrium isotherm and the Freundlich-
the empirical equilibrium isotherm are the most common models. The Langmuir model 
was originally developed to represent physisorption on a set of well-defined localized 
adsorption sites having the same adsorption energy, independent of the surface 
coverage and with no interaction between adsorbed molecules. The Langmuir equation 
can be expressed as [325]:  
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                                                                       [8-4]                                                          
 
Where, Qe is the amount of adsorbed material at equilibrium (mg/g), Ce the equilibrium 
concentration in solution (ppm), Qm the maximum capacity of adsorbent (mg/g), and kL 
is the “affinity parameter” or Langmuir constant (L/mg).  
On the other hand, the Freundlich isotherm, one of the more widely employed 
mathematical descriptions, usually fits the experimental data over wide range of 
concentrations. This isotherm gives an empirical expression encompassing the surface 
heterogeneity and the exponential distribution of active sites and their energies. The 
linear form of Freundlich equation, which is an empirical equation derived to model the 
heterogeneous adsorption, can be represented as follows [326]:  
                                
 
 
                                                                      [8-5] 
 
where Qe and Ce are defined as above, kF is Freundlich constant (L/g), and n is the 
heterogeneity factor. The values of kF and 1/n are determined from the slope and 
intercept of the linear plot of lnQe versus lnCe. The isotherm plots are shown in Figure 
8-4 and 8-5 and isotherm parameters for propranolol adsorption are represented in 
Table 8-3.  






Figure 8-4 (a) Sorption isotherm of propranolol onto Fe3O4/SiO2/CMCD MNPs and 
bare MNPs (T = 25°C, sorbent dosage = 60 mg/4 mL), (b) Langmuir isotherm plots. 
 





Figure 8-5 Freundlich isotherm plots for propranolol adsorption onto 
Fe3O4/SiO2/CMCD MNPs and bare MNPs (T = 25°C, sorbent dosage = 60 mg/4 mL). 
 
As can be seen from Table 8-3, maximum adsorption capacity of Fe3O4/SiO2/CMCD 
MNPs toward propranolol is 2.078 mg/g at 25°C and pH 7, whereas that using bare 
MNPs is 0.652 mg/g, at the same experimental conditions. Thus, Fe3O4/SiO2/CMCD 
MNPs had adsorbed propranolol more than three times than that by bare magnetic 
nanoparticles indicating that the modification of magnetite surface with CMCD which 
had hydrophobic cavity enhanced the adsorption capacities. However, all the 
experimental data were fitted well to Freundlich isotherm model than Langmuir model 
(R
2
 > 0.99). Thus, the adsorption process is governed by heterogeneous adsorption. 
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Table 8-3 Adsorption isotherm parameters for propranolol onto Fe3O4/SiO2/CMCD 










Qm (mg/g) 6.506 1.093 




Freundlich (1/n) 0.847 0.646 





8.2.2 Investigation of adsorption mechanism with FTIR and XPS 
spectroscopy 
To investigate the adsorption mechanism of Fe3O4/SiO2/CMCD MNPs toward 
propranolol, analysis of FTIR spectrum of the modified nanoparticles after adsorption 
of propranolol and in absence of propranolol were performed. The FTIR spectra of 
Fe3O4/SiO2/CMCD MNPs, propranolol and Fe3O4/SiO2/CMCD MNPs after sorption of 
propranolol are shown in Figure 8-6. As depicted in Figure 8-6 an obvious shift from 
1635 cm
-1
 (CMCD, OH in-plane bending vibration absorption) to 1627 cm
-1
 could be 
observed after adsorption of propranolol solution, which is ascribed to the inclusion 
complex formation between cyclodextrin derivative and guest molecule. This result 
provides evidence that propranolol entered hydrophobic cavity of CMCD. In the native 
propranolol, functional groups are found as follows: peaks at about 2962 and 2831 cm
−1
 
(characteristic of the aliphatic C–H stretching vibration), and peaks at about 1581–1450 
cm
−1
 (attributed to the benzene ring skeletal vibration). The peaks at 1581–1450 cm−1 
all disappeared after adsorption onto Fe3O4/SiO2/CMCD MNPs, which shows the 
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interaction of propranolol with the cyclodextrin cavity occurred on the modified 
magnetic nanoparticles‟ surface. Besides, the bands at 3236 and 3344 cm-1 are found 
due to presence of hydroxyl groups on the particle surface. The bands at about 3236 
cm
−1
 on the Fe3O4/SiO2/CMCD MNPs broaden to some extent probably due to OH 
groups of propranolol. Notably, the vibration of backbone of the silicate structure (at 
1088 cm
-1
) of Fe3O4/SiO2/CMCD MNPs before and after propranolol sorption remain 
same, which further shows that the interaction occurred mainly in between propranolol 
and cyclodextrin cavity. 
 
Figure 8-6 FTIR spectra of (a) Fe3O4/SiO2/CMCD MNPs before adsorption, (b) 
propranolol, (c) Fe3O4/SiO2/CMCD MNPs after adsorption of propranolol. 
 
To further scrutinize the adsorption mechanism of propranolol on magnetic 
nanoparticles, XPS analyses were carried out on propranolol and Fe3O4/SiO2/CMCD 
MNPs after adsorption of propranolol and the corresponding results are shown in the 
Figure 8-7 and Table 8-4. There are major changes in the N1s spectra of propranolol 
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before and after the adsorption onto Fe3O4/SiO2/CMCD MNPs, which indicates that the 
amino group of propranolol took part in adsorption and complex formation. Clearly, the 
spectrum of propranolol exhibits two N1s peaks at 398.4 and 400.5 eV which could be 
attributed due to N-H and N-C functional groups. After adsorption of propranolol onto 
Fe3O4/SiO2/CMCD MNPs, the spectrum shows that peak at 398.4 eV in propranolol is 
shifted to 401.2 eV and peak at 400.5 eV in native propranolol is shifted to 402.3 eV. 
Binding energy (BE) of the peaks shifted to higher eV after adsorption compared to that 
of native propranolol molecule. The significant change in BE of N1s indicates that 
propranolol-magnetic nanoparticle complex formation occurred. Because of the 
favorability of amide bond formation, free electron density of nitrogen atom is greatly 
reduced. As a result, the BE of N1s increased considerably. Furthermore, O1s spectra of 
Fe3O4/SiO2/CMCD MNPs depicts two oxygen peaks at 530.3 eV and 532.8 eV due to 
presence of C=O and C-O-H/C-O-C group, respectively which originates from presence 
of CMCD on nanoparticles‟ surface. After adsorption of propranolol on magnetic 
nanoparticles‟ surface, binding energy of C-O-H/C-O-C group shifted to higher eV 
which represents that interaction with the secondary hydroxyl group of cyclodextrin 
outer rim on the magnetic nanoparticles took place (data shown in Table 8-4). Apart 
from these, there are no major changes in C 1s spectra. 
Thus, from FTIR and XPS analysis, it can be estimated that the hydrophobic part of 
propranolol penetrated into the hydrophobic cavity of CMCD and nitrogen molecule 
was involved into hydrogen bond formation. Structure of beta cyclodextrin and 
adsorption mechanism are depicted in Figure 8-8.  
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Table 8-4 XPS data analyses for adsorption of propranolol. 
 
Element Binding energy (eV) 
Fe3O4/SiO2/CMCD 
MNPs 
Propranolol Fe3O4/SiO2/CMCD MNPs 
after adsorption of 
propranolol 




































Figure 8-7 XPS spectra of (a) propranolol before adsorption, (b) Fe3O4/SiO2/CMCD 















Figure 8-8 (a) Structure of beta cyclodextrin, (b) simplified schematic showing 
adsorption mechanism of propranolol onto Fe3O4/SiO2/CMCD MNPs. 
 
8.2.3 Spectroflurometry measurements and binding constant of 
CMCD/propranolol 
Fluorescence spectra of propranolol in pH 7 buffer containing various concentrations of 
CMCD are presented in Figure 8-9 (a). The fluorescence intensity of propranolol 
increased with increasing CMCD concentration with slight blue shift of fluorescence 
maximum. The change of fluorescence spectra is due to the interaction between 
propranolol and CMCD, implying the formation of propranolol-CMCD inclusion 
complex. Because cyclodextrin‟s non-polar cavity can offer hydrophobic environment 
for guest molecules, the fluorescence intensity would enhance when propranolol is 
included into the cyclodextrin‟s cavity. The revolving freedom of propranolol 
(a) 
(b) 
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decreases, resulting in an increase in fluorescence quantum yield of propranolol 
molecules.  
Inclusion constant (K) is an important parameter, which represents the inclusion 
interaction. The inclusion constants of complexes are estimated according to the 
double-reciprocal method. It can be obtained by the following equation [418, 419]. 
 
    
 
 
             
 
 
       
                                 [8-6] 
where, F is the determined fluorescence intensity of the propranolol solution at specific  
CMCD concentration. Fo and F∞ are the fluorescence intensity in the absence of CMCD 
and when all the propranolol molecules were included, respectively. K is the inclusion 
constant and [CD]0 denotes the concentration of CMCD solution. K can be calculated 
from a plot of 1/(F-F0) vs. 1/[CD]0. Figure 8-9 (b) shows the double reciprocal plots of 
1/(F- F0) versus 1/[CD]0 for propranolol inclusion complexation with CMCD at pH 7. 
The plot exhibits good linearity (the regression coefficient R
2
 ~ 0.993). This verifies the 
formation of inclusion complexes with a stoichiometry of 1:1 between propranolol and 
CMCD. The inclusion constant, K of CMCD with propranolol is estimated to be 3850 
M
-1
. This high value indicates great affinity of propranolol to CMCD and thus 










Figure 8-9 (a) Emission (λmax = 343 nm) spectra of propranolol (4.5x 10
-5
 mol/L, 
pH=7.0) solution at various CMCD concentrations (from 0 to 4.7 x 10
-4
 mol/L), (b) 
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8.2.4 Desorption studies 
The success of an adsorption process usually depends on the regeneration step of the 
adsorbent. Generally desorption of the adsorbed solute from adsorbent is accomplished 
by two methods: (1) by changing a physical operating condition, namely temperature, 
of the adsorber, which affects the equilibrium interaction between the adsorbent and the 
solute, (2) by performing a chemical reaction using some chemical reagent with higher 
affinity toward the adsorbed species so that it can be desorbed and removed from the 
system readily. There are a number of regeneration techniques such as thermal, steam, 
acid, base, and solvent regenerations. In this study, acetonitrile and methanol were used 
as desorbing agents for propranolol. Among these, methanol solution was found as 
effective desorbing agent. 
 Desorption of propranolol from nanomagnetic particles was carried out separately by 
10%, 30% and 50% methanol solutions at equilibrium and 25°C. Figure 8-10 shows the 
result of desorption studies of propranolol after adding 50% methanol solution at 
equilibrium with respect to solid loading. Around 94% desorption of propranolol was 
achieved using 50% methanol solution when 14.47 mg of solid adsorbent was added.  
 




Figure 8-10 Desorption of propranolol from Fe3O4/SiO2/CMCD MNPs as a function of 
loading of adsorbent. Adsorption condition:  propranolol 50 ppm; pH 7; temperature 
25°C, contact time 5 hrs. Desorption condition Fe3O4/SiO2/CMCD MNPs; 50% 




In summary, silica and carboxymethyl-β-cyclodextrin functionalized Fe3O4 magnetic 
nanoparticles were utilized for adsorptive removal of propranolol. Results from effect 
of pH study showed that adsorption capacities of the particles increased as solution pH 
was increased and the behavior was dominated by hydrophobic interaction between 
propranolol and the nanoadsorbents. Adsorption capacities of as synthesized particles 
were compared to bare nanoparticles and it was found that adsorption capacity of 
cyclodextrin derivative functionalized particles was three times higher than that of bare 
magnetic nanoparticles. Kinetic studies showed that the adsorption process was very 
fast, adsorption equilibrium reached within 1 hr and kinetic data followed pseudo 
second order model. All the adsorption equilibrium data were fitted well to Freundlich 
isotherm model thus showing heterogeneous adsorption. XPS and FTIR spectroscopy 
were applied to investigate adsorption mechanism and it was found that the 
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hydrophobic portion of propranolol penetrated completely into cyclodextrin cavity and 
amino group of propranolol interacted through hydrogen bond formation with the 
secondary hydroxyl group of cyclodextrin cavity. Flurometric studies revealed high 
binding constant between propranolol and CMCD which might have resulted in 
adsorption of adsorbate.  Finally, desorption studies showed that the nanoadsorbents 
could be regenerated using methanol solution and using 50% methanol solution almost 
complete regeneration of the adsorbent was achieved. Thus, the as-synthesized CMCD 
functionalized magnetic nanoparticles with all significant properties would have great 
potentials in adsorptive separation/ removal of beta-blocker. 
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The main aim of the study is to present a systematic and comprehensive study on the 
application of cyclodextrin derivative functionalized magnetic nanoparticles for 
separation of chiral biomolecules and environmental pollutants. Initially, silica and 
cyclodextrin derivative functionalized magnetic nanoparticles (CMCD coated MNPs) 
were synthesized and applied for adsorption separation of  single Trp, Phe and Tyr 
enantiomers and separation from racemic mixture as well. Later on, another 
cyclodextrin derivative functionalized MNPs (β-CDen MNPs) were synthesized and 
applied for separation of pharmaceuticals. Sorption separation of two different kinds of 
chemicals/ compounds (amino acid and PhACs/EDC) with different types of β-CD 
derivatives was explored. For this reason, adsorption/separation study of PhACs and 
EDC was not done using CMCD functionalized MNPs and β-CDen MNPs were not 
utilized for chiral separation of amino acids. The results are divided into five parts and 
presented in five separate chapters. These are silica and CMCD coated magnetic 
nanoparticles characterization results, adsorption and desorption results of single chiral 
amino acid enantiomers on silica and CMCD coated magnetic nanoparticles, chiral 
separation of amino acids using silica and CMCD coated magnetic nanoparticles, 
characterization results of amino-cyclodextrin functionalized magnetic nanoparticle and 
adsorption/desorption results of environmental pollutants (carbamazepine, naproxen 
and bisphenol A) on amino-cyclodextrin functionalized magnetic nanoparticle, detailed 
study of adsorption/desorption of beta-blocker propranolol using silica and CMCD 
coated magnetic nanoparticles.  
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The first part of experiment deals with synthesis of bare magnetic nanoparticles and 
functionalization of the surface with silica and CMCD followed by characterization of 
the chemical, physical and magnetic properties of the magnetic nanoparticles. Bare 
magnetic nanoparticles were synthesized and their surface was functionalized with 
silica and CMCD (Chapter 4). FTIR results showed the presence of Fe-O-Si stretching 
band and C-H stretching band, which indicated surface of the magnetic particles, was 
successfully functionalized with silica and CMCD. XRD patterns indicated that the 
silica and CMCD coated magnetic nanoparticles constitute iron oxide (Fe3O4). The 
XRD pattern also showed the characteristic peaks at 2θ of 30.22°, 35.56°, 43.08°, 
57.48°, 63.08°. Superparamagnetic behaviour of bare and coated magnetic 
nanoparticles was observed by VSM with saturation magnetization of 75 emu/g and 45 
emu/g, respectively. The size of silica and CMCD coated particles were measured by 
TEM and the result showed the particles were in nano scale with an average diameter of 
29 nm. Moreover, the specific surface area of the silica and CMCD modified nano-
particles was calculated as 74 m
2
/g using BET (Chapter 4). 
These nano-sized magnetic particles were scrutinized for adsorption of certain chiral 
aromatic amino acid enantiomers namely, D- and L-tryptophan (Trp), D- and L-
phenylalanine (Phe) and D- and L-tyrosine (Tyr) from phosphate buffer solutions under 
different conditions (Chapter 5). Adsorption capacities of the coated magnetic 
nanoparticles toward amino acid enantiomers were in the order: L-Trp>L-Phe>L-Tyr 
and under the same condition, adsorption capacities were higher for L-enantiomers than 
the corresponding D-enantiomers. Structure and hydrophobicity of amino acid 
molecules emphasized the interactions between amino acid molecules and the nano-
adsorbents bearing cyclodextrin, thus played important roles in the difference of their 
adsorption behaviors. All the equilibrium adsorption isotherms were fitted well to 
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Freundlich model. Higher amount of adsorption for the amino acid enantiomers was 
observed at pH close to the isoelectric point. Adsorption study results at different 
temperatures showed that maximum amount of adsorption occurred at 25°C and the 
amount decreased as temperature increased. Kinetic study results showed that the 
adsorption process was governed by pseudo second order kinetics. FTIR studies 
depicted significant changes after adsorption of amino acids onto nanoparticles. The 
stretching vibration frequencies of N-H bonds of the amino acid molecules were 
changed with complex formation through host-guest interaction.  
These as-synthesized silica and CMCD functionalized Fe3O4 magnetic nanoparticles 
were utilized for enantioselective separation of racemic aromatic amino acid solution 
(Chapter 6). The magnetic nanoparticles preferentially adsorbed L-enantiomers of Trp, 
Phe and Tyr than the D-enantiomers and offered 94%, 73% and 58% enantiomeric 
excesses toward Trp, Phe and Tyr enantiomers, respectively. Hydrophobicities of the 
amino acids influenced interaction with cyclodextrin molecules to different degrees and 
thus resulted in different enantiomeric excesses. Several analytical techniques such as 
XPS and FTIR spectroscopy were applied to investigate the enantioselective 
mechanism and it was observed that hydrophobic portion of amino acid molecules 
penetrated into cyclodextrin cavity and amino group of the amino acid molecules 
formed hydrogen bonds with secondary hydroxyl groups of cyclodextrins. Flurometric 
studies also supported the observation of higher binding of CMCD to L-enantiomer 
compared to D-enantiomers.  Thus, the as-synthesized CMCD functionalized magnetic 
nanoparticles with all significant properties would have great potentials in chiral 
separation technologies. 
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Afterwards, synthesis of amino-CD (β-CDen) functionalized magnetic nanoparticles 
and characterization of the chemical, physical and magnetic properties of the magnetic 
nanoparticles were carried out (Chapter 7). FTIR results showed the presence of C=O 
stretching band, antisymmetric glycosidic νa(C–O–C) vibrations and the coupled ν(C–
C/C–O) stretch vibration, which indicated that surface of the magnetic particles was 
successfully functionalized with amino-CD. XRD patterns indicated that the 
composition of the coated magnetic nanoparticles was pure Fe3O4. The XRD patterns 
also showed the characteristic peaks at 2θ of 30.5, 35.9, 43.4, 53.4 57, and 63.1. It 
was observed that TDGA and CDen coated magnetic nanoparticles were 
superparamagnetic particles by VSM with saturation magnetization of 75 and 57.1 
emu/g, respectively. The size of TDGA-CDen coated particles were measured by TEM 
and the result showed the particles were in nano scale with an average diameter of 
around 11.5 nm (Chapter 7). 
Amino-CD functionalized magnetic nanoparticles were utilized for adsorption of two 
pharmaceuticals (carbamazepine, naproxen) and one EDC (bisphenol-A) (Chapter 7). 
Adsorption kinetics showed that the process could be explained by pseudo-second-order 
kinetics. Adsorption capacities of the coated magnetic nanoparticles toward the three 
above mentioned chemicals were in the order: carbamazepine> naproxen> bisphenol A 
(under the same conditions) and adsorption capacities were moderated by 
hydrophobicity of the target molecules. The equilibrium adsorption isotherms were 
fitted well to Freundlich model. For carbamazepine, there was not much effect of 
solution pH on the adsorption capacity. Whereas, for naproxen as solution pH 
increased, adsorption capacity decreased and for bisphenol A, adsorption capacity of 
the adsorbent decreased slightly in the range of pH 9-11. These results from adsorption 
study at different pH showed that adsorption was dependent on the ionization of 
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PhACs/EDC and CDen MNPs. FTIR studies of the nanoparticles after adsorption of the 
chemicals depicted significant changes in νCH2 bands which indicated that inclusion 
complex formation had occurred between the PhACs/EDC and β-CDen. Moreover, 
desorption study showed that around 80%, 75% and 89% desorption of CBZ, NAP and 
BPA from the magnetic nanoparticles surface was achieved using ethanol as eluent. 
Later part of this PhD project dealt with utilization of silica and carboxymethyl-β-
cyclodextrin functionalized Fe3O4 magnetic nanoparticles for adsorption of propranolol 
from aqueous solution. Effect of pH study results showed that adsorption capacities of 
the particles increased as solution pH increased and the behavior was dominated by 
hydrophobic interaction between propranolol and the nanoadsorbents. When compared, 
adsorption capacities of silica and carboxymethyl-β-cyclodextrin functionalized 
particles were found to be three times higher than that of bare particles. Results from 
kinetic studies showed that the adsorption process was very fast, adsorption equilibrium 
reached within 1 hr and the kinetics data followed pseudo-second-order model. 
Adsorption equilibrium data were fitted well to Freundlich adsorption isotherm thus 
showing heterogeneous adsorption. Furthermore, XPS and FTIR spectroscopy were 
applied to investigate the adsorption mechanism and it was found that the hydrophobic 
portion of propranolol interacted with the cyclodextrin cavity and nitrogen molecule 
was involved in hydrogen bond formation. High binding constant between propranolol 
and CMCD was obtained when analyzed with flurometric titrations which might have 
resulted in good adsorption capacity of the adsorbent.  Finally, desorption studies show 
that the nanoadsorbents could be regenerated using methanol solution and using 50% 
methanol solution almost complete regeneration of the adsorbent was achieved.  
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In summary, nano-sized magnetic particles were prepared by chemical precipitation 
method and further modification of the particles‟ surface was done successfully. These 
surface functionalized magnetic nanoparticles can be used for separation of chiral 
biomolecules and environmental pollutants. The unique chemical, physical and 
magnetic properties of magnetic particles, such as nano-size, superparamagnetism, large 
specific surface area, and easy manipulation of surface modification make them suitable 
tool for the separation of chiral biomolecules and environmental pollutants. The results 
displayed the merits of easy synthesis of sorbents, rapid analysis and reliable 
quantitative detection. Because of the increasing demand for pure compounds, efficient 
strategies for analytical and preparative separations of chiral biomolecules and 
pharmaceuticals, endocrine disruptors and beta-blockers are required. Nearly all aspects 
of this technology, including synthesis, adsorption and analysis, can benefit greatly 
from the use of magnetic nanoparticles. Therefore, it is clear that in near future a variety 
of new approaches for chiral separation and removal of pharmaceuticals, EDCs and 
beta-blockers based on superparamagnetic nanoparticle will be developed, and this 
work will be a part of the general trend in development of this methodology. 
 
9.2 Recommendations 
In this work, synthesis of magnetite coated with cyclodextrin derivatives has been 
demonstrated. These as-prepared magnetic nanoparticles have been successfully 
utilized for separation of chiral biomolecules and other environmental pollutants. This 
thesis work is only a preliminary study. There are also several interesting directions for 
future research in the field of chiral separation and separation of environmental 
pollutants. Proposed future works are: 
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9.2.1 Separation of chiral biomolecules: 
(a) In Chapter 6, enantioseparation of single and racemic aromatic amino acids was 
achieved utilizing CMCD coated magnetic nanoparticles. Adsorption study was focused 
on mainly three aromatic essential amino acids, tryptophan, phenylalanine and tyrosine 
since they are frequently used as food additives. Detailed adsorption study of these six 
amino acid enantiomers were time consuming too. Tests could not be carried out to 
study adsorption of other amino acids due to lack of time. Further work should be 
directed to study adsorption of single non-aromatic amino acids for example (D-/L-
alanine, D-/L-valine, D-/L-leucine, D-/L-isoleucine) and enantioseparation of racemic 
amino acids   (DL-alanine, DL-valine, DL-leucine, DL-isoleucine) etc. using 
cyclodextrin derivative conjugated magnetic nanoparticles. Investigation should be 
carried out to explore the adsorption mechanism of non-aromatic amino acids on 
CMCD coated magnetites. Moreover, regeneration possibilities of the modified 
magnetite should be studied.  
(b) Desorption/regeneration possibilities of single amino acids (L-/D-Trp, L-/D-Phe, L-
/D-Tyr) were verified in Chapter 5. Desorption of D-enantiomers were less compared to 
corresponding L-enantiomers which could eb due to less affinity of D-enantiomers to 
methanol. Some future work should be done using different desorbing agents (ethanol, 
IPA) and multiple desorption steps to increase regeneration possibilities. 
(c) One important characteristic of amino acid enantiomers are their optical rotation. 
After release of separated enantiomers of amino acids from magnetic nanoparticles‟ 
surface, purity of the enantiomers should be characterized using optical activity 
measurement. Optical rotation of racemic amino acids as well as pure enantiomers can 
be determined. After separation of chiral racemic amino acids, optical rotation of the 
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separated enantiomers can be measured and compared to that of pure enantiomers. 
Furthermore, measurements with circular dichroism can be utilized to verify the purity 
of separated enantiomers. 
(d) It has been observed that for chiral drugs, there may be three to five stereoselective 
receptors, each of which triggers a different physiological response. The use of specific 
isomers could allow one to elicit more exact therapeutic effects. It is true for 
approximately 25 percent of pharmaceutical products; only racemic mixtures of 
propranolol and methadone are available for clinical use while rest of the 
pharmaceuticals should be used in pure enantiomeric form. Thus chiral resolution of 
racemic drugs should be studied utilizing the CD modified magnetite nanoparticles. 
(e) Enantioseparation was studied in low concentration of the aromatic amino acids (2 
mM) and method for quantification was done using HPLC in abovementioned 
concentration. Future work should focus on developing a method to quantify 
enantioseparation of amino acids in high concentration level (> 2mM).  
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9.2.2Removal of environmental pollutants: 
 
(a) In Chapter 7, adsorptive removal of two pharmaceuticals (carbamazepine, naproxen) 
and one EDC (bisphenol A) using amino-CD conjugated magnetic nanoparticles were 
done. Presence of hundreds of organic and inorganic pollutants has been reported in 
water along with the microbial population. It is found that some organic pollutants and 
metal ions are not biodegradable and biotransformable hence they persist in 
environment. Toxic organic pollutants include pesticides, phenols, polynuclear aromatic 
hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), plasticizers, and drug 
residues whereas toxic metal ions include arsenic, cadmium, platinum and chromium. 
Some researchers have worked on development of low cost adsorbents for removal of 
these pollutants from waste-water [462]. Advance works should be done utilizing 
cyclodextrin modified magnetite for removal of other toxic organic pollutants and toxic 
metal ions applying magnetic separation technique.  
(b) In this thesis, desorption study was done for removal of CBZ, NAP and BPA from 
aqueous water. Adsorption-desorption studies of the pharmaceuticals and EDC from 
cyclodextrin modified magnetic nanoparticles should be carried out in few cycles and 
recyclability of the particles should be checked. Recyclability of the magnetic 
nanoparticles depends on the desorption condition. Generally desorption is carried out 
either using some other chemical which has high affinity toward the sorbate or by 
changing the operating condition (temperature/ pressure). After desorption, surface 
properties of the magnetic nanoparticles can be examined using different analytical 
techniques (XPS spectroscopy, FTIR spectroscopy etc). To protect the magnetic core 
and improve regeneration possibility of the magnetic nanoparticles, carbon layer can be 
deposited on the magnetic core which will increase chemical and thermal stability of 
the particles. 
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9.2.3 Multifunctional nanoparticles: 
In recent years, the advent of multifunctional nanomaterials attracted enormous interest 
of biomedical research community. Rational combination of diverse building blocks 
such as metallic or semiconductor nanomotifs, organic molecules/polymers, 
biomolecules give rise to composite nanomaterials which exhibit a wide range of 
diagnostic and therapeutic capabilities; bioimaging, specific cell targeting, drug storage 
and controlled drug release etc., rendering them extremely intriguing and promising in 
biomedical research. Magnetic nanoparticles evidently are becoming prominent 
inorganic building blocks of such multifunctional nanocomposites because colloidal 
magnetic nanoparticles (MNPs), typically iron oxide (Fe3O4), exhibit 
superparamagnetism which can respond to external magnetic field. The fact that these 
superparamagnetic materials do not retain any magnetization after removal of the 
external magnetic field, and thus avoid aggregation, is a clear advantage for any in vivo 
application. Silica, (SiO2) has been extensively utilized as a coating material of MNPs, 
providing Fe3O4@Silica core-shell nanocomposites, because silica is known to have 
low-toxicity and is less prone to degradation in biological environment. Recently we 
have developed silica based multifunctional magnetic nanoparticles 
[Fe3O4@SiO2(FITC)-FA/CMCD NPs] which can be effectively used in fluorescence 
imaging, specific cell targeting and hydrophobic anticancer drug delivery. Confocal 
microscopic imaging studies show that the Fe3O4@SiO2(FITC)-FA/CMCD NPs could 
specifically target cancer cells due to the high expression of folate receptor on cancer 
cells such as HeLa cells. These Fe3O4@SiO2(FITC)-FA/CMCD nanoparticles should be 
used as an efficient adsorbent in controlled drug release applications. 
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9.2.4 Magnetic nanoparticles for separation of bio-molecules and waste-
water purification in large scale using High Gradient Magnetic Separation 
(HGMS) system: 
Future trend on magnetic separation should focus on large scale operation. High 
gradient magnetic separation (HGMS) for separation and purification purposes can be 
developed.  
Separation of chiral bio-molecules, pharmaceuticals (PhACs) and EDC utilizing 
magnetic nanoparticles has not been studied extensively in large scale utilizing 
magnetic nanoparticles. So, further work should be done on separation of bio-molecules 
in large scale operation using HGMS system. However, recycling of waste-water has 
always been expensive. Hence, magnetic separation should be applied to removal of 
pharmaceuticals, EDC from waste-water on a practical use scale. In the conventional 
methods (mainly biological decomposition process) large-scale equipment is necessary 
to process a large amount of waste-water and hence a large amount of capital 
investment is needed. Even if the sewage system is used, large expense for usage of the 
sewage is required.  
Figure 9-1 shows the possible use of HGMS system for chiral separation and removal 
of PhACs and EDC from waste-water. For HGMS system, the magnetic seeding 
technique can be developed for chemical species [463]. Magnetic seeding is a technique 
that the ferromagnetic particles are attached to the chemical species and then enable to 
separate them magnetically. This technique is called a colloid chemical method. For the 
large scale separation and purification purpose, magnetite nanoparticles can be 
synthesized first from iron oxides. The synthesized magnetite will absorb the chemical 
species and will form flocs. On the other hand, ferromagnetic filaments (magnetic filter) 
can be arranged in the magnetic field, and a high gradient magnetic field can be 
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generated in the neighbourhood. Though higher gradient of magnetic field can be 
generated by thinner magnetic filter, the achieved area is supposed to be small. For this 
purpose, 40-50 magnetic filters axially stacked in the superconducting magnet bore can 
be used. The system can be designed to wash the magnetic filter without discharging 
the magnet. The magnetic filter should have diameter large enough to withstand the 
magnetic force. The magnetic filter should endure hydraulic force for a long term. Thus, 
thickness of the ferromagnetic filament should be fat from the viewpoint of mechanical 
strength. 
 
In the magnetic separation system, ferromagnetic particles will be attached to chemical 
species in seeding tank. As the larger sized magnetic seeded flocs sediment in a short 
time, the separation tank where the floc precipitates should be installed. Afterwards the 
remaining water containing biomolecules, PhAC/ EDC will be introduced into the 
superconducting magnetic separation unit, and a magnetic separation is performed. For 
advanced separation process, second magnetic seeding tank can be installed. This 
process has been depicted in Figure 9-1. 
  






Figure 9-1 Overview of HGMS system [463].
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